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ABSTRACT 
 
Stem cell therapies and tissue engineering strategies are required for the 
clinical treatment of respiratory diseases. Previous studies have established protocols 
for the differentiation of airway epithelium from stem cells but have involved costly 
and laborious culture methods.  The aim of this thesis was to achieve efficient and 
reproducible maintenance and differentiation of embryonic stem cells to airway 
epithelium, in 2D and 3D culture, by developing appropriate bioprocessing 
technology.   
 
Firstly, the 2D differentiation process of human and murine ES cells into 
pulmonary epithelial cells was addressed.  The main finding in was that the 
proportion of type II pneumocytes, the major epithelial component of the gas-
exchange area of lung, differentiated with this method was higher than that obtained 
in previous sudies, 33% of resultant cell expressed the specific marker surfactant 
protein C (SPC) compared with up to 10%.   
 
Secondly, the maintenance and differentiation was carried out in 3D. A 
protocol was devised that maintained undifferentiated human ES cells in culture for 
more than 200 days encapsulated in alginate without any feeder layer or growth 
factors.  For ES cell differentiation in 3D, a method was devised to provide a 
relatively cheap and simple means of culture and use medium conditioned by a 
human pneumocyte tumour cell line (A549). The differentiation of human and murine 
ES cells into pulmonary epithelial cells, particularly type II pneumocytes, was found 
to be upregulated by culture in this conditioned medium, with or without embryoid 
body formation.   
 
The third step was to test whether this differentiation protocol was amenable 
to scale-up and automation in a bioreactor using cell encapsulation. It was possible to 
show that encapsulated murine ES cells cultured in static, co-culture or rotating wall 
bioreactor (HARV) systems, differentiate into endoderm and, predominantly, type I 
and II pneumocytes.  Flow cytometry revealed that the mean yield of differentiated 
type II pneumocytes was around 50% at day 10 of cultivation.  
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The final stage of the work was to design and produce a perfusion system 
airlift bioreactor to mimic the pulmonary microenvironment in order to achieve large 
scale production of biologically functional tissue.  The results of these studies thus 
provide new protocols for the maintenance of ES cells and their differentiation 
towards pulmonary phenotypes that are relatively simple and cheap and can be 
applied in bioreactor systems that provide for the kind of scale up of differentiated 
cell production needed for future clinical applications. 
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regulates the differentiation and undifferentiation of the 
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comparison, in vivo embryogenesis towards the 
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E9.5 to 10.  Transcription factors (Pax8, TTF1, Pdx1 and 
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trachea at E9.5 to 10 as the early bud evaginate into the 
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surfactant protein B (SPB) precursor protein and 
surfactant protein C (SPC) are transported to 
multivesicular bodies and, after proteolytic processing, 
stored in lamellar bodies.  SPB and SPC and surfactant 
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active surface film is required to maintain lung volumes, 
thereby preventing atelectasis and respiratory failure. 
(Adapted from: Whitsett and Weaver, 2002; Mallery, 
2005) 
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Figure 4.1 At day 10 in SAGM culture, the human EBs attached to 
the Petri dish and started forming mixed culture 
populations, including fibroblast-like cells (a and b) and 
neuron-like cells (c) (n=3). After 15 days in culture the 
differentiated cells looked flatter and more epithelium-
like (d) (n=3). 
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Figure 4.2 Projections from the differentiated human ES cell 
colonies were observed (a and b).  These long finger-like 
sprouts may have indicated early formation of endothelial 
cells or connections between neighbouring colonies (c 
and d) (n=3).   
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Figure 4.3 In A549-conditioned medium, at the early stage the EBs 
showed formation of the germ layers (a) and some started 
to attach to the Petri dish (b).  The attached cells grew 
flattened in shape and, after a few days, formed confluent 
monolayers (c) with cobblestone appearance (n=3).  At 
the end of day 30, the cells formed ring-like structures on 
the Petri dish (d and e) (n=2). 
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Figure 4.4 The formation of the typical three germ layers; endoderm, 
mesoderm and ectoderm (Joza et al., 2001; Dang et al., 
2002; Koika et al., 2007) day 2-3 murine EBs was 
observed when cultured in A549-conditioned medium (a 
and b) (n=5).  Also the cobblestone appearance of the 
monolayer culture was also observed (c). At the end of 
day 30, the cells showed formation of endothelium-like 
cells (d and e) (n=3). 
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Figure 4.5 Differentiated human ES cells at day 30 in SAGM culture 
condition (a) and in A549-conditioned medium (b-e) 
showed positive proSPC expression [positive FITC-green 
(Fluorescein isothiocyanate) expression counterstained 
nuclei with PI-red (propodium iodide)] (n=4).   
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Figure 4.6 Expression of SPB (a), CC10 (b), AQP5 (c and d) was 
detected in human ES cells cultured in A549-conditioned 
medium at day 30 [positive FITC-green expression nuclei 
counterstained blue with DAPI (4',6-diamidino-2-
phenylindole)] (n=3). Differentiated murine ES cells at 
day 15 in A549-conditioned medium showed proSPC 
expression (positive FITC-green [Fluorescein 
isothiocyanate] expression), nuclei counterstained blue 
with DAPI (e) (n=3).   
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Figure 4.7 TEM showed undifferentiated human ES cells with no 
obvious cytoplasmic organelles (a). Human ES cells 
cultured in SAGM showed mitotic activity (b) with 
obvious chromatin (black arrow) probably in the late 
anaphase process. Other important features which indicate 
type II pneumocyte formation are the numerous microvilli 
(mv) (c-f) and lamellar bodies (LB) (d-f) (n=1). 
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Figure 4.8 Human ES cells cultured in A549-conditioned medium 
showed frequent gap junction complexes (a), with 
desmosomes (blue arrow) at the margins of neighbouring 
cells (a,c). Other typical characteristics that were seen 
include microvilli (mv) (a-c), mitochondria (mc) (c) and 
lamellar bodies (LB) (c).  Mitotic activity with obvious 
chromatin (black arrow) was also observed, probably 
indicating the late anaphase process (e) (n=2). 
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Figure 4.9 Other cytoplasmic contents that were observed in the 
human ES cells cultured in A549-conditioned medium are 
numerous multivesicular bodies (mvb) (a), lamellar 
bodies (LB) (b,c), the rough endoplasmic reticulum (rer) 
(c), mitochondria (mc) (c),  lysosomes (d) and microvilli 
(mv) (e).   Features of Clara cells were also observed 
including abundant electron-dense granules (gr) (c,d).   
Other cells contained cilia bodies (f), indicative of the 
epithelium of proximal airways (n=2).   
 
124 
Figure 4.10 Murine ES cells cultured in A549-conditioned medium 
showed morphological changes similar to those observed 
in human ES cells, with formation of lamellar bodies 
(LB) (a) and microvilli (mv) (b), typical features of type 
II pneumocytes (n=1). 
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Figure 4.11 RT-PCR results on day 10, 20 and 30 of human ES cell 
differentiation in A549-conditioned medium show 
expression of SPC, SPB, CC10 and AQP5 mRNAs (n=3). 
Positive Oct 4 expression confirmed the pluripotency of 
the human ES cells at day 0 in the conditioned media. 
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Figure 4.12 Expression of SPC and AQP5 RNAs was detected in 
murine ES cells grown in A549-conditioned medium 
(n=5). Positive Oct 4 expression comfirmed the 
pluripotency of the murine ES cells at day 0 in 
conditioned medium. 
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Figure 4.13 The 2D scatter plot [SS (side scatter) vs FS (Forward 
Scatter)] showed the differentiated murine ES cells to be a 
homogeneous population (a). The scatter plot analysis 
showed as single parameter histogram, quantified the 
SPC-expressing cells as 32.41%±2.1 (mean±SD) of the 
population (c and d) and AQP5 as 4.5%±2 (mean±SD) (d 
and e) (b = negative control) (n=2).   
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Figure 5.1 Human ES cells growing on (a) feeder MEFs (n=10) and 
(b) feeder-free laminin (n=2) and (c&d) in alginate beads 
(n=10). 
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Figure 5.2 (a&b) In the early stage of encapsulation, some 
aggregates showed finger-like outgrowths.  (c&d) In 
prolonged culture, the shape of the aggregates remained 
oval or elongated as seen at day 210 (c). After 
decapsulation and culture in 2D, the aggregates showed 
spontaneous differentiation (d) with a morphology similar 
to that of a routinely cultured ES cell colony (n=5). 
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Figure 5.3 110 day old human ES cell aggregates resembling a day 4 
embryoid body without formation of germ layers or cystic 
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cavities. (a) Tightly packed cells within the aggregates 
were viable, even when the aggregates reached a size of 
400–500 mm (b) Live cells are distinguished by the 
presence of ubiquitous intracellular esterase activity, 
producing a bright green fluorescence (n=3). 
 
Figure 5.4 
 
Human ES cell aggregates without formation of three 
germ layers; endoderm, mesoderm and ectotoderm (Joza 
et al., 2001; Dang et al., 2002; Koika et al., 2007) and 
embryonic cavities observed at day 30 (a), 130 (b), 160 (c 
and d), 180 (e) to 210 (f) of culture immediately 
following decapsulation (n=7). 
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Figure 5.5 The human ES cell aggregates maintained their 
cohesiveness after decapsulation.  Aggregates at day 130 
(a) after decapsulation appear similar to 2 day old 
aggregates (b) (n=7). 
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Figure 5.6 At day 110 of culture, the alginate beads were dissolved 
and the human ES cell aggregates were released. 
Immunoreactivity for Oct-4 (a), SSEA-4 (b), TRA-1-60 
(c) and TRA-1-81 (d) was observed. The positive controls 
(insets – a’, b’ c’, and d’) demonstrate expression of the 
pluripotency markers in day 1 human EBs, whereas the 
negative controls (insets – a’’, b’’, c’’, and d’’) confirmed 
the specificity of the immunostaining by showing no 
staining when primary antibodies were omitted (n=3).  
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Figure 5.7 RT-PCR results confirmed expression at significant and 
constant levels of Oct-4 and Nanog RNAs throughout the 
culture time up to 260 days.  Sox2, h-TERT, UTF1, Rex2 
and DPPA5 RNAs (a) were also expressed (n=4). There 
was a lack of expression of germ layer markers; 
specifically AFP (endoderm-derived marker) and MAP2 
(ectoderm-derived marker) were not expressed throughout 
the culture period of 260 days (b). No expression of 
mFGF12 was detected throughout the culture period 
which indicates no possible animal contamination (c). 
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Figure 5.8 Beads at 110 days of culture were dissolved and the 
human ES cell aggregates attached to the culture plate. 
After a few days, fibroblast-like structures started to grow 
outwards from the aggregates (a).  The colonies were 
immunoreactive for TRA-1-60 (b) and alkaline 
phosphatase (c and d), which suggested that they maintain 
their ES cell pluripotency (n=3). 
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Figure 5.9 Human ES cell aggregates were also able to differentiate 
into neurons with typical dendrite morphology (a&b), 
chondrocytic lineage (c), as indicated by the Safranin O 
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(d) and Alcian Blue (e) staining, and pneumocytes, shown 
by their immunoreactivity for SPC (green; nuclei were 
counterstained with propidium iodide; red)(f) (n=3). 
 
Figure 5.10 TEM showed that undifferentiated encapsulated human 
ES cells, which grew in clusters, lacked cytoplasmic 
organelles (a and b).  In contrast, decapsulated human ES 
cells at day 110 directed to differentiate into type II 
pneumocytes showed numerous lamellar bodies and 
apical microvillus formation when culture in SAGM 
medium, the typical morphology of type II pneumocytes 
(c) (n=1).  
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Figure 6.1 After 8 days in co-culture with A549 cells, the single 
murine ES cells encapsulated in alginate started to form 
numerous small, elongated aggregates (a) as seen under 
the inverted microscope. By the end of day 20, the 
aggregates had grown larger and filled up the entire bead 
(b) (n=3). 
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Figure 6.2 Examination of the histology of cross sections of fixed 
beads at day 11 of co-culture with A549 cells revealed the 
formation of tree-like structures from the differentiating 
murine ES cells that branched out towards the periphery 
of the beads (a-c).  In contrast, the ES cells grown in 
A549-conditioned medium showed only aggregates at the 
same day (day 11) (d) (n=3).  
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Figure 6.3 Haematoxylin and eosin staining of cross sections of 
fixed beads showed discrete distribution of the aggregates 
of differentiated murine ES cells following 10 days of co-
culture with A549 cells.  There are some connective 
tissue-like structures (arrows) that appear to be holding 
the aggregates together (a, b) (n=3). (c) Shows a similarly 
stained section of adult murine lung for comparison. 
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Figure 6.4 Phalloidin (Rhodamine-red) attachment showed the 
distribution of actin revealing that the cells grew in close 
contact and formed aggregates or colonies at day 15 in the 
co-culture system (a).  Immunocytochemistry showed the 
presence of SPC (FITC-green) in the differentiated 
murine ES cells at day 15 of co-culture with A549 cells 
(b).  Nuclei were counterstained blue with DAPI (n=3). 
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Figure 6.5 TEM demonstrated the typical features of type II cells 
with formation of lamellar bodies and microvilli (a), 
engorged rough endoplasmic reticulum (rER) (b) and 
abundant electron dense lamellar bodies (LB) (c,d) (n=2). 
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Figure 6.6 TEM showed typical electron-dense cytoplasmic 178 
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organelles related to surfactant component metabolism, 
including rough endoplasmic reticulum (rER), Golgi 
apparatus (G) and numerous mitochondria (m) and 
lamellar bodies (LB) (a-d). Junction complexes were also 
seen, with desmosomes (arrow, b) at the margins of 
neighbouring cells, indicating cell-cell communication 
between epithelial cells (n=2). 
 
Figure 6.7 RT-PCR results for murine ES cells at days 10 and 20 of 
co-culture with A549 cells (Co-culture) or growth in 
A549-conditioned medium (Conditioned medium). 
Expression of mRNAs for Foxa2 (endoderm), SPC (type 
II pneumocytes) and AQP5 (type I pneumocytes) was 
noticeably higher at day 10 in both the culture conditions. 
However, the expression of AQP5 phenotype was 
constant over time and in both culture conditions (n=3). 
Key: Foxa2; forkhead transcription factor; SPC: 
surfactant protein C; AQP5: aquaporin 5; GAPDH: 
Glyceraldehyde 3-phosphate dehydrogenase; +ve: adult 
lung mRNA, -ve: water 
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Figure 6.8 De-capsulated murine ES cells were plated back onto T75 
flasks following 20days co-culture with A549 cells to 
grow in 2D culture for 10 days/2 passages. After 3 days, 
the cells had formed homogeneous flat and cobblestoned 
monolayers typical of epithelium (a).  Using 
immunostaining, it was possible to show expression of 
proSPC (green) confirming retention of the type II 
pneumocyte phenotype (b).  Nuclei were counterstained 
with DAPI (n=3). 
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Figure 7.1 Single cells were encapsulated (a) and after 10 days (b) 
the single cells started to form small aggregates that grew 
larger over time, as shown on days 20 (c), 25 (d) and 30 
(e) in A549-cultured medium (n=5). 
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Figure 7.2 A high level of viability (live cells-green, dead cells-red) 
was seen in cells observed at days 5 and 10 of culture in 
conditioned medium, but was found to decrease from day 
15 onwards [Figure 5.2 a (phase), a’(green-live cells), 
a’’(red-dead cells].  Cells grown in beads in maintenance 
medium (control) formed aggregates and were still viable 
(green) until day 30 in culture (Figure 5.2 b, b’, b’’) 
(n=3). 
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Figure 7.3 Cross-sections of beads cultured in conditioned medium 
showed (a, b) large cell aggregates accumulated around 
the border of the beads and there were not many cells at 
the core.  As showed from haematoxylin and eosin 
staining, the aggregates survived longer in culture, they 
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grew bigger in size and some showed branching or 
budding (c, d) (n=3).   
 
Figure 7.4 Immunocytochemistry showed that cells within beads 
grown in A549-conditioned medium expressed pro-SPC 
(immunostaining: FITC-green) at day 15.  Sections were 
stained with phalloidin (red) to show actin in the 
cytoskeleton and DAPI (blue) for the nuclei (a).  Small 
aggregates were formed at day 10 that filled entire beads 
by day 15 (b) (n=3). 
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Figure 7.5 TEM showed that the cells in beads cultured in 
conditioned medium migrated to the surface of the beads 
formed a thin monolayer surface that stretched along the 
whole surface of the bead (a, b) while the cells underneath 
showed signs of degeneration (dg) (n=2). 
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Figure 7.6 No obvious formation of cytoplasmic organelles was seen 
in cells grown in beads for 15 days in the maintenance 
medium (control) (a). In contrast, the typical features of 
type II with abundant lamellar bodies (LB) and type I 
pneumocytes with microvillus formation (mv) were 
observed, in encapsulated murine ES cells grown in 
A549-conditioned medium for 15 days (b-d) (n=2).  
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Figure 7.7 (a-d) TEM revealed the presence of a range of 
cytoplasmic organelles in encapsulated murine ES cells 
grown in A549-conditioned medium, including lamellar 
bodies (LB), rough endoplasmic reticulum (rER), Golgi 
apparatus (G), numerous mitochondria (mc) and oval to 
round electron-dense bodies of lysosomes (Ly) (n=2).   
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Figure 7.8 (a-c) On TEM, a mixture of lysosomal (Ly), 
multivesicular bodies (arrow) and lamellar bodies (LB) 
was observed indicating a form of transformation from 
one structure to another to form a functional organelle 
(n=2). 
 
201 
Figure 7.9 RT-PCR results confirmed the differentiation of 
endoderm (FoxA2 RNA) as well as that of pneumocytes; 
SPC RNA (type II) and AQP5 RNA (type I).  The 
expression of SPC was observed at day 10 culture in 
conditioned medium and had reduced by day 20 while 
expression of SPA and AQP5 was maintained throughout 
the whole culture period (n=3).   
Key: GAPDH- Glyceraldehyde 3-phosphate 
dehydrogenase; +ve :whole lung RNA; -ve: water; 
FoxA2: forkhead box A2; SPC: surfactant protein C; 
SPA: surfactant protein A; AQP5: Aquaporin 5. 
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Figure 7.10 (a,b) Alginate beads were dissolved and the decapsulated 
single cells were grown as monolayer in basic 
maintenance medium showed homogeneous flat and 
cobblestoned shape. Immunostaining demonstrated 
expression of proSPC (FITC-green) (b) (n=2). 
 
203 
Figure 8.1 At day 10, small cell aggregates were visible in beads 
cultured in either maintenance medium (a) or A549-
conditioned medium (b). The size of the aggregates 
increases as seen in day 15 manienance medium (c) and 
conditioned medium (d).  At day 20, the cell aggregates 
grown in beads in maintenance medium were very large 
with an additional dark or dense spot at the core which 
indicates degeneration or apoptosis (e).  Aggregates in 
beads cultured in A549-conditioned medium started to fill 
the entire bead, becoming crowded and difficult to 
observe (f) (n=5).   
 
225 
Figure 8.2 Haematoxylin and eosin stain of cells in day 20 beads 
cultured in the A549-conditioned medium shows huge 
cell aggregates that were dispersed within the beads (a 
and b).  Immunocytochemistry demonstrated pro SPC 
(FITC; green) expression counterstained with phalloidin 
to show actin (red) for cytoskeleton and DAPI for the 
nuclei (blue) at day 10 conditioned medium in HARV 
bioreactor (c) (n=3).  
 
226 
Figure 8.3 Flow cytometry detected proSPC-expressing cells, 
10.8%±1.9 (mean±SD) of the total cell population and 
AQP5 2.17%±0.76 as early as day 5 of culture in 
conditioned medium. At day 7, the proportion had 
increasesd to 36.7%±1.39 for proSPC expression and 
3.86%±1.34 for AQP5 expression (a, b, c).  However, the 
highest proportion of proSPC-expressing cells was 
detected at day 10 with 51.1%±4.4.  The proportion of 
cells expressing AQP5 form day 5 to 15 varied between 
2.17%±0.76 and 6.88%±1.18 (n=3). 
 
227 
Figure 8.4 TEM revealed the presence of the typical electron-dense 
cytoplasmic organelles of surfactant metabolism, 
including rough endoplasmic reticulum ER (rER), Golgi 
apparatus (G), numerous mitochondria (mc) and lamellar 
bodies (LB) (b and c) at day 7 conditioned medium 
cultivated in HARV. TEM of ES cells cultured in 
maintenance medium did not show any significant 
cytoplasmic organelles but apoptotic bodies (Ab) were 
observed (a). Another interesting finding of the 
differentiated cells within the bead was the observation of 
cytoplasmic lamellar bodies directing towards the surface 
of the epithelial layer or the surface microvilli (d) (n=2). 
228 
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Figure 8.5 Other cytoplasmic organelles observed on TEM of the 7 
day old cells cultivated in conditioned medium in HARV, 
include oval to round electron-dense bodies of lysosomes 
(Ly) (a) and electron-dense multivesicular bodies (mvb) 
(c and d). Lipid droplets (Lp) were also seen (d) (n=2).   
 
229 
Figure 8.6 Aggregates that escape and emerged from the surface of 
the alginate hydrogel also demonstrated similar 
observation with more abundant lamellar bodies filling 
most of the cytoplasmic space (a-d) with microvilli (mv), 
lamellar bodies (LB), lysosomes (Ly), multivesicular 
bodies (mvb), rough endoplasmic reticulum (rER) (n=2). 
230 
 
Figure 8.7 
 
Three zones could be distinguished in the cell aggregates 
that demonstrate the transformation of undifferentiated 
ES cells into type I and II pneumocytes (a).  The first 
zone consisted of undifferentiated cells. The second 
contained cells with mitotic processes (mito). The third 
zone had an outer epithelial lining that consisted of cells 
with short and long microvilli  (mv) (a-c) and the cells 
beneath it were cuboidal cells with abundant lamellar 
bodies (d and e), lysosomes (Ly) and multivesicular 
bodies (mvb) (n=2). 
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Figure 8.8 RT-PCR results confirmed the expression of endoderm 
(FoxA2 mRNA) as well as RNAs for SPC (marker for 
type II pneumocytes), AQP5 (type I pneumocytes) and 
CCSP (Clara cells) in encapsulated murine ES cells 
cultivated in the HARV integrated system (n=4).  
Key: Foxa2: forkhead transcription factor; SPC: 
surfactant protein C; AQP5: aquaporin 5; CCSP: Clara 
cell secretory proteinGAPDH: Glyceraldehyde 3-
phosphate dehydrogenase; +ve: adult lung mRNA, -ve: 
water 
 
232 
Figure 8.9 To analyse the functionality of the differentiated cells, 
encapsulated cells from day 10 conditioned medium 
cultivated in HARV were decapsulated and cultured as 
2D. TEM confirmed the typical features of type II 
pneumocytes with abundant lamellar bodies (LB), 
microvilli (mv) and tonofilaments (tono), lysosomes (Ly) 
and mutivesicular bodies (mvb) (a-d) (n=2).   
 
233 
Figure 8.10 De-capsulated individual cells were plated onto T75 
flasks to grow as monolayers or 2D cultures. The 
decapsulated cells showed homogeneous flat and 
cobblestone shape (a).  Immunostaining showed proSPC 
expression in the monolayer cells (b) and RT PCR 
confirmed the expression of SPC mRNA following a few 
234 
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passages (c) (n=3). 
 
Figure 8.11
  
Flow cytometry analysis demonstrated that 40.09% ±0.14 
(mean ±SD) of the cells in 2D culture expressed proSPC 
(a) and 4.41% ±0.41 expressed AQP5 (b) (n=3).    
 
235 
Figure 8.12 SEM showed the presence of two different types of cells 
on the monolayer cells (decapsulated from HARV 
culture), the flat type I pneumocytess and the dome-
shaped type II pneumocytes (a). The surface of the culture 
was covered with homogeneous, flat cells with elongated 
morphology that looked like polygonal network with 
numerous short microvilli (black circle) (a,b). There were 
also junctional complexes (c-green arrow) between 
individual cells that indicated cell-to-cell contacts and 
interaction.  Budding or protrusion from the surface of the 
lining cells was observed and believed to be the evidence 
of lamellar body exocytosis to the external surface (black 
and white arrow) (c,d, e) (n=2).   
 
236 
Figure 8.13 Lamellar body exocytosis was observed with 
LysoTracker (LTG; green) and FM1-43 (a).  Fluorescence 
resulted from accumulation of LTG in pre-exocytotic 
lamellar bodies. FM1-43 stained lamellar content (arrow) 
after fusion with plasma membrane.  This evidence 
corresponds with that obtained on TEM analysis showing 
protrusion of lamellar bodies and lipids from the cell 
surface (b-d) (n=3).  
 
237 
Figure 9.1 The complete prototype of the airlift bioreactor, design 
from SolidWorks 2005 SP3 ®.   
 
257 
Figure 9.2 The body or the vessel of the airlift reactor according to 
the specific measurements (in millimetres). 
 
258 
Figure 9.3 Figure shows the inner tube or the draught tube according 
to the specific measurements (in millimetres). 
 
259 
Figure 9.4 Figure shows the gas sparger connector located at the 
bottom of the vessel or body according to the specific 
measurements (in millimetres). 
 
260 
Figure 9.5 Figure shows the perforated gas sparger insert located in 
the connecter according to the specific measurements (in 
millimetres). 
 
261 
Figure 9.6 Schematic representation of the perfusion airlift 
bioreactor 
 
262 
Figure 9.7 The complete set-up of the perfusion system located in an 263 
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incubator at a temperature of 37oC in 5% (v/v) CO2 and 
19% (v/v) oxygen. 
 
Figure 9.8 Geometrical dimensions of the airlift bioreactor 
 
264 
Figure 9.9 The figure showed the full measurements of the vessel 
with the lid, draft tube and gas sparger connected 
 
265 
Figure 9.10 Encapsulated A549 cells cultivated at day 4 in the HARV 
(a) and airlift (b) bioreactors were predominantly 
separate.  At day 10, most of the cells grown in the 
HARV had aggregated (c) but those in the airlift 
bioreactor still remained mainly separate (d) (n=2).   
 
266 
Figure 9.11 The results of the viability assay showed an increment 
over time in the numbers of live A549 cells cultivated in 
the HARV bioreactor.   A similar overall increase in cell 
numbers was obtained with the airlift bioreactor (AL) but 
a more linear rise occurred.  Statistical analysis showed 
significance differences at day 4 (P<0.01**), day 6 
(P<0.05*) and day 10 (P<0.01**) between the results 
obtained with the HARV and airlift (AL) bioreactors 
(n=2).  
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CHAPTER 1 
INTRODUCTION 
__________________________________ 
 
1.1 Tissue engineering: stem cell sources and strategies  
 
Tissue engineering has been described in several articles published in the 
1990s by two leaders in the field, Langer and Vacanti, as ‘the persuasion of the body 
to heal itself, through the delivery to the appropriate sites of molecular signals, cells, 
and supporting structures’. Since then, the phrase ‘tissue engineering’ has been used 
globally to describe one of the major components of regenerative medicine, which 
follows the principles of cell transplantation, material sciences and engineering (Atala, 
2007) with the ultimate clinical goal of creating a functional tissue for implantation in 
patients, to replace or repair damaged, diseased, or aged tissues (Pancrazio et al., 
2007).  The most common concept underlying tissue engineering is the combination 
of a scaffold or matrix, living cells and/or biologically active molecules to form a 
'tissue-engineered construct' to promote the repair and regeneration of tissues 
(Hutmacher and Garcia, 2005).  Furthermore, to achieve large scale tissue structures 
there must be appropriate transport of nutrients to and waste from the cells as they 
begin to form a tissue or organ (Lavik and Langer, 2004). In order for any engineered 
tissue to be effective, it must contain sufficient cells that remain functional over 
clinically relevant time periods (Petersen and Niklason, 2007).   
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One promising area of interest in regenerative medicine and tissue engineering 
is the use of stem cells, whether derived from embryos, fetuses, or adults, that present 
an important cell source for the derivation of potentially ‘younger’ and more 
functional cell populations. Somatic (or adult) stem or progenitor cells are capable of 
substantial expansion but these cells are difficult to obtain from many tissues.  
However, pluripotent or totipotent embryonic stem cells can be expanded indefinitely, 
although their differentiation fate can be difficult to control (Petersen and Niklason, 
2007).   
 
The use of stem cells has the potential to alter significantly the perspective of 
tissue engineering.  Successful long-term restoration of continuously self-renewing 
tissues, for example the skin (Ruszczak and Schwartz, 2000; Pellegrini et al., 1999), 
depends on the use of extensively self-renewing stem cells. The list of tissues that 
could be engineered is growing steadily. This is due in large part to recent progress in 
stem cell biology and recognition of the unique biological properties of stem cells 
(Bianco and Robey, 2001). 
 
Pilot studies made in a variety of systems, including blood vessels (Kocher et 
al., 2001; Jackson et al., 2001), cartilage (Johnstone and Yoo, 1999), bone (Bruder et 
al., 1998; Krebsbach et al., 1998; Petite et al., 2000; Kon et al., 2000), nerves 
(Bjorklund, 2000), highlight great prospects for future stem cell-based tissue 
engineering. However, translation of these studies into clinical reality has been 
reached so far in only a few areas and notably only in those areas in which there has 
been long-standing insight into stem cell biology (Bianco and Robey, 2001). 
 
Appreciation of the inherent diversities of organ systems and cognate stem 
cells is essential for development of adequate strategies of intervention in specific 
areas. With the prospect of stem cell-mediated gene therapy, the very definition of 
tissue engineering evolves into engineering of tissue function (Bianco and Robey, 
2001). Today, stem cell-based approaches to tissue reconstruction open unpredicted 
applicable and market opportunities but enthusiasm over what unquestionably 
represents a markedly innovative technique with huge therapeutic potential must be 
balanced against stringent standards of scientific and clinical investigation. In 
addition, we must remain aware of the wide range of basic and applied issues 
 31
associated with each system, with the targeted problems, and with the predicted 
solutions (Bianco and Robey, 2001). 
 
From a tissue engineering angle, the derivation of stem cell-based constructs 
can be summarized into five broad strategies (Chai and Leong, 2007) as shown in 
Figure 1.1.  Firstly, and most commonly, stem cells can be amplified by ex vivo 
expansion and differentiated into the target cell type before being seeded onto an 
appropriate scaffold.   Secondly, stem cells can be amplified and differentiated in situ 
on the scaffold before implantation.  This applies mostly for adult stem cells.  In the 
third strategy, stem cells are partially differentiated into progenitor cells either before 
or after seeding into scaffolds.  These constructs transiently release progenitors that 
migrate into surrounding regions where they undergo terminal differentiation, 
integrate and contribute to regeneration of the injured area.  The fourth strategy 
comprises isolation of stem cells, for example by encapsulation in biodegradable 
hydrogels.  This latter strategy has been shown to be suitable for soft tissue repair or 
treatment of solid tissues with critical size defects that are too fragile for surgical 
intervention (Chai and Leong, 2007).  In the last approach, cells are seeded onto 
scaffolds that could be directly implanted into the body, or after a period of 
cultivation in vitro, for instance, with bioreactors.  During this time, scientists can 
control the different signals to which cells are exposed and, consequently, learn which 
are better at pushing cells toward the desired differentiation pathway (Baroli, 2007). 
The present study will integrate all the five strategies in order to build a basis for 
generation of the final target tissue of the lung.  
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Figure 1.1  Summary of tissue engineering strategies. The five main strategies shown 
here are described in further detail above. 
 
 
1.1.1 The challenges of tissue engineering 
 
Despite enormous advances in tissue engineering, current major challenges 
include the difficulties in generating vascularized tissues as well as in mimicking the 
complex structure and architecture of biological tissues (Khademhosseini and Langor, 
2007).  Engineering a complex organ, such as the lung, liver, kidney, heart, or small 
intestine, presents so many scientific challenges that development of clinically 
applicable replacement tissues has not yet been realized. Problems to be faced in the 
development of any complex tissue, including lung, depend on the development of 
better systems to promote angiogenesis, the selection of appropriate cell sources, the 
reproducible differentiation of the selected cell type or types along organ-specific 
lineages, and the development of appropriate scaffolds or matrices to enhance and 
support three-dimensional (3D) production of tissues. Construction of complex 
organs such as the lung that involve more than one cell type is one of the greatest 
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challenges encountered in the field of tissue engineering (Darling and Athanasiou, 
2003). An understanding of the factors involved in the differentiation potential of the 
selected cell source is invaluable. The aim of tissue engineering is to produce a 
material that closely matches or mimics the native tissues (Darling and Athanasiou, 
2003) but one of the major problems in engineering of any tissues for clinical 
application is selecting human cell sources with the potential to provide sufficient 
numbers of cells for development of tissue used to repair critical defects caused by 
disease or injury beyond the repair capabilities of the human body (Nichols and 
Cortiella, 2008). 
 
Another major challenge that must be overcome is the inadequate supply of 
suitable cells.  This problem will become more critical when the engineering of bulk 
tissue or complex organs is contemplated, particularly when autologous tissue 
production is needed.  It is important to maintain large quantities of undifferentiated 
cells to provide sufficient starting material (Chai and Leong, 2007) for subsequent 
indefinite quantities of differentiated and progenitor cells.  To achieve this, it is 
important to combine fundamental biological and engineering approaches by 
fabricating a suitable bioreactor that will help to initiate reproducible and unlimited 
cell populations to fulfil clinical requirements.    
 
1.2 Cell sources - embryonic stem (ES) cells 
 
A promising cell source for producing any required phenotype, including the 
functional lung epithelial cells that are the target of this thesis, are embryonic stem 
(ES) cells. ES cells are capable of indefinite expansion, pluripotent or totipotent 
differentiation, and attempts are being made to generate patient-tailored ES cell lines 
that overcome immunological complications (for review see Rippon et al., 2008). For 
regenerative medicine purposes, ES cells could provide a virtually inexhaustible cell 
source.  In this study, murine and human ES cells were used to derive alveolar 
epithelial and other pulmonary phenotypes using 2D and 3D culture approaches. 
 
Stem cells, the ‘mothers’ of all cells, derived from different cell sources  have 
a very extensive regeneration capacity and have become an important resource in 
tissue engineering technology.  A stem cell is defined as a clonal precursor of more 
 34
identical stem cells, as well as specialized or differentiated progeny of one or more 
defined types. Whether one is considering stem cells that comprise an embryo 
developing into an adult organism or cell niches residing in various adult tissues, stem 
cells are subjected to a wide variety of control mechanisms.  In particular, a number 
of their functions or fate decisions, including survival, death, proliferation, migration, 
lineage commitment and differentiation, are tightly regulated by processes that are 
slowly being elucidated (Anderson, 2001; Weissman et al., 2001; Viswanathan et al., 
2002; Wagers et al., 2002).  
 
Stem cells were first identified in murine bone marrow in the 1960s by Till, 
Becker and colleagues, who observed that single cells could give rise to all 
haematopoietic lineages in vivo (Till et al, 1961; Becker et al., 1963).  In 1974, 
embryonic carcinoma cells from reproductive tissue tumours were generated by 
Evans and colleagues and shown to develop into cells from each of the embryonic 
germ layers: ectoderm, mesoderm and endoderm. Later, in 1981, pluripotent murine 
ES cells were derived from normal tissue, namely an early-stage mouse embryo 
(Evans and Kaufmann, 1981). 
 
 The discovery of murine ES cells more than 25 years ago and the more 
recently established human ES cells (Thomson et al., 1998), represented major 
advances in biology, experimental medicine and tissue engineering.  ES cells provide 
unique opportunities for establishing an in vitro model of early mammalian 
development and represented a putative new source of differentiated cell types for 
cell replacement therapy, thereby opening new scenarios for medical applications 
(Prelle et al., 2002, Keller, 2005). The establishment of human ES cell lines, in theory, 
enables the generation of all the tissues of which human beings are comprised (Hirai, 
2002).   
  
 
1.2.1 From pluripotency to differentiation 
 
One of the most important issues in ES cell research is the development of a 
method for their efficient differentiation into specific cell types. Several ES cell 
differentiation approaches have been developed to date. The most frequently 
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employed method involves a step in which the ES cells are made to aggregate, 
forming structures called embryoid bodies (EBs) (Keller et al., 2005). When the 
essential factors for the maintenance of undifferentiated states are removed and the 
cells are cultured in suspension, the ES cells differentiate spontaneously and form 
spherical aggregates, EBs. In these three-dimensional conformations, the cells begin 
to cross-induce each other, compelling them to differentiate, in a manner reminiscent 
of that observed in early embryogenesis (Leahy et al., 1999). Shortly after the 
formation of EBs, endodermal-like cells appear in the outer layer. Later, the EBs 
assume a unique structure, characterized by a central cavity. These unique 
conformations are referred to as cystic EBs and consist of double-layered structures, 
an inner ectodermal layer and an outer endodermal layer. As the suspension culture 
continues, mesodermal-like cells begin to appear, in addition to differentiated 
endodermal and ectodermal cells (Keller et al., 1995).   
 
The enhancement of ES cell differentiation towards a specific lineage (Pera 
and Trounson, 2004; Trounson, 2005) can be achieved by the following: activating 
endogenous transcription factors; transfection with ubiquitously expressing 
transcription factors; exposure to selected growth factors; or co-culture with cell types 
capable of lineage induction. ES cells may be induced to form the lineage of interest 
by a combination of growth factors and/or their antagonists (Loebel, et al., 2003). 
These instructors of lineage formation accelerate differentiation in vitro and mimic 
the markers of natural developmental pathways (Trounson, 2006). 
 
Self-renewal of human ES cells is regulated by exogenously added and 
autocrine factors that interact with each other and the cells in the extracellular milieu. 
Interactions between these factors in an extracellular context and the crosstalk 
between the intracellular signalling pathways activated by them contribute to 
maintenance of the undifferentiated ES cell state. Together, these signals support an 
emerging perspective that human ES cells, like murine ES cells (Ying et al., 2003) 
(and perhaps stem cells in general), maintain their undifferentiated state by inhibiting 
signalling (and gene expression) programmes that lead to the development of specific 
cell types. It is particularly appealing, therefore, to consider the ES cell as an unstable 
steady state (Waddington and Roberson, 1966; (Zhang and Wang, 2008) (as shown in 
Figure 1.2) balanced in a high energy landscape, with a tendency upon perturbation to 
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differentiate (to a lower energy state) along different lineages. Understanding this 
balance, as well as how to perturb it systematically, will be an important aspect of ES 
cell research, especially that of human ES cells, in the next few years (Rao and 
Zandstra, 2005). 
 
Figure 1.2 Model of ES cell self-renewal and pluripotency.  The round object 
represents an ES cell located on a sharp point or platform representing the unsteady 
state of the cell lying between differentiation and undifferentiation.  The two main 
factors that contribute to the self renewal and differentiation of ES cells are the 
external and internal factors.  Oct4, Nanog and Sox2 are the main genes causing 
formation of the core transcription regulatory network and control ES cell 
pluripotency.  The activity of the core regulatory network is modulated by multiple 
extrinsic factors, which are different for human and murine ES cells. (Adapted from 
Zhang and Wang, 2008 and Rao and Zandstra, 2005). 
 
 
1.2.2 Murine ES cells 
 
Following the isolation of stable pluripotent embryonic stem (ES) cell lines 
(Evans and Kaufman, 1981), interest focused on the use of these cells as vectors for 
transmission of genetic alterations into the mouse germline (Smith, 1992; Rathjen et 
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al., 1998). Recently, the long-recognised potential of ES cells for modelling 
embryonic development and as a source of cell populations for experimental analysis 
has become to be realized. A relatively detailed knowledge of murine embryology at 
the cellular and genetic levels, coupled with the availability of well characterized ES 
cells with extensive and defined differentiation capacity in vitro, means that much of 
the work in this area is being pioneered using murine ES cells (Rathjen et al., 2001).   
 
 Traditionally, murine ES cells have been expanded continuously in vitro when 
co-cultured with mitotically inactivated embryonic fibroblasts, resulting in stem cells 
capable of multi-lineage differentiation (Evans and Kaufman, 1981).  The factor 
provided by the feeder cells that promotes self-renewal and inhibits differentiation 
was later identified as leukemia inhibitory factor (LIF), a member of the IL-6 
cytokine family (Smith et al., 1988; Williams et al., 1988). Later, murine ES cells 
have been derived and maintained using various empirical combinations of feeder 
cells, conditioned media, cytokines, growth factors, hormones, serum and serum 
replacements.  Progress towards elucidating the complex molecular mechanisms in 
murine ES cell self renewal and pluripotency has been discussed in several review 
papers.  For example, the signalling pathway is reported to involve LIF-STAT3, 
MAPK-ERK, P13K, Wnt, TGFB and BMP pathway (Liu et al., 2007).  In addition, 
there are important transcription factors, such as Oct3/4, Nanog and chromatin, and 
epigenetic modification plays a role until the differentiation pathway.  Despite limited 
current knowledge, there is a high possibility of discovering the molecular 
mechanisms that give rise to the unique properties of ES cells that can then be 
exploited as powerful tools in basic discovery and clinical applications (Liu et al., 
2007).   
 
The formation of embryoid bodies (EBs) is an easy and conventional method 
for in vitro differentiation induction of ES cells. Murine ES cells form EBs on 
withdrawal of LIF and attachment of ES cells to the culture dish or embryonic feeder 
cells (Wiles, 1993; Keller, 1995; Weiss and Orkin, 1996). Hematopoietic cells, 
cardiomyocytes, skeletal and smooth muscle cells, neuroectoderm, neurons, glial cells, 
epithelial cells, keratinocytes, melanocytes, insulin-secreting cells as well as alveolar 
epithelial cells have been derived following EB formation, although the efficiency of 
the differentiation induction into individual cell lineages varies significantly (Sato and 
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Nakano, 2001). The initial aim of in vitro ES cell differentiation induction was the 
elucidation of the development and differentiation mechanisms of various cell 
lineages but, after the establishment of human ES cells, it became a potentially useful 
approach to obtain cells for therapy (Sato and Nakano, 2001). 
 
Murine and human ES cells express similar markers of pluripotent cells, such 
as Oct4, Nanog, ALP and high levels of telomerase activity.  Although the same 
pluripotency genes are expressed in both species, their functions and downstream 
signalling pathways may differ.  However, the important factor is to understand the 
mechanisms involved in pluripotency so that differentiated cells can be 
reprogrammed to mimic the embryo-like state with the early cell signalling formation 
and pluripotent markers regulated in early embryogenesis, and then somatic cells 
created and monitored that can later be used in clinic (Liu et al., 2007).  
 
 
1.2.3 Human ES cells 
 
Human ES cells are formed from the mechanically or immunosurgically 
isolated inner cell mass (ICM) of preimplantation-stage blastocysts produced for the 
treatment of infertile couples (Trounson, 2001; Trounson, 2002).  They may also be 
derived from earlier morula-stage human embryos (Strelchenko et al, 2004), or intact 
blastocysts, after the removal of the glycoprotein shell known as the zona pellucida in 
an acidified solution or by enzymatic digestion in pronase (Verlinsky et al., 2005).  
Another developmental technique is the use of somatic cell nuclear transfer (SCNT), 
or therapeutic cloning, for producing ES cells in vitro, to obtain cells that are 
genetically matched to the donor by creating an ovum with a donor nucleus (Hwang 
et al., 2005). 
 
Early human embryogenesis is broadly similar to that of mice, but it is 
relatively inaccessible to experimental analysis and manipulation compared with 
other lower systems commonly used in developmental biology (Draper and Fox, 
2003).  The use of in vitro human ES cell lines will facilitate studies on early human 
development, which so far have been impossible (Semb, 2005).   
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1.2.3.1 Human ES cell derivation  
 
In order to obtain human ES cells, donated embryos or embryos generated 
from donated eggs and sperm are grown in culture to the blastocyst stage (Landry and 
Zucker, 2004).  The blastocyst forms at approximately 4 to 5 days after fertilization 
and contains from 64 to several hundred cells organized in an outer shell, the 
trophectoderm, and a collection of polarized inner cells termed the inner cell mass 
(ICM).  The ICM is the locus of pluripotent cells destined to yield all the tissues of 
the organism.  In the process of obtaining ES cells, the trophectoderm is removed by 
immunosurgery, and the ICM is disaggregated and plated on feeder cells.  The 
resulting cell colonies are mechanically isolated and re-plated until homogeneous 
colonies are obtained (Rosenthal, 2003).   
 
New human ES cell lines derived in this manner need to be fully characterized 
to ensure that they fulfil the following criteria: expression of ES cell-specific cell-
surface markers such as TRA-1-60, TRA-1-81, GCTM-2, SSEA-3 and SSEA-4; high-
level expression of telomerase; normal and stable karyotype after long-term growth; 
expression of stem-cell markers such as Oct4 and Nanog; teratoma formation after 
injection into severe combined immunodeficient mice (which demonstrates their 
capacity to differentiate into derivatives of all three embryonic germ lineages); and 
differentiation under in vitro conditions into cells of the three lineages.  According to 
Hyslop et al., (2005) more than 300 human ES cell lines have been reported 
worldwide and this number increases every year. 
 
1.2.3.2 Formation of embryoid bodies (EBs) 
 
EB differentiation has been shown to recapitulate aspects of early 
embryogenesis (Figure 1.3)., including the formation of a complex three-dimensional 
architecture where in cell-cell and cell-matrix interactions are thought to support the 
development of the three embryonic germ layers and their derivatives (Keller, 1995; 
Itskovitz-Eldor et al., 2000). 
 
Presently, almost all human and most murine ES cell lines require aggregation 
of multiple ES cells to initiate EB formation efficiently (Itskovitz-Eldor et al., 2000; 
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Dang et al., 2002).  Standard methods of EB formation include hanging drop, liquid 
suspension, and methylcellulose culture.  These culture systems maintain a balance 
between allowing ES cell aggregation necessary for EB formation and preventing EB 
agglomeration for efficient cell growth and differentiation (Dang et al., 2002). 
 
The length of EB culture is dependent upon the ultimate target cell type and 
EB differentiation appears to correlate well temporally with the post-implantation 
development of embryos (Keller, 1995).  Mesodermal and ectodermal precursors 
form within a few days, whereas some endodermal cell types may benefit from more 
extended culture time, up to 10 days, to a stage where most EB have cavitated and 
become cystic (Figure 1.3) (Abe et al., 1996; Leahy et al., 1999). 
 
Following the formation of EBs, cells are returned to adherent culture 
conditions in which specialized cells develop in the outgrowth area of differentiation.  
Not surprisingly, progress in directing and characterizing the in vitro differentiation 
of murine ES cells is significantly more advanced than for human ES cells (for review 
see Rippon and Bishop, 2004)..  Work by Wobus 2001 and Boheler et al., 2002, has 
shown the appearance of primitive cardiomyocytes in the human ES cell culture,  
which can initially be observed as areas of ‘twitching’ in EBs after several days in 
suspension culture, and then later as large patches of synchronously contracting cells 
in adherent culture.  Murine ES cell-derived cardiomyocytes have been shown to 
express tissue-specific markers, including structural cardiac proteins, cardiac 
receptors and cardiac transcription factors (Wobus 2001 and Boheler et al., 2002).  
Preliminary data on engraftment of murine ES cell-derived cardiomyocytes into 
mouse models has also indicated that these cells are capable of integrating into 
endogenous heart tissue, vascularizing, and continuing to differentiate in vivo; (Klug 
et al., 1996; Johkura et al., 2003).  Towards the production of cardiomyocytes for 
tissue engineering of human cells, work is now proceeding on techniques to scale-up 
the differentiation process (Zandstra et al., 2003), strategies to select out the 
appropriate cell type from the differentiated human cell population (Muller et al, 
2000), and cardiomyocytes are now being generated from human ES cells based on 
protocols optimized for murine ES cells (Kehat et al., 2001; He, et al., 2003; 
Mummery et al., 2003).  Some researcher have also shown that spontaneous 
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neovasculogenesis occurs in differentiating human EBs (Gerecht-Nir et al., 2003; 
Levenberg et al., 2002).  .   
 
The derivation from ES cells of phenotypes with ectodermal, mesodermal or 
endodermal origins has been documented including skin reconstitution, bone, 
cartilage (Kramer et al, 2003), hepatocytes (Yamada et al., 2002 and Jones et al., 
2002), pancreatic islets (Lumelsky et al., 2001) and others; and more recently, of type 
II pneumocytes (Ali et al., 2002; Rippon et al., 2004; Qin et al., 2005; 
Samadikuchaksaraei et al., 2006; Rippon et al., 2006; Wang et al., 2007) and airway 
epithelial tissue (Rippon et al., 2004; Rippon et al., 2006; Coraux et al., 2005; 
Winkler et al., 2008).   However, progress in deriving endodermal lineages from ES 
cells is lagging significantly behind that of the ectoderm and mesoderm layers at 
present time (Rippon and Bishop, 2004). 
 
The majority of the reports of ES cell differentiation in vitro have so far 
focused on differentiation of cells in adherent culture following EB formation.  
However, for many tissue engineering applications, the incorporation of differentiated 
cells into higher-order structures will be essential for implants to be functional, and 
the acquisition of an appropriate 3D structure may also further direct the maturation 
and specialization of differentiated cell types (Rippon and Bishop, 2004).  In general, 
differentiated progeny of ES cells have been difficult to sustain in 3D culture due to 
problems in controlling cell proliferation and survival, and the presence of a highly 
mixed population of cell types (Rippon and Bishop, 2004).  Human ES cells have 
been differentiated on a polymeric scaffold designed for the support of complex tissue 
structures rather than via EB formation and these were observed to form structures 
with the characteristics of neural tissues, cartilage and liver, as well as a network of 
blood vessel-like tubules (Levenberg et al., 2003).  ES cells might therefore provide a 
means to generate a histologically complete tissue construct, which would not rely 
entirely on full vascularization by the host circulatory system alone for survival 
(Rippon and Bishop, 2004). .  
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Figure 1.3 The formation of embryoid bodies in vitro and, in comparison, in vivo 
embryogenesis towards the development of the three lineages; ectoderm, mesoderm 
and endoderm.  (Modified from Hyslop et al., 2005) 
 
 
1.2.3.3 Feeder-free culture 
 
As yet, there has not been an analysis of transcription profiles of human ES 
cells derived on various feeder cells or reports of common active factors that maintain 
human ES cells (Trounson, 2006).  Unlike murine ES cells, the differentiation of 
human ES cells in the absence of a feeder cell layer is not prevented by LIF (Draper 
et al., 2004; Brimble et al., 2004). The basis of this lack of response of human ES 
cells to LIF is not clear. Some researchers have attributed it to the poor activation of 
STAT3 pathway in human cells (Rugg-Gunn et al., 2005), whereas others suggest 
that it is because of the absence or relatively low level of expression of components 
of the LIF pathway (Lee et al., 2005; Cheng et al.,2003). The presence of bFGF is 
considered to be essential in these feeder-free culture systems (Xu et al., 2001). 
However, there are alternatives to murine embryonic fibroblasts (MEFs) tried by 
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different researchers.  Optimizing culture conditions for human ES cells is extremely 
important and is discussed in considerable detail by Hoffman and Carpenter (2005). 
 
The pluripotency of human ES cells is maintained when the cells are grown 
on and/or with: 
 
i. STO, a permanently growing cell line, derived from mouse embryos, has 
been used to establish and maintain human ES cells in the pluripotent state. 
There is a suggestion that, although STO cells might produce sufficient 
amounts of cell-surface factors for the renewal and maintenance of 
undifferentiated human ES cell, they may not produce sufficient amounts 
of soluble factors for self-renewal of human ES cell growing without 
direct contact with STO feeder cells (Park, et al., 2003). 
 
ii. Conditioned culture medium from murine embryonic fibroblasts (MEFs) 
can maintain human ES cells when grown on Matrigel or laminin 
extracellular matrices (Sato et al., 2004; Xu et al., 2001; Sjogren-Jansson 
et al., 2005). MEF-conditioned medium (MEF-CM) has been successfully 
used to maintain undifferentiated human ES cell cultures (Robin and 
Schulz, 2004). A human ES cell line has also been established on plastic 
dishes coated with extracellular matrix from MEFs, which was dried and 
sterilized (Klimanskaya et al., 2005). Considering that most normal cells 
require adhesion to an extracellular matrix for survival and growth, and 
human ES cells express integrin α_6 and α_1 (laminin-specific receptor), 
it appears that some soluble factors produced by MEFs may be important 
for adhesion of human ES cells. The ability of different matrices to 
support human ES cells growth in MEF-conditioned medium has been 
evaluated (Xu et al., 2001).  Human ES cells seeded onto Matrigel in 
MEF-CM have good survival and undifferentiated morphology. The 
combination of appropriate matrix proteins, such as Matrigel or laminin, 
and MEF-CM supports the growth of undifferentiated human ES cells. 
The ability of conditioned media from cell lines other than MEF (e.g., 
NHG, STO, BJ5ta, or hTERT-RPE) to allow human ES cells to grow 
without differentiation has been tested but without much success (Xu et al., 
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2001). Therefore, conditioned media only from particular cells or cell lines 
support human ES cell growth. Whether the effect is due to production of 
factors that favour human ES cell growth and/or the removal of toxic 
factors from the medium is not yet known (Bodnar et al., 1998). 
 
iii. Feeder-free, serum-free cultures of human ES cells can be maintained in 
medium with unconditioned serum replacement supplemented with 
different growth factors (Rosler et al., 2004; Carpenter et al., 2004; Amit 
et al., 2004). Activin A has been shown to be secreted by MEFs, and 
culture medium enriched with activin A is capable of maintaining human 
ES cell in the undifferentiated state (Beattie et al., 2005). Amit and co-
workers have reported that the combination of fibroblast growth factor-2 
(FGF2), transforming growth factor-_α (TGFα), LIF, and a proprietary 
serum replacer can achieve serum-free, feeder-free maintenance of human 
ES cells on a fibronectin extracellular matrix (Amit et al., 2004). A report 
suggests that Wnt signalling modulation can support the short-term 
maintenance of some stem cell markers in human ES cell cultures in the 
absence of a feeder cell layer (Sato et al., 2004). Human serum has also 
been used to coat tissue culture dishes, then dried and used for culture of 
human ES cells in the presence of medium conditioned by human ES cell-
derived mesenchymal phenotypes (Stojkovic et al., 2005).  Pebay et al. 
(2006) have demonstrated that sphingosine-1-phosphate and platelet-
derived growth factor are active serum components that can replace the 
need to use serum for human ES cell culture. These observations show 
that signalling pathways for human ES cell renewal may be activated by 
tyrosine kinases synergistically with those downstream from 
lysophospholipid receptors. 
 
iv. Human feeder cell layers have been used, such as fetal muscle, fetal skin, 
adult Fallopian tube epithelial cells (Richards et al., 2002; Amit et la., 
2003; Richards et al., 2003), foreskin fibroblasts (Hovatta et al., 2003), 
adult marrow cells (Cheng et al., 2003) and adult endometrial cells (Lee et 
al., 2005).  Human adult breast parenchymal cells show typical 
morphology similar to MEF cells, e.g., high nucleus-to-cytoplasm ratio, 
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one to three prominent nucleoli, and close spacing between the cells (Lee 
et al., 2004). Human ES cells grown on a human embryonic fibroblast 
layer are comparatively thinner and flatter and the spacing between cells is 
greater than that on MEFs or a human breast parenchymal cell base (Lee 
et al., 2004).  
 
v. Autogenic feeders. A few researchers have reported the use of human ES 
cell-derived fibroblasts, comprising fibroblast-like structures derived from 
spontaneous differentiation of human ES cells that permit continuous 
growth of undifferentiated and pluripotent human ES cells (Stojkovic et 
al., 2005; Yoo et al., 2005; Wang et al., 2005; Choo et al., 2008). 
 
 
Some of these systems have proven useful for generating viable human ES 
cells (Cheon et al., 2006).  However, while these systems eliminate direct contact 
between human ES cells and MEFs and enable larger scale production, they are 
limited by; 
 
i. low success rates in the initial transfer of human ES cells from feeder to 
feeder-free conditions (Cheon et al., 2006) 
ii. the presence of animal-derived proteins 
iii. development of a mixed population of undifferentiated and differentiated 
human ES cells (Rosler et al., 2004; Carpenter et al., 2004; Amit et al., 
2004). 
 
Additionally, signals received from the feeder layers do not operate through 
the leukaemia inhibition factor (LIF) / gp130 pathway (Sato et al., 2004; Humphrey 
et al., 2004), as is the case with murine ES cells.  Consequently, alternate signalling 
pathways, activated by contact of the human ES cells to feeder layers and / or soluble 
factor(s) present in the conditioned medium, mediate the maintenance of pluripotency.   
It remains unclear, however, as to what factors in the conditioned medium act to 
support the self-renewal of human ES cells.  The generation of human ES cell 
reporter lines that contain a specific marker for undifferentiated cells would provide 
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invaluable tools for investigating the factors that control self-renewal and allow much 
needed improvements to be made to current culture conditions (Gerrard et al., 2005).   
 
Xu et al., (2005) demonstrated that human ES cells can be maintained in 
bFGF alone or in combination with other growth factors in a serum replacement, non-
conditioned medium (SR medium). They found that cultures maintained in bFGF 
alone or in combination with other factors such as stem cell factors (SCFs), fetal liver 
tyrosine kinase-3 (Flt3L), thrombopoietin (TPO) and the IL-6 family members IL-6, 
leukaemia inhibitory factor (LIF), ciliary neutrophic factor (CNTF), and oncostatin M 
(OSM); showed characteristics similar to MEF-conditioned medium control cultures, 
including morphology, surface marker and transcription factor expression, telomerase 
activity, differentiation and karyotypic stability. 
 
 To date, there is minimal information on factors regulating the self-renewal of 
human ES cells (Prowse et al., 2005).  In comparison, there are three pathways in 
murine ES cells involving the transcription factors Nanog (Chambers et al., 2003; 
Mitsui et al., 2003), Oct 4, and Stat 3 (Niwa et al., 1998; Williams et al., 1988). Lim 
and Bodnar (2002) used a proteomic approach to identify factors in the conditioned 
medium of MEF cells used for the support of human ES cells.  The conditioned 
medium revealed a complex network of proteins of varying known functions and of 
intracellular and extracellular origin.  With consideration of the trend towards the use 
of human-derived tissue for the culturing of human ES cells,  Prowse et al, 2005; 
investigated the proteins in the conditioned medium of human neonatal fibroblasts 
(HNFs) used as feeder layers for culturing human ES cells (Amit et al., 2003; Hovatta 
et al., 2003).  They  identified a total of 102 proteins classified into 15 functional 
groups that were considered most likely to be involved in the maintenance of human 
ES cell growth, differentiation and pluripotency as these groups contained proteins 
involved in cell adhesion, cell proliferation and inhibition of cell proliferation, Wnt 
signalling and inhibition of bone morphogenetic proteins (Prowse et al., 2005). 
 
1.3 Target organ - the lung 
 
1.3.1 Lung embryogenesis 
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The structure of the lung varies in complexity among vertebrate species but is 
highly conserved in its position along the foregut, ventral to the oesophagus, between 
the thyroid and stomach (Fig. 1.4). Lungs are spatially organized along both cephalo-
caudal (from the conducting airways to the peripheral saccules) and dorsal-ventral 
axes. Mammalian lungs are usually asymmetrically lobulated; for example, the 
murine lung consists of four right and one left main lobes. Pulmonary situs is 
determined by genes regulating left-right asymmetry (Raya et al., 2006). Formation 
of the lung also requires information that regulates right and left asymmetry and the 
gradual tapering of the conducting airways that lead to ever smaller tubes that ending 
in the alveoli where gas exchange occurs. The lung buds arise from the lateral-
oesophageal sulcus stemming from between the thyroid and the stomach along the 
foregut endoderm expressing organ-selective genes (Serls et al., 2005; Zhu et al., 
2004). 
 
The mammalian lung develops as an outgrowth of the embryonic gut.  In man, 
it originates from a diverticulum of the ventral wall of the primitive oesophagus 
somewhere between 4 and 5 weeks of gestation (Bishop, 2004).  When the human 
embryo is approximately 4 weeks of age, the respiratory diverticulum, or lung bud, 
appears as an outgrowth from the ventral wall of the foregut.  As a result, the internal 
epithelial lining of the lung and associated airways are of endodermal origin.  During 
its separation from the foregut, the lung bud forms the trachea and bronchial buds 
which, by week 5, enlarge to form the right and left mainstem bronchi (Fig. 1.4). As 
the lung buds continue to grow and penetrate into the coelomic cavity, they are 
covered by mesoderm, which gives rise to the visceral and parietal pleura (weeks 6-8). 
The bronchial tree continues to divide into smaller airways through week 26. At about 
this time, some of the cuboidal cells of the respiratory bronchioles become thin and 
flat, forming type I pneumocytes. They are intimately associated with a growing 
network of capillaries and are now referred to as terminal sacs or primitive alveoli. 
During the seventh month, sufficient vascularization is present to provide adequate 
gas exchange so that a premature infant could survive. Type II pneumocytes develop 
as well during this period and the amount of surfactant within the alveolar fluid 
steadily increases, particularly during the last 2 weeks before birth (Sadler, 1995). 
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A complex and well-integrated sequence of signalling and regulatory 
pathways is responsible for the development of the human lung, from lung bud to 
alveolus (Aliotta et al., 2005). Airway branching is directed by interactions between 
the epithelium and mesenchyme. Demayo et al. (2002) reported that when distal lung 
mesenchyme is grafted onto tracheal epithelium, airway branching occurs. Further, 
tracheal epithelium exhibited all of the ultrastructural characteristics of type II 
pneumocytes and expression of surfactant protein C (SP-C) was noted 24 h post-
grafting. Fibroblast growth factors (FGF)-1, -2, and -7 appear to play an integral role 
in transformation of the tracheal epithelium (Cardoso and Williams, 2001). In 
contrast, when distal lung epithelium was engrafted with tracheal mesenchyme, the 
epithelial cells assumed a tracheal phenotype and all distal lung epithelial markers 
were suppressed. In the developing rodent, this phenomenon may be organ-specific as 
others have demonstrated that tracheal epithelium can not be induced to form lung 
buds if grafted with gut mesenchyme (Cardoso and Williams, 2001). Platelet-derived 
growth factor (PDGF)-A is expressed on the epithelial cells of embryonic lungs but 
its receptors are found within the mesenchyme surrounding the branching epithelium. 
Mice deficient in PDGF-A lack alveolar septation, resulting in early neonatal death 
(Bostrom et al., 1996). This observation provides further evidence that epithelial-
mesenchymal communication is vital for proper lung development (Aliotta et al., 
2005). 
 
The known factors that drive lung development include various transcription 
factors, signalling molecules, extracellular matrix proteins and their receptors 
(Demayo et al., 2002).  Proper development can not occur unless the interactions of 
the growth factors are timed precisely; disruption of this process can result in altered 
lung morphogenesis. For example, control of cell proliferation and branching of the 
airways is dependent on expression of bone morphogenic protein (BMP)-4, which in 
turn is controlled by FGF-10 (Weaver et al., 2000). Mice lacking FGF-10 do not form 
structures beyond the mainstream bronchi (Sekine et al., 1999).  In a murine knockout 
model of the transcription factor Nkx2.1, lung structures beyond the secondary or 
tertiary bronchi do not form (Minoo et al., 1999). The sonic hedgehog (-/-) phenotype 
is similar to Nkx2.1 (-/-) as these mice also display limited distal cellular 
differentiation (Pepicelli et al., 1998).  While FGF plays a key role in early lung 
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development, it also participates in alveogenesis; FGF receptor (FGFR)-3 and -4 
knockout mice lack alveolar formation (Weinstein et al., 1998). 
 
Retinoids play a fundamental role in lung development and, much like FGF, 
produce different outcomes at different stages of development. Retinoid signalling is 
controlled by a number of factors including retinaldehyde dehydrogenase-2 (Raldh2) 
which produces active retinoic acid (RA), retinoid receptors (RARs and RXRs), and 
enzymes that degrade RA. These factors are expressed at different times and locations 
in the developing lung and tightly control the influence of RA on gene expression and 
overall development (Cardoso and Williams, 2001). Disruption of RA signalling in 
mice lacking Raldh2 or in rats that are deficient in vitamin A, results in early 
embryonic lethality or in lung agenesis (Dickman et al., 1997; Niederreither et al., 
2000). Although RA is thought to be critical in early lung development, RA 
signalling in the epithelium becomes markedly down-regulated when epithelial 
tubules are branching and differentiating. Wongtrakool et al. (2003) demonstrated 
that, when RAR  or receptors were expressed constitutively in the distal lung, RA 
signaling persisted, resulting in lung immaturity (Aliotta et al., 2005). 
 
Expression of transcription factors or markers characteristic of specific organs 
is observed along the anterior-posterior axis of the foregut tube before formation of 
each organ (Serls et al., 2005; A. M. Zorn and J. M. Wells, unpublished observations). 
TTF-1, an Nkx2 homeodomain- containing transcription factor, marks the region 
from which lung buds arise (Fig. 1.4). As a general theme, many of the transcription 
factors required for development of the early foregut are reutilized later in lung 
morphogenesis (Zaret, 2002). For example, deletion of the Foxa2, Catnb, Sox17, 
Gata-6, Stat3 genes, and other transcription factors expressed in endodermally 
derived cells along the foregut, results in failure of normal embryonic patterning well 
before the formation of the lung (Ang and Rossant, 1994; Huelsken et al., 2000; 
Kanai-Azuma et al., 2002; Morrisey et al., 1998; Sugawara et al., 2003). 
Nevertheless, many of these transcription factors play important roles in lung 
morphogenesis, functioning later in gestation and in the postnatal period. As 
formation of specific organs along the foregut is dependent on paracrine signalling 
between cells of the endodermally derived tube and cells from neighbouring 
mesenchyme, transcription factors controlling foregut growth and differentiation (e.g., 
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FOXF1, GLI family members, POD-1, and others) are also critical for lung 
morphogenesis. 
 
 
 
 
 
 
 
 
 
 
1.3.2 Lung structure and function 
 
The lung itself is composed of both upper and lower respiratory tract, and the 
anatomy and physiology are different in these regions as are the cell types found there.  
The architecture of the lung is very complex as the epithelial domain, progressing 
proximally from the proximal cartilaginous airway (trachea and bronchi) until the 
terminal gas exchange unit (alveoli) contain unique type of cell lineages with 
different structure and function, making the cell type a challenge in regenerative 
medicine. To form an organ such as the lung, capable of conducting respiratory gases, 
the epithelium must undergo cell proliferation, branching morphogenesis, and 
alveolar saccule formation, to generate sufficient surface area (Warburton et al., 
1998).  Furthermore, the cells must differentiate into at least 40 distinct types of lung 
A B 
C 
Figure 1.4 Lung morphogenesis. Lung bud formation and branching morphogenesis. 
(A) Mouse endoderm is depicted at about E9.5 to 10.  Transcription factors (Pax8, 
TTf1, Pdx1 and Foxa2) and markers (Alb:Albumin; ss:somatostatin) identify cells that 
contribute to organ formation along the anterior posterior axis. TTf1 gene is expressed 
at sites of lung and thyroid formation, with the latter in cells expressing both Pax8 and 
TTf1. (B) Lung bud and trachea at E9.5 to 10 as the early bud evaginate into the 
mesenchyme. (C) Conducting and peripheral regions of the lung at approximately 
E12.  Later in morphogenesis (E17-18) peripheral saccules are formed. (Source: 
Maeda et al., 2007). 
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cell lineages determined by well coordinated epithelial-mesenchymal interactions that 
activate and repress the transcriptional factor-mediated mechanisms, peptide growth 
factor signalling, cell cycle control mechanisms and extracellular matrix expression 
and signalling (Warburton et al., 1998). 
 
The proximal part of the lung, the cartilaginous airways, is lined by pseudo-
stratified epithelium and upper airways with ciliated columnar cells and mucus 
secreting cells (goblet cells) (Lane et al., 2007).  The lower airway are lined with 
cuboidal, non-ciliated cells known as Clara cells, which are important for detoxifying 
inhaled pollutants and secrete Clara cell secretory protein (Lane et al., 2007).  And 
lastly the alveoli are lined with type I and II epithelial cells.  The pulmonary 
interstitium contains several specialized lineages of mesenchymal origin including 
fibroblasts, myofibroblasts and smooth muscle cells.  The vasculature comprises 
several populations of arterial, venous, capillary endothelial cells, together with 
smooth muscle and other specialized cells such as lymphatic endothelial cells in the 
vessel walls (Warburton et al., 1998). The definition of what is engineered lung can 
be as simple as replication of the distal lung epithelia or as complex as the 
development of fully functional replacement tissues that include both distal lung and 
branching airways (Nichols and Cortiella, 2008). 
 
The respiratory system has two functional components: a conducting system 
for transport of inspired and expired gases into and out of the lungs and an interface 
for passive exchange of gases between the atmosphere and blood.  The alveoli, which 
constitute the bulk of the lung tissue, enveloped by rich networks of capillaries 
provide a huge area where blood and air are separated by a very thin barrier allowing 
gas exchange.  Each type of airway has its own characteristic structural features, but 
there is a gradual, rather than abrupt, transition from one type of airway to the next 
along the whole length of the tract (Young and Heath, 2002). 
 
1.3.3 Alveolar epithelial cells 
 
Alveoli and respiratory bronchioles form the most distal part of the respiratory 
tract.  The alveolar wall consists of three components: surface epithelium, supporting 
tissue and blood vessels (Young and Heath, 2002).  The alveoli are lined by a simple 
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squamous epithelium comprising two morphologically and functionally different 
types of cell: type I and type II pneumocytes (Figure 1.5).  Type I pneumocytes are 
large elongated cells covering approximately 95% of the blood-gas exchange area.  
They constitute part of the extremely thin gaseous diffusion barrier.  Type II 
pneumocytes are cuboidal cells, rich in organelles with prominent nucleoli and 
vacuolated cytoplasm that are specialized in the production and secretion of 
surfactant (Hollande et al., 2004).  
 
Clara cells of the respiratory bronchioles synthesize other components of 
surfactant.  Clara cells are the progenitor cells in small airways (Giangreco et al., 
2002).  After airway injury, Clara cells in stem cell niches proliferate and migrate to 
replenish the injured terminally differentiated epithelial cells (Reynolds et al., 2000).  
After alveolar injury, Clara cells can be seen in the alveolus, suggesting the response 
of the terminal airway epithelium to alveolar injury exceeds the rate of alveolar 
epithelial cell repair (Nettesheim and Szakal, 1972; Betsuyaku et al., 2000).  Clara 
cell 10 and 16 kilodalton proteins (CC10, CC16), the predominant products of the 
nonciliated cells in the epithelial lining of bronchioles, have been shown to have 
immunomodulatory and anti-inflammatory activities, and play an important role in 
controlling inflammatory in the airway (Shijubo et al., 1999).  Another secretory 
protein, Clara cell secretory protein (CCSP) is a 16-kD homodimeric protein that has 
a similar role in regulating the acute inflammatory response in the lung (Stripp et al., 
2002). 
 
Type II pneumcytes retain their capacity for cell division and can differentiate 
into type I pneumocytes in response to damage to the alveolar lining (Young and 
Heath, 2002).  Since the cytoplasm of type I pneumocytes covers such an extensive 
area, their characteristic nuclei are relatively infrequently seen in histological sections 
(Young and Heath, 2002).  The hallmark of type I cell development has been the 
acquisition of a highly flattened and broadly, attenuated cellular extensions, a 
morphogenetic event that occurs in the last 2 to 3 days of gestation in rodents. 
However, histogenesis is only one of several markers of the type I cell phenotype and 
may be one of the last to be expressed. In type I cells of the mammalian lung, 
multiple aquaporins have been identified at each level of the respiratory tract and the 
descriptions of 5 aquaporin (AQP)-null phenotypes have been published (AQP1, 
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AQP2, AQP3, AQP4, and AQP5) (Preston et al., 1994; Ma et al., 1998; Deen et al., 
1994; Ma et al., 1997; Ma et al., 1999). AQP5 is found at the apical membrane of 
type I pneumocytes, but no aquaporin has been identified in the basolateral membrane 
of these cells, or in type II pneumocytes (King et al., 1996). The postnatal expression 
of AQP5 in the distal lung (King et al., 1997) and the appearance of AQP5 in 
differentiating alveolar pneumocytes have both been described (Borok et al., 1998). 
AQP5 is abundant in the apical membranes of glandular acini, whereas basolateral 
membranes contain other aquaporins. It was originally predicted that AQP5 plays a 
major function in glandular secretions (Raina et al., 1995), and a study using AQP5-
deficient mice show a marked reduction in saliva formation (Ma et al., 1999). 
 
Only the nucleus and perinuclear area of type I cells can be resolved in the 
light microscope, although the flattened cellular extensions can be visualized readily 
when labeled for specific marker proteins. Individual cells appear able to form 
epithelial surfaces of more than one alveolus, resulting in a complex architecture that 
may contribute to their susceptibility to injury (Weibel, 1971). Until 50 years ago, the 
existence of type I cells was debated; some investigators argued that the gas exchange 
surface was created by an extensive capillary bed that lacked an epithelial covering. 
However, in 1952 electron microscopy (EM) studies provided incontrovertible 
evidence for the presence of type I cells that, along with type II cells, form a complete 
epithelial lining of the peripheral lung (Low, 1952). Although much is known about 
the functions of type II cells in terms of synthesis of surfactant lipids and proteins, 
proliferative capacity, and other biologic properties, the general functions of type I 
cells are relatively unexplored because there were no marker molecules that could be 
used for definitive identification of type I cells. Useful markers must discriminate 
between type I and type II cells; this has been particularly problematic because type II 
cells are known to be progenitors of new type I cells after cell injuries (Evans et al., 
1975).  
 
Useful markers must also distinguish type I cells from alveolar microvascular 
endothelial cells because these cells have somewhat similar morphology and are 
difficult to resolve in the light microscope. The identification of at least two marker 
proteins that fulfill these criteria has catalyzed efforts to explore the fundamental 
biological properties of this important alveolar cell. A second problem has been the 
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lack of reproducible methods to isolate viable type I cells from the lung for in vitro 
studies. Although this has been successfully accomplished in a few laboratories 
(Dobbs et al., 1998), the cells appear to be fragile and are susceptible to injury during 
isolation procedures. An alternative has been to identify cell systems or cell lines that 
express known markers of type I cells in vivo for use in basic cell and molecular 
studies.  Type I cells have been described as terminally differentiated cells, 
suggesting that they are incapable of cell division and cannot change their phenotype. 
Given that the cells have a long turnover time (40–120 days), it has been difficult to 
prove that they cannot undergo replication or alter their phenotype in the normal lung. 
Furthermore, the current understanding of the impermanence of gene silencing 
indicates that all cells, including type I cells, may have unexpected plasticity and 
proliferative capacities (Dobbs et al., 1998).  
 
In an important early study (Evans et al., 1975), Evans described the 
stereotypic response of the alveolar epithelium to peripheral lung injuries. These 
insults preferentially damage type I cells and leave type II cells unscathed. The 
damaged cells slough into the alveolar spaces, leaving a denuded basement membrane. 
Neighbouring type II cells undergo mitosis; one daughter cell then represses type II 
cell genes, initiates expression of type I cell genes, and acquires the characteristic 
type I cell morphology. Thus, in the lung, postmitotic, highly differentiated type II 
cells express de novo the markedly different type I cell molecular phenotype. 
Virtually nothing is known about the molecular regulation of these complex events, 
yet they are the key to lung repair and healing (Williams, 2003). 
 
Type I and type II pneumocytes play an essential role in pulmonary 
physiology.  Being in contact with the external environment, they are frequently 
injured and a continuous renewal of the alveolar epithelium is necessary to maintain 
cellular homeostasis (Hollande et al., 2004).  In normal adult tissue, type II 
pneumocytes are considered to be either progenitor or stem cells of the alveolar 
epithelium (Uhal, 1997; Emura, 1997).  They may divide to generate type II 
pneumocytes or differentiate into type I pneumocytes.  This transformation has also 
been observed in cultures of alveolar cells from healthy adults (Danto et al., 1995; 
Reynolds et al., 1999).  These studies have shown that culture conditions can affect 
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the differentiation of type II pneumocytes (Reynolds et al., 1999) as well as the 
reverse process (Danto et al., 1995).   
 
Figure 1.5 Diagram of an alveolus and underlying capillary. The alveoli are lined by a 
simple squamous epithelium comprising two morphologically and functionally 
different types of cell: type I and type II pneumocytes.   
 
 
1.3.4 Surfactant secretion 
 
Pulmonary surfactant consists of phospholipids and proteins with surface 
active properties and it covers the alveolar surface and terminal airways. The alveolar 
surface consists of the alveolar wall, the film that covers the wall, and the alveolar 
pores at the contact surface, in contact with the air. The alveolar wall is made up of a 
single cell-layer epithelium which contains the pores, called the Kohn’s pores (Popovi 
et al., 2006). Type II cells produce and store the pulmonary surfactant and react as a 
precursor of cells type I which also have a phagocyte activity. The liquid phase of the 
limiting lining is called hypophase, and its surface is the surface film or air liquid 
interface. The molecular surfactants are concentrated on the air-liquid contiguous 
surface with the polar side turned to the liquid phase and the nonpolar side turned to 
the air phase. These molecules reduce the surface tension on the air-liquid contiguous 
surface, and that provides the stability of the alveoli at the end of the expirium, 
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preventing their collapse (Gobran and Rooney, 2001). Other functions of surfactant 
are: prevention of oedema by the effect of the transepithelial fluid activation and the 
bacteria phagocytosis stimulation with the help of the macrophage, which gives the 
surfactant an important role in the ultimate line of the lungs’ defence (Popovi et al., 
2006) 
 
The presence in surfactant of specific proteins was noted for the first time in 
1973. In line with the nomenclature introduced by Possmayer in 1988, proteins called 
SP (surfactant protein)-A, and SP-D are hydrosoluble, while SP-B and SP-C are small, 
hydrophobic proteins that are derived from the precursor of the bigger proteins. 
Proteins in the composition of surfactant have many functions. SP-A and SP-B are 
essential for forming the tubular myelin and grouping of lamellar bodies, which is 
important for the preserving and secretion of surfactant. SP-A is a metabolic regulator 
that controls the secretion and the repeated input of other surfactant components using 
the specific membrane receptors on the type-II cells, and it represents a non-immune 
protein of the ultimate defence. SP-D was only isolated a short time ago and has 
many structural and functional similarities with SP-A, but the precise role of SP-D is 
still to be identified. SP-D does not associate with surfactant lipids or participate in 
surfactant function. Surfactant from which SP-D has been removed retains the 
features of the surface active molecules, but it is still assumed that SP-D has the role 
of the ultimate defence protein (Weaver and Whitsett, 1991).  
 
SP-B expression increases along with the progression of the gestational age, 
and it is localized in respiratory epithelial cells only in the distal lung. This protein is 
the extreme stimulator of lipid surfactant adsorption and formation of the surface film 
(Possmayer, 1990). Lack of SP-B in premature infants manifests in the extreme form 
of the Respiratory Distress Syndrome (RDS) that is not likely to be cured with 
surfactant treatment. About 30% of newborn infants who die of unexplained acute 
RDS lack the SP-B protein. The lack of SP-B in humans and mice is related to the 
lack of lamellar bodies in type-II cells, as well as to the lack of the conversion of 
proSP-C into SPC. That is the reason why these newborn infants do not have SP-B or 
active SP-C. They also lack the organelles to recycle surfactant, and that explains 
their weak response to surfactant therapy.  
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SP-C is a very hydrophobic protein. It is associated with phospholipids in the 
alveolar surfactant and facilitates surface adsorption, although SP-C-based surfactants 
may not reach very low surface tension on surface compression. Hydrophobic 
surfactant proteins are essential in the process of forming lamellar bodies, as lamellar 
bodies are not present in the type II cells that lack SP-B (Chander and Fisher, 1990). 
Surfactant synthesis occurs in the smooth and the rough endoplasmatic reticulum of 
the type II cells (Weaver et al., 2002), that begin to differentiate between the 20th and 
24th gestational weeks. Differentiation of type II cells requires close contact with 
lung fibroblasts, which alternately produce the peptides known as fibroblast 
pneumocyte factor, assisting the synthesis of the surface active material. The 
secretion of lamellar bodies is acheived by exocytosis (Mason and Voelker, 1998; 
Rooney, 2001), the fusion of their external membrane and the apical cell membrane, 
and later by the diffusion of their contents into the alveolar space. The phospholipid 
composition of isolated lamellar bodies is virtually identical to that of surfactant 
obtained by lung lavage (Rooney, 1992), and there is abundant evidence that 
surfactant phospholipids are secreted together with lamellar body contents (Chander 
and Fisher, 1990; Mason and Voelker, 1998; Rooney, 2001; Wright and Dobbs, 1991). 
The surfactant dispersed into the alveolar space has three different cycles: recycling, 
degradation and elimination. During recycling, the surfactant components are reused 
by the type-II cells and incorporated again into the lamellar bodies.  
 
Lamellar bodies are enriched in SP-B and SP-C (Oosterlaken-Dijksterhuis et 
al., 1991), and it has been established that these hydrophobic proteins are secreted 
together with the phospholipids (Weaver et al., 2002) and by the same regulated 
process (Gobran and Rooney, 2001). In contrast, secretion of SP-A and SP-D occurs 
independently of lamellar bodies and is either not regulated or regulated by a different 
mechanism (Gobran and Rooney, 2001; Mason et al, 2002).  
 
1.3.5 Surfactant release from type II cells via exocytosis 
 
 
Lipid and protein components of surfactant are secreted via exocytosis of 
“lamellar bodies,” i.e. via fusion of surfactant-containing vesicles with the plasma 
membrane. Surfactant within lamellar bodies is densely packed as circular 
arrangements of lipid membranes. The exocytotic process of lamellar bodies bears 
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some cytological, biochemical, and functional properties that distinguish it, in many 
aspects, from secretion in other cell types. First, lamellar bodies are very large, 
among the largest secretory vesicles in mammalian cells. Second, vesicle contents are 
secreted into a small fluid volume termed hypophase, subphase, or alveolar-lining 
fluid (ALF), which covers the epithelial cell layer and separates it from the air space 
(Dietl et al., 2001). Third, the secreted product (surfactant) is lipophilic and therefore 
poorly soluble in an aqueous environment. This probably results in the accumulation 
of various macromolecular aggregates of surfactant in the ALF.   
 
In general, the regulation of surfactant secretion involves processes before 
exocytosis, such as vesicle transport, docking, or priming, but may also include 
events after membrane fusion, such as fusion pore expansion (Rahamimoff and 
Fernandez, 1997). Despite these various sites of regulation, the fusion of the vesicle 
membrane with the plasma membrane is a central and discrete step in the course of 
secretion (Mair et al., 1999).  
 
 
Secretagogue stimulation of type II cells in culture results in rapid formation 
of a fusion pore between the lamellar body and plasma membrane followed by a 
much slower and prolonged release of surfactant from the lamellar body (Haller et al., 
2001). Modulation of fusion pore size, and consequently surfactant release, is also 
calcium-dependent providing an additional level of regulation of surfactant secretion. 
Interestingly, there is preliminary evidence that following discharge of some of its 
surfactant cargo, the lamellar body is released from the cell surface and moves to a 
more internal location (Dietl and Haller, 2000); the latter observation, if true, has 
important implications for lamellar body biogenesis (Dietl et al., 2001).   
 
The results of an electron microscopic autoradiography study with 3[H] 
leucine established that newly synthesized protein in type II cells was sequentially 
detected in the endoplasmic reticulum, Golgi and multivesicular bodies, and lamellar 
bodies (Chevalier and Collet, 1972). There is abundant electron microscope evidence 
for fusion of multivesicular bodies with lamellar bodies, suggesting that this event 
represents the final stage in the delivery of newly synthesized proteins to the lamellar 
body (Figure 1.6). Turnover of surface film components in the alveolar airspace 
results in the internalization of SP-B and SP-C into the endocytic pathway of type II 
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epithelial cells and recycling of these peptides to the lamellar body via a pathway that 
traverses the multivesicular body. It is therefore likely that the multivesicular body 
plays a critical role in integrating the biosynthetic and recycling pathways in type II 
epithelial cells to maintain surfactant homeostasis (Weaver et al., 2002). 
 
Figure 1.6  The exocytotic process of lamellar bodies.  Surfactant phospholipids and 
proteins are synthesized by alveolar type II cells lining the alveoli.  Surfactant lipids 
and surfactant protein B (SPB) precursor protein and surfactant protein C (SPC) are 
transported to multivesicular bodies and, after proteolytic processing, stored in 
lamellar bodies.  SPB and SPC and surfactant lipids are secreted into the alveolar 
subphase and interact with surfactant protein A to form a tubular myelin reservoir 
from which multilayer and monolayer surface are formed, thus reducing surface 
tension at the air-liquid interface.  Surfactant remnants are taken up and reutilized or 
catabolized by type II epithelial cells.  Formation of the active surface film is required 
to maintain lung volumes, thereby preventing atelectasis and respiratory failure. 
(Adapted from: Whitsett and Weaver, 2002; Mallery, 2005) 
 
 
1.3.6  The clinical need 
 
Respiratory diseases account for more than 845,000 hospital admissions each 
year second only to injury and poisoning as a cause of emergency admissions. Of the 
580,000 deaths each year in the UK, one in five is due to respiratory diseases with 
35,000 deaths being attributed to lung cancer followed by pneumonia and chronic 
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obstructive pulmonary disease (COPD) (Hubbar, 2006).  Many chronic lung diseases, 
such as COPD, remain without cure and are only treatable with lung transplantation.  
However, the demand for organ transplants is high yet the shortage of donor organs 
severely limits this clinical approach. One of the factors that determine the lung’s 
capacity for repair is the ability of stem cells to proliferate and differentiate to replace 
damaged cells and tissues.  There is a great hope that ES cells, embryonic germ cells, 
or even adult somatic stem cells can be engineered as an unlimited source of cells to 
enhance organ-specific repair or replace lost tissues (Neuringer and Randell, 2004). 
 
Consequently, research in respiratory medicine involving the interdisciplinary 
fields of tissue engineering and stem cell bioprocessing have emerged as a promising 
and potential new alternative for the treatment of lung diseases. 
 
1.3.7 Progress towards the development of a tissue engineered lung 
 
Over the last decade, bioengineering has enlarged the possibilities to develop 
tissue models (Langer and Vacanti, 1993) by combining conventional cell culture 
approaches with a concept according to which most cells can adopt specific three-
dimensional orientation and organization in an extracellular matrix, in response to 
proper stimuli induced mechanically in vitro (Paquette et al., 2004).  One of them is 
the study of the potential use of stem cells as a source for cell transplantation, as well 
as therapeutic implications for currently untreatable acute or chronic lung diseases 
and to determine why the current treatments are ineffective.  
 
A great deal of progress has been made in the development of many complex 
tissues but, before considering the design process to engineer lung tissue 
replacements, it is important to understand aspects of the anatomy and physiology of 
the normal lung as well as that of the diseased or damaged lung (Nichols and 
Cortiella, 2008). 
 
The confluence of studies investigating mechanisms of lung development, 
repair following injury, and development of in vitro methods for the derivation of 
lung epithelium either from pluripotent embryonic stem cells or multipotent adult 
 61
somatic cells, represent the initial building blocks that could pave the way toward 
cell-based therapies for lung disease (Stripp and Reynolds, 2005). 
 
1.3.8 Embryonic stem cell studies towards lung development 
 
 Endoderm is the last of the three germ layers to form during embryonic 
development in vivo.  This endoderm lineage was considerably harder to derive from 
ES cells than mesoderm and ectoderm germ layers and therefore considerably a 
complex process (Gadue et al., 2005).  Although a number of different approaches 
have been established to upregulate ES cell differentiation towards lung epithelial 
phenotypes, the yields of lung progenitor cells still remain comparatively low 
(Rippon et al., 2008). 
 
The first report of the detection of a lung epithelial phenotype, type II 
pneumocytes, in differentiated murine ES cell cultures was made in 2002 (Ali et al., 
2002). The protocol used in this study was based on a simple hypothesis that a 
commercial cell culture medium called SAGM (Small Airway Growth Medium, 
Cambrex BioScience, Wokingham) optimized for the growth of primary distal lung 
epithelial cells would contain a cocktail of soluble factors that could also increase the 
yield of lung epithelial cells from ES cells (Rippon et al., 2008). This was indeed the 
case, although ES cells were unresponsive to the serum-free medium until they had 
achieved a relatively advanced state of differentiation, suggesting that it selected out 
spontaneously differentiated type II pneumocytes rather than actively drove 
differentiation. Derived pneumocytes were shown to express surfactant protein C 
(SPC) mRNA and protein, and contained sparse lamellar body–like vesicles in the 
cytoplasm, but unfortunately were present in only very low numbers in the final 
culture. Subsequent attempts to optimize the growth factor composition of SAGM 
and increase pneumocyte differentiation yielded only modest results (Rippon et al., 
2004). SAGM treatment has since been shown to enhance type II pneumocyte 
differentiation from human ES cells with similar results (Samadikuchaksaraei et al., 
2006). 
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A more complex, but potentially very effective, method to drive 
differentiation is to recapitulate the embryonic environment by direct co-culture of ES 
cells with developmentally relevant cell types (Rippon et al., 2008). The profound 
role that embryonic lung mesenchyme plays in the specification of regional epithelial 
phenotypes along the pulmonary tree has been long established in developmental 
biology (Shannon et al., 1994; Shannon et al., 1998). Correspondingly, co-culture of 
murine EBs with mesenchyme dissected from the distal tips of mid-gestation murine 
fetal lungs (Embryonic Days E11.5–E13.5) directed the differentiation of epithelial 
cells expressing thyroid transcription factor (TTF)-1, a marker of early pulmonary 
epithelium, and SPC in three-dimensional channels reminiscent of the embryonic 
lung (Van Vranken et al., 2005; Van Vranken et al., 2007). This was also effective 
when mesenchyme and EBs were separated by a porous membrane, suggesting that 
the mechanisms involved paracrine signalling. Although the co-culture differentiation 
method is not amenable to scale up, as it is highly labour intensive, it does provide a 
useful model system to dissect the developing respiratory epithelial niche. 
Accordingly, more recent work indicated that the inductive power of embryonic lung 
mesenchyme is stage-specific, being most effective at Embryonic Day E11.5, just 
before the initiation of distal lung branching morphogenesis (Denham et al., 2006). 
Similarly, attempts have been made with human ES cells, but murine lung 
mesenchyme was largely unable to initiate lung-specific marker expression, 
suggesting that the pulmonary niche exhibits species specific differences (Denham et 
al., 2007). 
 
A method of cell reprogramming based on the exposure of permeabilized cells 
to cell extracts derived from the mature target cell type has been used by Qin et al., 
(2005). This method was originally developed to switch the phenotype of mature cells, 
for example, by deriving T lymphocytes from the 293T fibroblast cell line (Hakelien 
et al., 2002). However, it also proved a highly effective method to differentiate ES 
cells into alveolar epithelial cells, obtaining yields of approximately 10% SPC-
expressing cells within 7 days (Qin et al., 2005). Briefly, ES cell differentiation was 
initiated by EB formation, and then 10-day-old EBs were dissociated and 
permeabilized with streptolysin O, before exposing to an extract of murine type II 
pneumocytes (MLE-12 cell line). SPC-expressing cells appeared between Days 3 and 
7 after cellular reprogramming; this observation was specific to the MLE-12 cell 
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extract and not observed with a fibroblast cell extract. Putative type II pneumocytes 
derived by this method were shown to co express TTF-1 and SPC, contained 
abundant lamellar bodies, and over time appeared to transdifferentiate to type I 
pneumocytes. Together, these data argue against the SPC-expressing ES cells 
representing merely a transient transfer of phenotypic markers from the cell extract, 
and instead suggest that the ES cells acquired a type II pneumocyte phenotype by 
differentiation (Rippon et al., 2008). 
 
Another attempt at upregulating endodermal differentiation was established 
that could specifically enhance endoderm formation and suppress that of the other 
two germ layers during the very early stages of ES cell differentiation, before the 
emergence of mature somatic lineages. The most effective strategy yet developed is 
to mimic embryonic signalling events and expose ES cells to saturating 
concentrations of activin A, a member of the Nodal signalling family, during the first 
7 days of differentiation (Rippon et al., 2008). In 2004, a landmark paper clearly 
demonstrated that high levels of activin A promoted the sequential emergence of 
definitive endoderm from murine ES cells, followed by the formation of pancreatic b-
cell and hepatocyte lineages (Kubo et al., 2004). Accordingly, lung epithelial 
differentiation was also found to be enhanced by early treatment of ES cells with 100 
ng/ml activin A (Rippon et al., 2006). In this study, the use of fetal bovine serum was 
largely replaced by a synthetic, partially defined additive (KnockOut Serum 
Replacement). Interestingly, the absence of serum appeared to cause the premature 
arrest of pulmonary epithelial differentiation at a primitive fetal-like phenotype 
(Rippon et al., 2008). 
 
Most attempts to derive pulmonary epithelium from ES cells have focused on 
obtaining type II pneumocytes. However, the derivation of airway epithelium from 
murine ES cells has also been achieved (Coraux et al., 2005). In this work, a 
proportion of murine ES cells were induced to differentiate into non-secretory Clara 
cells simply by culture on a collagen I matrix. When these cells were raised to an air–
liquid interface, they then gave rise to a fully differentiated airway epithelium 
containing Clara cells, ciliated cells, and basal cells arranged in a structure strikingly 
reminiscent of murine airway epithelium in vivo. This demonstrates not only those 
pulmonary phenotypes other than alveolar epithelium that can be obtained from ES 
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cells but also that physical cues can be as effective as chemical stimuli in initiating 
and directing differentiation (Rippon et al., 2008). 
 
A recent study by Wang and co-workers has developed a transfection and 
culture technique that facilitates, via genetic selection, the differentiation of human 
ES cell into an almost pure population of type II cells.  The purity and characteristics 
of type II cells were demonstrated, including expression of surfactant proteins A, B, 
and C, α-1-antitrypsin, and the cystic fibrosis transmembrane conductance receptor, 
as well as the synthesis and secretion of complement proteins C3 and C5. In this 
study, genetically modified human ES cells containing a single copy of the human 
SPC promoter-Neor fusion gene were used enriched with G418 antibiotic selection.  
However, these differentiated type II pneumocyte-like cells survived for only 2 days 
in culture in the absence of G418 (Wang et al., 2007). 
 
 
1.4 3D matrices 
1.4.1 Alginate hydrogel 
 
 
Challenges related to the cellular components of an engineered tissue include 
cell sourcing, expansion, and differentiation as well as regulatory and production 
issues, such as sterility, safety, storage, shipping, quality control, and scale-up 
(Naughton, 2001). Other challenges are associated with the biomaterial scaffolds 
designed to deliver the cells and guide tissue growth and differentiation. These 
biomaterials must meet several criteria to maximize the chances of a successful repair, 
including biodegradability and/or biocompatibility, facilitating functional tissue 
growth, and appropriate biomechanical properties (Awad et al., 2002; Hunziker, 
2002; Freed et al., 1993; Freed et al., 1994). Various researchers have investigated 
the ability of alginate and agarose hydrogels to act as a scaffold material for 
chondrocytes to regenerate cartilage tissue (Rowley et al., 1999; Mauck et al., 2000; 
Buschmann et al., 1995; Paige et al., 1996; van Susante et al., 1995; Lee et al., 1998; 
Buschmann et al., 1992; Fragonas et al., 2000; Chubinskaya et al., 2001; Chang et al., 
2001). Among the hydrogel biomaterials, the seaweed-derived alginate and agarose 
are typically thought to be inert because they lack native ligands that could allow 
interaction with mammalian cells (Rowley et al., 1999). 
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Hydrogels have been studied increasingly as matrices for tissue engineering 
(Lee and Mooney, 2001).  Hydrogels for use as tissue engineering scaffolds are 
generally designed to contain pores large enough to accommodate living cells or 
dissolve/degrade away, releasing growth factors and thereby creating pores into 
which living cells may penetrate and proliferate.   One significant advantage of 
hydrogels as tissue engineering matrices is that the hydrophobic bond may covalently 
incorporate cell membrane receptor peptide ligands, in order to stimulate adhesion, 
spreading and growth of cells within the hydrogel matrix.  The disadvantage is low 
mechanical properties which results in difficulty in handling (Lee and Mooney, 2001). 
 
Alginate is a collective term for a family of polysaccharides produced by 
brown algae (Painter, 1983) and bacteria (Gorin et al., 1966; Govan et al., 1981). 
Chemically, they are linear co-polymers of 1f4 linked â-D-mannuronic acid (M) and 
R-L-guluronic acid (G) arranged in a blockwise pattern along the chain with 
homopolymeric regions of M (M blocks) and G (G blocks) residues interspersed with 
regions of alternating structure (MG blocks) (Figure 1.7). In its biosynthetic pathway, 
alginate is produced via a post-polymerization reaction involving a C-5 inversion on 
the M residues of mannuronan. This reaction is catalyzed by the mannuronan C-5 
epimerases. Since all natural alginates are produced from homopolymeric 
mannuronan by the same basic C-5 inversion from M to G, the remarkable variability 
in composition and sequence found in the polysaccharide is solely due to the different 
catalytic properties of the various epimerases (Høidal et al., 1999; Strand et al., 2003).  
 
The most relevant application of alginate in the biotechnology field is 
connected with its ability to form stable gels when in contact with solutions of 
divalent cations, such as calcium. The ionotropic gelation of alginate has been 
described, based on X-ray fibre diffraction data from dehydrated specimens (Atkins, 
1973a; Atkins, 1973b), using the so-called “egg-box” model (Figure 1.7) (Grant et al., 
1973; Morris et al., 1978). According to this model, chain-chain associations are 
induced by the presence of calcium and junction zones are formed between 2/1 
helical chains of G sequences that present cavities suitable to accommodate divalent 
cations in a chelate type of binding. Circular dichroism and electron microscopy 
evidences describe junctions between G sequences as microcrystalline dimmers 
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(Morris et al., 1978) or composed of very few laterally associated chains (Smidsrød, 
1974). 
 
 
 
 
 
 
 
 
1.4.2 Encapsulation of cells 
Encapsulation of animal cells into alginate hydrogels has been used with a 
large number of different cells types (Sun, 1997; Chang, 1996; Tyler, 1990).  
Immobilization of ES cell into such gels, and their proliferation, should give rise to a 
large number of isolated ES cell aggregates and later EBs that might be able to 
differentiate to cells of all three germ layers.  The number of equally developed EBs 
that could be generated using this technology can not be reached with any other 
current method.  Encapsulated ES cells can grow as compact colonies within the 
Figure 1.7  (A) Diagram showing different gel network structures of an alginate 
hydrogel. (B) Chemical properties of the alginate structure.  Alginate is a polysaccharide 
co-polymer made of guluronic and mannuronic acid groups.  In the presence of divalent 
calcium ions, the calcium is ionically substituted at the carboxylic site.  A second 
alginate strand can also connect at the calcium ion, forming a link in which the calcium 
ion attaches two alginate strands together.  The result is a chain of calcium-linked 
alginate strands that form a solid gel (egg-box model).  (Modify from Bienaime et al., 
2003)  
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beads and give rise to morula- and, subsequently, blastula-like structures.  The ability 
to generate large numbers of EBs by encapsulation makes microbead-grown EBs a 
potential in vitro source for tissue engineering approaches.  The differentiated EBs 
can then easily be released from the beads by Ca2+ depletion (Magyar et al., 2001). 
 
Research by Magyar et al. (2001) showed that murine ES cell colonies, when 
released from 1.6% alginate microbeads, can further differentiate to cystic EBs with 
beating cardiomyocytes.   Gerecht-Nir et al., (2004a) reported the formation of 
human EBs in dynamic culture using a rotating cell culture system.   The slow-
turning lateral vessel (STLV) of a specific bioreactor significantly enhances the 
formation and differentiation of human EBs, as compared with conventional Petri 
dishes.  These studies also showed that, by controlling cell aggregation via 
manipulation of human EBs was more efficient, yielding highly proliferating human 
EBs with enhanced differentiation capabilities (Gerecht-Nir et al., 2004a). 
 
Later, Gerecht-Nir et al., (2004b) reported the formation of human EBs within 
3D porous alginate scaffolds.  The confining environments of the alginate scaffold 
pores enabled efficient formation of EBs with a relatively high degree of cell 
proliferation and differentiation, encouraged round, small-sized EBs and induced 
vasculogenesis in the forming EBs to a greater extent than in static or rotating 
cultures.  Alginate scaffolds are characterized by macromolecular structures 
resembling the extracellular matrix; their hydrogel nature enables efficient cell 
seeding and tissue engineering (Glicklis et al., 2000; Leor et al., 2000; Shapiro and 
Cohen, 1997).  The porosity of the alginate scaffolds can be controlled during 
fabrication, yielding sponge-like material with > 90% porosity, connecting pore 
structures and pore sizes ranging from 50 to 200 µm in diameter (Zmora et al., 2002). 
 
Dang et al. (2004) demonstrated that mass encapsulation of human and 
murine ES cells is a practical method for controlling cell aggregation in vitro.  They 
determined that encapsulation of ES cells was necessary for efficient EB formation, 
cell proliferation and differentiation in stirred-suspension bioreactors.  The ability to 
measure and control culture conditions accurately in stirred-suspension bioreactors 
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will be a valuable tool for understanding and optimizing delivery profiles of 
exogenous factors that affect ES cell differentiation. 
 
Although the concept of alginate encapsulation of cells has been around for 
more than 20 years (Lim and Sun, 1981), the current study represents the first 
application of the technology to human ES cells and the derivation of distal epithelial 
lung cells using a bioreactor for scaling up production. 
 
 
1.5 Bioreactors for tissue engineering 
 
 
Bioreactors are being increasingly introduced into tissue engineering 
laboratories as they bring great advantages compared with standard static seeding 
conditions.  Flow and mixing within the bioreactor can be controlled to enhance mass 
transfer of nutrients, gases, metabolites and regulatory molecules, to regulate the size 
and structure of the forming tissue (Lalan et al., 2001). 
 
In order to achieve large-scale tissue structures, there must be appropriate 
transport of nutrients to and waste from the cells as they begin to form a tissue or 
organ.  Several culture systems have been developed to provide the necessary 
transport conditions for cell growth in three dimensions, including perfusion reactors 
(Bancroft et al., 2002), rotating-wall vessel reactors (Carrier et al., 1999) and 
spinning-flask reactors (Sikavitsas et al., 2002).  These reactors have unique flow 
patterns and a degree of controllable mechanical stimuli derived from the flow, but 
their primary benefit is generally in their transport properties (Lavik and Langer, 
2004). 
  
Many studies have shown that cell and tissue growth is enhanced in response 
to mechanical stresses under fluid flow as compared to that under static incubation 
conditions.   A bioreactor may be defined as a system that simulates physiological 
environments for the creation, physical conditioning and testing of cells, tissues, 
precursors, support structures and organs in vitro (Barron et al., 2003).   
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 The design and functional requirements of the tissue to be engineered 
determine the specific design requirements, e.g. cells, scaffolds and hydrodynamic 
conditions in the bioreactor (Freed and Novakovic, 2000).  In the design of a 
bioreactor, both biomechanical and biochemical controls are essential in the creation 
of a simulated physiological environment for cell and tissue growth.  Pulsative forces, 
pressure, reservoir, mechanical valve, the pump, the processing chambers, filter, flow 
rate, shear stress, frequency, stroke rate and stroke volume are extremely important 
design considerations.  The biochemical environment is equally important in the 
design of a bioreactor.  The transfer of nutrients to the cells and removal of waste 
products is necessary for the healthy development of tissue (Barron et al., 2003).  
 
 The first step in engineering functional tissue is cell seeding.  According to 
Freed and Novakovic (2000), cell seeding requirements include high yield to 
maximize cell utilization, high kinetic rate to minimize time in suspension for 
anchorage-dependent and shear-sensitive cells and uniform distribution of attached 
cells for rapid and uniform tissue growth. 
 
Bioreactors are widely used for cultivating mammalian, insect and microbial 
cells in the mass production of useful products, e.g. antibiotics, fermentation products 
and recombinant proteins. Another important application of bioreactors is to simulate 
in vivo conditions for the growth of cells and tissues, thereby providing an in vitro 
laboratory method for addressing fundamental biomedical questions. Proper in vivo 
simulation requires both formation of three-dimensional cell aggregates to allow 
crucial cell-cell interactions and the strict control of environmental conditions 
(Saarinen et al., 2003). 
 
One major challenge is how to translate the research-scale product designs 
into large-scale production of biologically functional tissues that are reproducible, 
safe and economically competitive. These requirements render bioreactors essential in 
the ex vivo engineering of living tissues. The most common approach is to immobilize 
the appropriate cells (e.g. chondrocytes or stem cells) in porous, biodegradable, and 
biocompatible scaffolds which provide templates for tissue development and cultivate 
the cell/scaffold constructs in a bioreactor that confers a dynamic in vitro 
environment for tissue growth. The in vitro cultivation of 3D-constructs in the 
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bioreactor that supports efficient nutrition of cells, possibly combined with the 
application of mechanical stimulation to direct cellular activity, differentiation and 
function, is an important step towards the development of functional grafts (Freed and 
Novakovic, 2000). Furthermore, the bioreactor provides a more well-defined culture 
condition than in vivo tissue regeneration, thus it is useful for systematic, controlled 
studies of cellular differentiation and tissue development in response to biochemical 
and mechanical cues. Today, a wide variety of bioreactor types have been developed 
for the tissue engineering of such tissues as vocal fold (Titze et al. 2005), retina (Dutt 
et al. 2003), skin, muscle, ligament, tendon, bone, cartilage and liver (Lyons and 
Pandit, 2005).  However, the use and design of a bioreactor towards generating lung 
epithelial cells have not been developed. 
 
 
1.5.1 High Aspect Ratio Vessel (HARV) bioreactor 
 
The National Aeronautics and Space Administration (NASA) designed the 
first bioreactor to simultaneously integrate co-cultivation, low shear, high mass 
transfer and three-dimensional growth (Duray et al., 1997; Unsworth and Lelkes, 
1998; Vunjak-Novakovic et al., 2002). This bioreactor was referred to as a rotating-
wall vessel bioreactor, wherein cells are grown in microgravity (Freed et al., 2002; 
Freed et al., 1999; Sutherland et al., 2002). The High Aspect Ratio Vessel (HARV) is 
a non-perfused, horizontally rotating bioreactor with a large radius and a short length, 
a cylindrical vessel with a gas exchange membrane at its base. The size and design of 
HARV permits large surface area for gas exchange per unit of reactor volume.  
 
Although shear stress is essential in modulating the mechanical properties of 
tissue constructs, high shear stress results in the formation of undesired capsules 
surrounding the tissues (Freed and Vunjak-Novakovic 1995), hence various 
bioreactors featured with low shear stress have been developed. The most commonly 
used bioreactor that exploits the benefit of low shear stress is a rotating wall vessel 
wherein the cells are grown in a microgravity environment. The HARV is already 
commercially available (Synthecon, Houston, TX) and is configured with the inner 
membrane of which is a silicone gas exchange membrane. These vessels contain 50 
ml of culture medium and are operated horizontally by solid-body rotation at rates of 
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15–40 rpm (Figure 1.8). The rotating wall vessel is also modified to contain the 
medium inlet at one end and the medium outlet via a filter on the central cylinder to 
engineer cartilage in the microgravity environment of space (Freed et al. 1997). The 
rotation of inner and outer cylinders generates the microgravity due to a dynamic 
equilibrium between the acting gravitational, centrifugal and drag forces, and 
suspends the cell/scaffold constructs in a freefall manner. It has been shown that 
engineered cartilage and cardiac tissues grown in the rotating wall vessel are 
structurally and functionally more superior to constructs grown in static or spinner 
flasks. These rotating wall vessels have also been used for the culture of retinal cell 
line to generate 3D retina-like structures (Dutt et al. 2003), bone (Yu et al. 2004) and 
temporo-mandibular joint disc (Detamore and Athanasiou 2005).  
 
Figure 1.8 (A,B) HARV bioreactor commercially available from Synthecon, Houston, 
TX.  (B) A scheme showing the co-ordinated system of the HARV.  A 50 ml vessel 
rotated at its horizontal Z axis at w rpm.  The HARV is a vessel of diameter dH ~ 
10cm and height HH ~ 0.64 cm and filled with 50ml solution.  (Source: Synthecon, 
US; Gao et al., 2001). 
 
A 
B 
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1.5.2 Airlift bioreactor (AL) 
An airlift (AL) bioreactor comprises gas and liquid mixture in circulating 
movement and involves three main aspects; the riser, gas separator and down-comer 
(Gavrilesu and Tudose, 1996).  Airlift bioreactors are generally classified as 
pneumatic reactors without any mechanical stirring arrangements for mixing. The 
turbulence caused by the fluid flow ensures adequate mixing of the liquid. The draft 
tube is provided in the central section of the reactor. The introduction of the fluid 
(air/liquid) causes upward motion and results in circulatory flow in the entire reactor. 
As sparging from the air bubbles is very damaging to the cells, the draft tube is 
needed to prevent direct contact between the cells and the upcoming air. The cells 
receive oxygen from that air. The air/liquid velocities will be low and hence the 
energy consumption is also low. AL bioreactors can be used for both free and 
immobilized cells (Martin and Vermette, 2005).  In this study, micro-carrier beads 
were used as supporting cells in the reactor.  
 
There are very few reports on AL bioreactors for metabolite production. The 
advantages of AL reactors include the elimination of the attrition effects generally 
encountered in mechanical agitated reactors. They are ideally suited for aerobic 
cultures since oxygen mass transfer co-efficients are quite high in comparison to 
those of stirred tank reactors (Martin and Vermette, 2005). 
 
1.5.2.1  Advantages vs. disadvantages of an airlift bioreactor system 
For tissue engineering purposes, a bioreactor must provide the appropriate 
environmental conditions necessary for the cells to regenerate a functional tissue.  AL 
reactors have been used in various microbial fermentations as they have the 
characteristics of relatively low-shear stress, simple mechanical structure, low-energy 
consumption and higher cell mass production (Chao et al., 1999).   
 
According to Williams, (2002); an AL bioreactor provides some advantages 
compared with conventional bioreactors and they are: 
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i. simple design with no moving parts or agitator shaft seals; less 
maintenance, less risk of defects and easier sterilization 
ii. lower shear rate, for greater flexibility 
iii. efficient gas-phase disengagement 
iv. large, specific interfacial contact-area with low energy input 
v. well controlled flow and efficient mixing 
vi. well defined residence time for all phases 
vii. increased mass-transfer due to enhanced oxygen solubility 
viii. large-volume tanks possible, increase the output 
ix. greater heat removal compared with conventional stirred tanks 
 
The main disadvantages are: 
i. greater air throughput and higher pressures needed, particularly for large-
scale operation 
ii. low friction with an optimal hydraulic diameter for the riser and 
downcomer 
iii. lower efficiency of gas compression 
iv. difficult to maintain consistent levels of substrate, nutrients and oxygen 
with the cells circulating through the bioreactor and conditions changing 
v. inefficient gas/liquid separation when foaming occurs 
 
An AL bioreactor was designed and used in this study because the system 
mimics the environment of the lung, with turbulence flow and pneumatic reactions.  
As no previous study has used an AL bioreactor for human or murine ES cell 
differentiation, this is an entirely novel approach.  The details and the design of the 
AL bioreactor will be discussed in the Chapter 9. 
 
1.6 Stem cell bioprocessing 
 
 The discovery of murine ES cells (Evans and Kaufman, 1981) and the 
derivation and culture of human ES cells (Thompson, 1998) represent major advances 
in biology with immense potential for tissue engineering and regenerative medicine 
(Hirai 2002; Prelle et al. 2002; Keller 2005). Culture of ES cells requires precise 
methods to maintain their undifferentiated state and, subsequently, to direct their 
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differentiation to target phenotypes. The traditional culture process is fragmented, 
consisting of a maintenance/expansion phase, an embryoid body (EB) formation 
phase, followed by terminal differentiation to the desired cell lineage (Conley et al. 
2005). Each phase presents obstacles that need to be overcome before widespread 
clinical application becomes standard practice. Specifically, during 
maintenance/expansion the ES cells, especially human ES cells, are traditionally 
cultured on feeder cells, such as murine embryonic fibroblasts (MEFs), in order to 
retain their undifferentiated state (Thomson et al. 1998; Reubinoff et al. 2000). 
Consequently, the quality of the feeder cells and the consistency of the culture 
conditions are critical elements in generating high quality ES cells that retain their 
“stemness”. Additionally, it has been suggested that prolonged culture of human ES 
cells can ultimately result in culture adaptation where the cells lose their true 
undifferentiated state (Draper et al. 2004).  
 
Additional considerations are the standardization and automation of ES cell 
culture; however, the trade-off between expensive automation systems (Mason et al. 
2006) and standardization remains an open challenge for the stem cell bioprocessing 
community. Several methods of expansion and differentiation of adherent ES cells 
exist, in either static or bioreactor systems, including EB cultivation (Fok et al. 2005; 
Schroeder et al. 2005; Cormier et al. 2006; zur Nieden et al. 2007), encapsulation 
(Dang et al. 2004; Bauwens et al. 2005), use of micro-carriers as substrates for cell 
attachment (Fok et al. 2005; Abranches et al. 2007), automated tissue platforms 
(Narkilahti et al. 2007; Terstegge et al. 2007), and perfusion bioreactor systems 
(Fong et al. 2005; Oh et al. 2005). Currently, the most robust method for generating 
differentiated cells from ES cells is through formation of EBs, where ES cells 
spontaneously differentiate and form tissue-like spheroids in suspension culture 
(Dang et al. 2004).  
 
The conventional methods of EB formation are impractical for large-scale cell 
production (Fok et al. 2005) and generate heterogeneous cell types not suitable for 
therapeutic applications. To address this, the use of bioreactors is essential to meet 
large scale production needs, with the inherent benefit of amenability to process-
control strategies. Automated cell culture allows monitoring and analysis of cell 
cultures faster and more accurately than comparable traditional methods. Events such 
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as apoptosis, cell division, cellular movement and attachment can be continuously 
monitored and observed and recorded for up to several weeks (Narkilahti et al. 2007). 
Terstegge recently described a system for semi-automated cell plating, media change, 
growth factor addition and cell harvesting for both human and murine ES cells 
(Terstegge et al. 2007). Furthermore, Narkilahti and co-workers, through monitoring 
the dynamic growth of human ES cells in both automated and conventional culture 
systems, reported that automated cell culture and analysis provides the optimal tool 
for the evaluation of human ES cell culture, allowing continuous monitoring of living 
cells that would be impossible to achieve by conventional methods (Narkilahti et al. 
2007). Consequently, the expansion and/or differentiation of ES cells in a variety of 
bioreactors have been investigated (Narkilahti et al. 2007). Stirred and perfusion 
bioreactors maintain significant advantages over static culture due to the 
homogeneous environment they provide and the control over crucial culture 
parameters, such as oxygen and nutrient supply, pH, and metabolite removal (King 
and Miller, 2007).  
 
In general, perfusion, or frequent feeding, enhances culture performance by 
replacing exhausted nutrients and removing inhibitory metabolic by-products (King 
and Miller, 2007). The complexity and fragmentation of ES cell culture has directed 
several groups to demonstrate that EBs can be formed directly from enzymatically 
dissociated murine ES cells in stirred bioreactors (Schroeder et al. 2005) or a rotary 
cell-culturing system (Botta et al., 2006). Murine EBs can also be formed in stirred 
vessels by removing LIF from ES cell aggregates produced in the same vessels (Fok 
et al. 2005) or by encapsulating ES cell aggregates in agarose beads (Bauwens et al. 
2005). After formation, the EBs grew in size and retained their differentiation 
potential, such as cardiomycyte differentiation (Bauwens et al. 2005; Schroeder et al. 
2005). Tightly controlled mixing conditions have proven critical in these stirred 
suspension bioreactors in producing EBs of uniform size and quality. Furthermore, 
more recently, an integrated bioprocess for the culture, expansion and differentiation 
of murine ES cells has been demonstrated (Randle et al. 2007). In this system, 
encapsulated undifferentiated murine ES cells were cultured in rotary cell culture 
system in a single step process that does not require the formation of EBs or the 
disruption of cell aggregates, resulting in the formation of 3D mineralized constructs 
(Randle et al. 2007). Differentiation of encapsulated ES cells has been used 
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successfully for a wide range of tissue engineering applications and into several 
specific lineages. Dang et al. demonstrated the controllable and scalable culture of 
murine and human ES cells encapsulated in agarose hydrogel. Encapsulation 
permitted the use of high-cell-density culture and enabled EB formation and 
differentiation to haematopoietic cells in a suspension bioreactor (Dang et al. 2004). 
 
1.6.1 Challenges in stem cell bioprocessing for lung cellular therapies 
 
The design principles (Lim et al., 2007) pertinent to stem cell bioprocessing 
can be categorized into three groups, namely a) process components, b) process 
requirements, and c) process function, as summarised in Figure 2. A combination of 
generic, off-the-shelf, and personalized manufacturing paradigms must be considered 
as no single technology satisfies all requirements.  The process components consist of 
the cell source and type, the elucidation of appropriate signals required for cellular 
development, in addition to scaffold and bioreactor design and implementation. 
Process requirements address practical considerations of bioprocessing satisfying 
good manufacturing practices such as, quality assurance, bioprocess monitoring 
control and automation, in addition to product transportation. Finally, the process 
components and process requirements need to ensure the end-product’s functionality, 
integration and longevity to name but a few vital factors included in the process 
function. Identification of the optimal cell source, key cellular signals, delivery of 
suitable growth mimicry factors via appropriate scaffolds and provide on a controlled 
culture environment through the use of bioreactors, are essential tailor-made 
requirements in stem cell bioprocessing and tissue engineering. Clearly, application-
specific approaches are required; however, certain common methodologies can be 
applied. This review will only address when dealing with process components 
methodology applicable to stem cell bioprocessing for lung cellular therapies. 
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Successful stem cell bioprocessing, in terms of expansion and differentiation, 
depends on the control of key process variables: (i) the physiochemical environment 
(pH, O2, etc), (ii) nutrients and metabolites, and (iii) growth factors (Lim et al., 2007). 
Many growth and transcription factors, glucose, oxygen, lactate, glutamine and pH 
play an important role in the metabolic homeostasis of the developing lung, which 
include trachea and lobe formation, branching morphogenesis, proximal-distal 
epithelial differentiation, and mesenchymal development (Shannon and Hyatt, 2004). 
Furthermore, the above-mentioned physicochemical parameters, which can be 
measured and controlled in real time (Kirouac and Zandstra, 2008), enable the 
development of a suitable bioprocesses that mimic the normal environment of the 
lung.   
 
Oxygen plays an important role in stem cell maintenance and differentiation. 
Several studies have revealed that oxygen levels profoundly influence stem cell 
niches and promote the differentiation of certain types of stem or progenitor cells, 
while inhibiting the differentiation of others (Simon and Keith, 2008). It has been 
shown that culture of ESCs in hypoxic conditions reduces differentiation during 
propagation (Ezashi et al., 2005). Furthermore, Ezashi et al (2005) demonstrated that 
Figure 1.9  The design principles of stem cell bioprocessing.   
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hESCs grow more efficient under low oxygen conditions (3%-5%). Oxygen plays an 
important role in the differentiation of fetal lung cells in vitro. Studies performed in 
rats have shown that a hypoxic oxygen tension maintained lung morphogenesis in 
vitro (Gebb and Shannon, 2000) with increased terminal branching and cellular 
proliferation in fetal lung explants that were cultured at 3% oxygen compared with 
21% oxygen. Similarly, a study performed in murine lung demonstrated that a low 
oxygen environment (3%) stimulated pulmonary vascular and epithelial branching 
morphogenesis in vitro (van Tuyl et al., 2005). Increased epithelial branching was 
accompanied by increased SPC expression, implying that low oxygen maintains an 
appropriate epithelial differentiation pattern. Furthermore, low oxygen also stimulates 
vascularisation and is accompanied by a significant increase in platelet endothelial 
cell adhesion molecule (CD-31 or Pecam-1) and vascular endothelial growth factor 
(VEGF) expression (van Tuyl et al., 2005). 
 
Glucose provides not on only a source of energy but also a variety of cellular 
signals.  Glucose concentration affects ES cell differentiation; it has been 
demonstrated that early human and murine embryo development in vitro is enhanced 
by low glucose levels (Conaghan et al., 1993; Quinn, 1995).  However, the traditional 
protocols for ES cell maintenance and differentiation are primarily based on media 
with high glucose concentrations (Chang and Zandstra, 2004).  Whereas, traditionally 
the differentiation of EBs in suspension cultures was done at high (25mM) glucose 
concentration, Khoo et al. (2005) examined the growth and proliferation of EBs in 
different glucose concentrations demonstrating that the highest EB growth occurred 
in 5.5 mM glucose media. Glucose has traditionally been thought to be the primary 
substrate for energy metabolism in the developing lung (Fisher, 1989).  Previously, it 
has been described that high glucose levels inhibit biochemical and morphological 
maturation of fetal lung in vitro.  Morphologic analysis of right upper lobe fetal rat 
explants revealed significant decreases in the number of type II pneumocytes and 
lamellar bodies per alveolar lining cell in high glucose-treated explants derived from 
days 19-20 of gestation (Gewolbi et al., 1996).  Similarly, lactate is an important 
precursor for fetal lung glycogen.  In vitro studies using rabbit fetal lung explants 
indicated that the presence of both glucose and lactate may be necessary for glycogen 
accumulation in the developing fetal lung (Engle et al., 1987).   
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The lungs synthesizse glutamine (Plumley et al., 1990) and are involved in 
glutamine metabolism because they contain the necessary prerequisite machinery, 
glutamine synthesise (Abcouwer et al., 1992; Abcouwer et al., 1995), to catalyse de 
novo glutamine biosynthesis. The lungs also extract glutamate, the precursor for 
glutamine biosynthesis, from the pulmonary circulation (Welbourne, 1988).  Fox et al. 
(1996) measured the rate of oxidation of glutamine, glucose, lactate and 3-
hydroxybutyrate in type II pneumocytes isolated from day 19 fetal rat lungs reporting 
that the rate of glucose oxidation was 2.13 +/- 0.36, significantly lower than that of 
glutamine. In their study, they documented that glutamine and other alternate 
substrates are oxidized preferentially over glucose for energy metabolism by the day 
19 fetal rat lung type II pneumocytes (Fox et al., 1996). 
 
Another important parameter, pH, is a potent modulator of cellular 
proliferation and differentiation.  It is believed that pH gradients may have significant 
effects on the viability, growth and differentiation of stem cells. However, no studies 
exist that have reported the optimum pH range for stem cell differentiation into 
pneumocytes. In haematopoietic cultures, pH variations of as much as 0.5 units, 
depending on culture duration and cell density, occur, and culture pH was found to 
have substantial effects both on progenitor cloning efficiency and cell differentiation 
(McAdams et al., 1997). In vivo measurements of alveolar pH in the developing fetal 
lamb have shown the luminal fluid to be acidic (pH 6.3).  
 
Growth factors are important mediators of cellular growth and differentiation 
in the developing and adult lungs.  In lung morphogenesis, growth factors specify 
patterns of branching and control airway size and cell fate, among other functions 
(Desai and Cardoso, 2002). During the initial stages of lung bud morphogenesis and 
subsequent formation of the bronchial tree, activation of fibroblast growth factor 
(FGF) signalling in the epithelium by mesenchymal-derived FGF10 is critical (Sekine 
et al, 1999). Control of cell proliferation and cell fate of the nascent bud is dependent 
on the distal expression of bone morphogenic protein 4 (BMP4), a transforming 
growth factor β (TGFβ) super family member, whose expression is in turn controlled 
by FGF10 (Weaver et al., 2000). Additional mechanisms stimulating growth of the 
epithelial tubules involve factors, such as epidermal growth factor (EGF)/TGFα, 
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hepatocyte growth factor, and FGF7. TGFβ1 signalling is thought to prevent local 
budding and to maintain proximal airways in an unbranched form by suppressing 
epithelial cell proliferation and by promoting synthesis of extracellular matrix 
components around airways (Warburton et al., 2000; Cardoso et al., 2001). During 
the last step of alveolization, septation of the distal saccules to form the definitive 
alveoli requires FGF and PDGF signalling (Weinstein et al., 1998; Bostrom et al., 
1999). In the fully developed lung, these signals are presumably balanced to maintain 
cellular activities at equilibrium, so that normal lung structure and function are 
preserved (Desai and Cardoso, 2002). 
 
Advances in optical technologies are now allowing for real-time monitoring 
and quantification of the physicochemical parameters described above, a strategy that 
can be applied to cell therapy associated measurements (Kirouac and Zanstra, 2008).  
These include chemical and fluorescent lifetime sensors for measuring pH, pO2 and 
pCO2 (Sud et al., 2006); spectroscopic analysis for measuring organic molecules, 
such as glucose and lactate; in situ microscopy and digital image processing, which 
are capable of measuring cell density, size distribution, aggregation, and phenotype 
(Dykstra et al., 2006); and affinity sensors for real-time protein quantification 
(Becker et al., 2007).  Such real-time monitoring technologies enable continuous 
evaluation of critical culture parameters, thus ensuring that the culture is within the 
optimal conditions. 
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CHAPTER 2 
 
AIMS AND OBJECTIVES 
 
_____________________________________________________________________ 
 
2.1 Overview of the experiments 
 
 To achieve the aims of this study, an interdisciplinary approach was 
developed, combining elements of cell biology and engineering.  The stem cells used 
were human and murine embryonic stem (ES) cells, selected on the basis of their 
pluripotency, availability and comparative ease of growth.   Encapsulation in alginate 
hydrogel was chosen as a means to culture these cells in three dimensions (3D) and 
bioreactors were used to enhance and scale-up the differentiation of ES cells to lung 
epithelial phenotypes.  In the first instance, a commercially available HARV 
bioreactor was used and then a purpose-built integral bioprocessing system was 
designed.  Differentiation of ES cells into type II pneumocytes was assessed by 
analysis of gross morphology on inverted microscopy and scanning electron 
microscopy.  Cell ultrastructure was studied with transmission electron microscopy. 
Expression of proteins and genes was characterized using immunocytochemistry and 
RT-PCR, respectively, and quantitative analyses of cell phenotypes were made with 
flow cytometry.  Cell viability was quantified using Live/Dead assay and Alamar blue.   
 
 Thus, this study is divided into 3 main phases;  
Phase 1: 2D embryonic stem cell differentiation 
Phase 2: 3D system for the maintenance and differentiation of ES cells 
Phase 3: 3D integrated stem cell bioprocessing 
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Figure 2.1 Diagrammatic representation of the integrated bioprocessing approach to 
differentiating stem cells to pulmonary epithelium adopted in this study 
 
 
2.2 AIMS 
 
The general aim of this thesis is to achieve efficient and reproducible maintenance 
and differentiation of embryonic stem (ES) cells to airway epithelium by developing 
appropriate bioprocessing technology.  Specifically, to develop and establish a novel 
culture method to maintain ES cell pluripotency in 3D and to enhance and upregulate 
the differentiation into endoderm and, subsequently, type II pneumocytes, in a 
specific conditioned medium.  Also to create a basis for the automation of the process 
using bioreactors as a means to scale-up the differentiation and expansion of 3D 
alveolar epithelial cells in vitro, resulting in large scale production of alveolar 
epithelial cells for tissue engineering and other applications.  
 
 
 
 83
2.3 OBJECTIVES 
 
The specific objectives according to the 3 phases are: 
Phase 1: 2D embryonic stem cell differentiation 
1. To enhance the differentiation of murine and human ES cells into pulmonary 
epithelial cells using an approach that is designed to facilitate scale up of the 
process 
 
Phase 2: 3D system for the maintenance and differentiation of ES cells 
2. To maintain the undifferentiated state and pluripotency of human ES cells in a 
feeder-free system without passaging or embryoid body formation during 
prolonged culture. 
 
Phase 3: 3D integrated stem cells bioprocessing 
 
3.  To develop an efficient single step culture system to produce pulmonary 
epithelial cells in an established bioreactor system 
4. To design and develop a novel bioreactor system that mimics the pulmonary 
environment. 
 
2.4 HYPOTHESES 
 
Pulmonary epithelial cells, specifically type II pneumocytes, can be derived 
from embryonic stem (ES) cells via the method of upregulated differentiation via EB 
formation. However, as the existing protocols provide only low yields of target cells 
and require prolonged, time-consuming culture methods, their potential for future 
experimental and therapeutic applications is very limited. It is hypothesized, therefore, 
that it is possible to develop new means both to maintain ES cells in vitro and to 
upregulate their differentiation to pneumocytes that can not only be carried out more 
quickly and with less operator input but also provide larger proportions of target cells 
than existing methods. 
 
Specifically the hypotheses examined in this study were that: 
1. Culturing human and murine ES cells in static culture in medium conditioned 
by cells of a human lung carcinoma line with properties of type II 
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pneumocytes (A549) will enhance their differentiation into pulmonary 
epithelial cells, in particular type II pneumocytes. 
2. Encapsulation of human ES cells in alginate hydrogel maintains their 
undifferentiated state and pluripotency in prolonged culture.  
3. If A549-conditioned medium upregulates the differentiation of pneumocytes 
from ES cells in static culture, a similar effect can be obtained in 3D culture 
following cell encapsulation in alginate 
4. The process of differentiating encapsulated murine ES cells in A549-
conditioned medium can be automated by adapting it for use in an established 
bioreactor system (HARV)  
5. An airlift bioreactor system can be devised that mimics the pulmonary 
environment that is as good as or better than the HARV bioreactor in scaling 
up the differentiation of ES cells into pulmonary epithelial cells using A549-
conditioned medium. 
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CHAPTER 3 
 
MATERIALS AND METHODS 
 
_____________________________________________________________________ 
 
 
3.1 General overview of the materials and methods 
 
 This chapter describes the practical approaches used to achieve the 3 main 
strategies that were discussed in Chapter 2. The differentiation of ES cells into type II 
pneumocytes either in 2D or 3D was assessed by analysis of gross morphology on 
inverted microscopy and scanning electron microscopy.  Cell ultrastructure was 
studied with transmission electron microscopy. Expression of proteins and genes was 
characterized using immunocytochemistry and RT-PCR, respectively and quantitative 
analyses of cell phenotypes were made with flow cytometry.  Cell viability was 
quantified using Live/Dead assay and Alamar blue.  The procedures described in this 
chapter were used to characterize and analyze the cells obtained using the 2D and 3D 
approaches towards the formation of lung epithelial cells. 
 
3.2 Cell culture 
 
 3.2.1 Human ES cell culture 
 
3.2.1.1 Culture medium  
 
For human ES (hES) cells, the culture medium consisted of KNOCKOUT D-
MEM, optimized D-MEM (Dulbecco’s Modified Eagle’s Medium) with high glucose 
and sodium pyruvate without L-glutamine, 20% (v/v) KNOCKOUT SR (serum free) 
(all from Gibco, Invitrogen, Life Technologies, Paisley UK ) supplemented with 
2mM L-glutamine, 0.1 mM non-essential amino acids solution, 0.1mM 2-
mercaptoethanol and 4ng/ml human recombinant basic fibroblast growth factor 
(bFGF) (all from Gibco, Invitrogen, Life Technologies, Paisley UK). 
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3.2.1.2 Human embroid body medium 
 
This medium consisted of the same ingredients as the culture medium 
mentioned above (3.2.1.1) but without adding human recombinant basic fibroblast 
growth factor (bFGF). 
 
3.2.1.3 Human ES cell line 
 
The human ES cell line used in this study was H1 from WiCell Research 
Institute Inc., Madison. 
 
3.2.2 Murine ES cell culture 
 
3.2.2.1 Culture medium  
 
 Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco, Invitrogen, Life 
Technologies, Paisley UK) high glucose/no pyruvate was supplemented with 10% 
(v/v) fetal bovine serum (FBS; PAA Laboratories Ltd., UK), 2mM L-glutamine, 0.1 
mM B-mercaptoethanol (all supplied by Gibco, Invitrogen UK) and 1000 U/ml 
ESGRO (LIF) (Chemicon, Millipore Upstate, UK). 
 
3.2.2.2 Murine embryoid body (EB) medium 
 
 This medium consisted of the same ingredients as the culture medium 
mentioned above (2.2.2.1) but without adding leukaemia inhibitory factor (LIF). 
 
 3.2.2.3 Murine ES cell line 
 
The murine ES cell line used in this study is E14TG2α cell line (American 
Type Culture Collection, Virginia, USA; # CRL-1821). 
 
3.3 Directing human ES cell/murine ES cell differentiation to alveolar type II 
pneumocytes 
   
3.3.1 SAGM medium 
 
 Small Airway Growth Medium (SAGM) (Biowhittaker, Watersville, MD; 
marketed in the UK by Cambrex, Wokingham, UK) was selected for use in this study 
as it was designed for the growth of mature distal lung epithelium and work by 
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colleagues (Ali et al., 2002; Samadikuchakarei et al., 2006; Rippon et al., 2006) 
previously showed that culture in this medium enhances the differentiation of human 
and murine ES cells into alveolar epithelial cells.  SAGM consists of a basal medium 
(Small Airway Basal Medium, SABM; the formulation has not been published but it 
does not contain any hormones, growth factors and vitamins other than group B 
vitamins [personal communication with the technical specialist of Cambrex]).  To 
make SAGM, the following factors are added: 0.5 mg/ml bovine serum albumin, 
5µg/ml insulin, 10 µg/ml transferrin, 30 µg/ml bovine pituitary extract, 0.5 µg/ml 
epinephrine, 6.5 ng/ml tridothyronin, 0.1 ng/ml retinoic acid, 0.5 µg/ml 
hydrocortisone, 0.5 ng/ml human epidermal growth factor, 0.05 mg/ml gentamicin 
sulphate and 0.05 mg/ml amphotericin B.  
 
3.3.2 A549-conditioned medium 
 
Cells of the human type II pneumocyte adenocarcinoma line (A549, ATCC: 
American Type Culture Collection, Virginia, USA; # CCL 183; Lieber  et al. Int. J. 
Cancer 17,62-70:1976) were defrosted and grown in the T75 flasks (Orange Scientific, 
Braine-l'Alleud, Belgium) in F12 Kaighn’s Nutrient supplemented with 15% (v/v) 
fetal bovine serum (FBS; PAA Laboratories Ltd., UK) and 2mM L-glutamine 
(Invitrogen, UK)).  The cells, which reached confluency within 2-3 days, were fed 
every 2 days. The conditioned medium was collected every 2-3 days filtered through 
a 0.22µm filter (Millipore Upstate, UK) to remove cell debris and kept at -80oC for 
long storage. 
 
3.4 3D cultures 
 
 3.4.1 Encapsulation technique 
 
The alginate hydrogel used consisted of 1.1% (w/v) low viscosity alginic acid 
from brown algae (Sigma Aldrich, UK) and 0.1% (v/v) bovine gelatin (Sigma Aldrich, 
UK) (all dissolved in Phosphate-Buffered Saline (PBS), pH 7.4) solution at room 
temperature.  1.1% (w/v) alginic acid (Sigma Aldrich, UK) was prepared by 
dissolving the acid powder with PBS and stirring the solution for a few hours as the 
acid powder is difficult to dissolve. 
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Monolayer cells cultured in T75 flasks (Orange Scientific, Braine-l'Alleud, 
Belgium) were detached using enzymatic treatment with 0.05% (w/v) trypsin-EDTA 
without calcium and magnesium (Gibco, Invitrogen UK). Cell counts were performed 
using trypan blue (Sigma Aldrich, UK) to get 20,000 cells per bead. The cells were 
centrifuged at 1000 rpm (revolutions per min) for 5 min, supernatant was removed 
and cell pellets were then resuspended together with the alginate solution.   
 
To get a uniform bead size, a Pharmacia peristaltic pump (Model P-1; 
Amersham Biosciences, UK) was used.  The cell-gel solution passed through at a 
flow rate of 20 rpm (revolutions per min) and a drop height of 3 cm using a 25-gauge 
needle (Becton Dickinson, UK).  The tubing was autoclaved and then further 
sterilized with 1M NaOH for 30 minutes and washed three times with sterile PBS.  
Beads were dropped into a sterile, room temperature solution comprising 100 mM 
calcium chloride (CaCl2) (Sigma Aldrich, UK) and 10 mM (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) (HEPES) (Sigma Aldrich, UK), in distilled water (pH 
7.4).  The liquid cell-gel solution discharged from the pump gelled immediately on 
contact with the CaCl2 solution, forming spherical beads (2.3-2.5 mm in diameter 
after swelling).  The beads were kept in gently stirred CaCl2 solution for 6-8 minutes 
at room temperature and then washed three times in PBS and placed into appropriate 
medium. 
 
3.4.2 Alginate bead dissolution 
 
A sterile depolymerization buffer was used to dissolve the beads that consisted 
of Ca2+-depletion solution with 50 mM tri-sodium citrate dihydrate (Fluka, UK), 77 
mM sodium chloride (BDH Laboratory supplies, UK) & 10 mM HEPES (Sigma 
Aldrich, UK). These ingredients were dissolved in PBS. The beads with medium 
were washed twice before adding the dissolving solution.  Later, the beads were 
incubated at 37oC for about 5 minutes while stirring gently.  The solution that 
contained dissolved beads was centrifuged at 1250 rpm for 5 minutes and the pellet 
washed once with PBS and centrifuged again, at 1000 for 3 minutes. 
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3.4.3 High Aspect Ratio Vessel (HARV) bioreactor  
 
The High Aspect Ratio Vessel (HARV) (manufactured by Synthecon Ltd., USA), 
also know as a rotating wall bioreactor, was developed by Synthecon in connection 
with the National Aeronautics and Space Administration (NASA) programme to 
study tissue and cellular engineering in a low-shear, non-turbulent environment. It has 
a large radius-to-depth ratio (40 mm x 10 mm) providing a substantial surface area on 
the rear face for gas exchange through a gas-permeable membrane. The medium 
volume is 50 ml. The culture vessel itself is a disposable, sterile, clear plastic circular 
unit with two sampling or injection Luer lock ports and a half inch drain/fill port. 
Input of media/beads was performed through the fill port and air bubble removal was 
undertaken through the Leur valves. Bubble removal was performed daily. The 
HARV units were attached to a rotator base which sat in a humidified incubator and 
were controlled by an external electrical unit. 
 
 
3.5 Imaging 
 
3.5.1 Light microscopy 
 
Phase contrast images were captured from a IX70 inverted microscope 
(Olympus, Southall, UK) equipped with a colour CoolPix 950 digital camera (Nikon, 
Kingston-upon-Thames, UK) or black and white, high resolution charge coupled 
device (CCD)-Camera (Soft Imaging Systems GmbH, Germany) with analySISB and 
analySISD software; or a BX60 upright (Olympus UK Ltd., Southall) microscope 
equipped with an Axiocam digital camera (Carl Zeiss, Jena, Germany). 
 
3.5.2 Fluorescence imaging 
 
Fluorescence images were captured from two types of microscope, an inverted 
IX70 microscope (Olympus UK Ltd., Southall) equipped with a colour CoolPix 950 
digital camera (Nikon, Kingston-upon-Thames, UK) or black and white, high 
resolution charge coupled device (CCD)-Camera (Soft Imaging Systems GmbH, 
Germany) with analySISB and analySISD software; or a BX60 upright (Olympus UK 
Ltd., Southall) microscope equipped with an axiocam (Carl Zeiss, Jena, Germany).  
The other was an upright microscope, BX-60 epifluorescence (Olympus UK Ltd., 
Southall), and images were captured with Axiocam digital camera (Carl Zeiss, Jena, 
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Germany) and analysed using KS-300 software (Imaging Associates, Thames, UK).  
FITC (fluorescein isothiocyanate) and GFP (green fluorescent protein) were viewed 
at an excitation wavelength of 490 nm, TRITC (tetramethyl rhodamine iso-
thiocyanate) and Texas Red at 570 nm and nuclear counterstain with DAPI (4'-6-
Diamidino-2-phenylindole) at 360 nm.  
 
 3.5.3 Scanning electron microscopy (SEM) 
Monolayers of cells were cultured on a round coverslip (VWR International 
Ltd., UK) in 6 well plates or bacterial Petri dishes (Orange Scientific, Braine-l'Alleud, 
Belgium).  The culture medium was removed and the cells rinsed in PBS twice and 
then fixed in 2.5 % (v/v) glutaraldehyde in cacodylate buffer (pH 7.2) for 30 minutes.  
Samples were then rinsed in 0.1M phosphate buffer twice and dehydrated through a 
series of ethanols (50%, 70%, 95% and 100% (v/v) twice) for 15 min at each 
concentration.  This was followed by incubation in hexamethyldisilane (Sigma-
Aldrich, UK) for 5 min. Samples were then placed on the mounting stand (Agar 
Scientific, UK) and stored in an air tight chamber for long-term storage.   Just prior to 
viewing the mounted samples were sputter-coated (Emitech, UK) in a vacuum with 
an electrically conductive layer of gold and viewed using the Jeol JSM-840A 
scanning electron microscope and images photographed and saved on the hard disk. 
 
3.5.4 Transmission electron microscopy (TEM) 
 
Samples, in the form of cell suspensions, embryoid bodies or beads, were 
washed in buffer containing 0.1M phosphate and 0.1M sucrose, rinsed in PBS twice 
and then fixed in 3% (v/v) glutaraldehyde in cacodylate buffer (pH 7.2) for 30 min.  
Cells were then post-fixed in 1% (v/v) osmium tetroxide in 0.1M cacodylate buffer, 
transferred to 50% (v/v) ethanol, centrifuged and the resultant cell pellets were 
encased in molten agar.  The agar blocks were dehydrated and infiltrated with 
Araldite epoxy resin (Taab Laboratories Ltd, Reading, UK) and embedded in moulds.  
The resin was polymerized at 60oC for 24 hours and semi-thin (1µm) and ultra-thin 
(60-80nm) sections were cut using a Reichert-Jung Ultracut E ultramicrotome (Leica 
Microsystems Nussloch GmbH,Wetzlar, Germany) .  The semi-thin sections, for 
selection of areas of interest on light microscopy, were stained using a solution of 
0.8% (v/v) toluidine blue (Agar Scientific, Stansted, UK) in 0.8% (w/v) borax 
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containing 0.16% (w/v)  pyronin Y.  The ultra-thin sections were stained in a 
saturated solution of uranyl acetate in 50% (v/v) ethanol, followed by Reynold's lead 
citrate.  Ultrathin sections were observed in a Philips CM10 transmission electron 
microscope (Amsterdam, The Netherlands). 
 
 
3.6 Histology 
 
 3.6.1 Paraffin-embedded samples 
 
Samples in the form of embryoid bodies or beads were fixed in 4% (w/v) 
paraformaldehyde (PFA) for 30 minutes at room temperature and then placed in PBS 
for 15 minutes prior to dehydration.   
 
3.6.1.1 Paraffin embedding 
 
Fixed embryoid bodies (EBs) or beads were taken through a series of 
increasing ethanol concentrations (50%, 70%, 95% and 100% (v/v)) for 30 minutes 
and three changes for each concentration to remove all the water.  The ethanol was 
then completely replaced with neat xylene which was then replaced with paraffin-
saturated xylene at room temperature overnight.  The beads and EBs in paraffin-
saturated xylene were placed in an oven (60oC) for 20 minutes and the xylene 
completely replaced with liquid paraffin.  The samples were then embedded, 
sectioned (5 µm) and left at room temperature overnight to adhere to Vectabond™-
coated (Vector Laboratories, UK) glass slides.   
 
3.6.1.2 Haematoxylin and eosin stain (H&E) 
 
For haematoxylin and eosin staining, the paraffin was removed from the 
sections by immersion in xylene, decreasing ethanol concentrations and then tap 
water.  Sections were then dipped in haematoxylin (Harris’ solution; VWR 
International Ltd., UK) for 30 seconds, washed in running tap water for 2-3 minutes 
and examined for sufficient staining.  Excess stain was removed by decolourizing in 
0.5-1% (v/v) HCl (Sigma Aldrich, UK) in 70% (v/v) ethanol (Fisher, UK) for a few 
seconds and then washing in tap water for 5 minutes.  Sections were finally dipped in 
 92
1% (v/v) eosin (VWR International Ltd., UK) for 2 minutes and washed briefly in tap 
water to remove excess stain.  The tissue was dehydrated by dipping in ethanol (70% 
[v/v] once, 100% [v/v] twice), cleared in xylene (VWR International Ltd., UK) and 
mounted in DPX mounting solution (VWR International Ltd., UK). 
 
3.6.1.3  Antigen retrieval 
 
For immunocytochemistry of paraffin-embedded samples, de-waxed sections 
were autoclaved in a tri-sodium citrate, dihydrate buffer (10 mM, pH6.0) (Sigma 
Aldrich, UK) and allowed to cool and dry in order to increase immunogenicity. 
 
   
3.6.2 Frozen samples 
 
3.6.2.1  Fixation and embedding 
 
Samples were fixed in 4% (w/v) paraformaldehyde (Sigma Aldrich, UK) 
overnight at 4ºC.  After rinsing with PBS twice, the beads were incubated with 30% 
sucrose (w/v) (Sigma Aldrich, UK) at 4oC overnight.  The next day, beads were 
washed twice with PBS and placed in OCT (Optimal Cutting Temperature) 
compound (VWR International Ltd, UK) in a 50ml centrifuge tube (VWR 
International Ltd, UK).  The intact beads together with the OCT compound in the 
centrifuge tube were then immersed in isopentane (Sigma Aldrich, UK) suspended in 
liquid nitrogen for 1-2 minutes until the OCT compound solidified.  The frozen beads 
were kept at -80oC overnight or at least 1 hour before sectioning.  Frozen beads in 
OCT compound were sectioned at 7µm and placed on poly-l-lysine-coated glass 
slides (VWR International Ltd., UK).  The sections were immersed in fixative 
containing; 70% (v/v) ethanol (Fisher, UK), 4% (v/v) formalin (Sigma Aldrich, UK), 
5% (v/v) glacial acetic acid (Sigma Aldrich, UK) in distilled water.  Sections were 
allowed to fix for 2-5 min and were then placed in two changes of 70% (v/v) ethanol, 
each for 30 sec, followed by two changes of distilled water. 
 
3.6.2.2 Haematoxylin and eosin (H&E) stain 
 
The 7µm sections were stained as described in 3.6.1.2 
 93
 
  
3.7 Immunocytochemistry 
 
 
 Immunocytochemistry was performed throughout all experiments that include 
paraffin-embedded and frozen sections according to the following protocol.  Live 
samples that were cultured in 4 or 8 well chamber slides (VWR International Ltd., 
UK) were washed once with phosphate-buffered saline (PBS) (Invitrogen, UK) and 
then fixed with 4% (v/v) paraformaldehyde (Sigma-Aldrich, UK) for 30 minutes.   
 
Fixed samples, paraffin embedded or frozen sections were washed three times 
with PBS (Invitrogen, UK), followed by permeabilization with 0.1% (v/v) Triton X-
100 (Sigma-Aldrich, UK).  After washing twice in PBS, non-specific binding was 
blocked by incubation with 10% (v/v) rabbit, goat or mouse serum (Vector 
Laboratories, USA) according to the origin of the primary antibodies.  The primary 
antibodies were diluted according to the manufacturer’s protocol with 0.1% (w/v) 
bovine serum albumin (BSA) (Sigma-Aldrich, UK) and 0.01% (w/v) sodium azide 
(Sigma-Aldrich, UK) in PBS.  Sections were incubated with primary antibodies 
overnight at 4oC.  The following day, sections were washed three times with PBS and 
secondary antibodies conjugated with fluorescent dye, diluted in 0.1% bovine serum 
albumin (BSA) (Sigma-Aldrich, UK) in PBS, were applied for 1 hour at room 
temperature.  The species of the secondary antibodies was selected according to the 
origin of primary antibodies used.  Lastly, the samples were counterstained with 4’,6 
diamidino-2-phenylindole (DAPI) or propidium iodide (PI) (Vector Laboratories, 
USA) to visualize cell nuclei.  
 
3.8 Reverse Transcriptase-PCR 
 
 3.8.1 Ribonucleic acid (RNA) extraction 
 
RNA was extracted from the sample or cell culture using the total RNA 
isolation kit (Qiagen Ltd., UK) according to the manufacturer’s protocol.  Briefly, 
attached cells were trypsinized and spun down to get a cell pellet.  The pellet was 
then dissolved in 350 to 600 µl lysis buffer which contained 10 µl/ml B-
mercaptoethanol.  The amount of lysis buffer provided with the kit depends on the 
cell number.  The lysis buffer that contains the cell lysate can be stored at -80oC for 
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long storage before proceeding with the RNA extraction protocol.  Cell lysates were 
resuspended gently a few times until there was no visible sign of cell clumps and 
transferred to the QIAshredder tube (Qiagen LtD., UK) to homogenize the cell lysate.  
The tube was centrifuged at maximum speed for 2 minutes.  To purify the RNA, 
equal volumes of 70% (v/v) ethanol were added to sample solutions, gently mixed 
and then transferred into the RNeasy mini spin column (Qiagen Ltd, UK).  Following 
centrifugation at 15000 rpm for 15 seconds, solutions were discarded and at this step 
the RNAs were present on the spin column membrane. 700µl of RW1 buffer was 
added to the column and centrifuged at maximum speed for 15 seconds.  Again the 
solution was discarded and the column was transferred to a new 2ml tube and 500 µl 
RPE solution was added and centrifuged again at 15000 rpm for 2 min.  Lastly, the 
column was transferred to a new tube and 30 µl of RNAse-free water added in the 
middle of the membrane carefully and centrifuged at maximum speed for 1 min. 
Finally, the extracted RNA was diluted 20 times and the concentration and purity (at 
260/280nm) of RNA extracted was measured using an UV spectrophotometer 
(Eppedndorf BioPhotometer, Germany).  Samples were stored at -80oC for long 
storage until further use. 
 
3.8.2 Primer design 
 
The sense and anti-sense primers were designed using Primer Express 2 
software (Applied Biosystems, Warrington, UK).  The oligonucleotide designs were 
purchased online from Invitrogen, UK. 
 
The lists of RT-PCR primers sequences for the identification of murine ES 
cells differentiation are as listed below in Table 3.1: 
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Table 3.1  RT-PCR primer sequences (murine ES cells) 
Gene Primer sequence (5’ – 3’) Annealing 
temp. (ºC) 
Amplicon 
size (bp) 
SPA 
 
F: AGGCAAACACGGTGTCTAAG 
R: GATGTAAAGTGGACGAAGG 
57 219 
SPC F: CAGCTCCAGGAACCTACTGC 
R: CACAGCAAGGCCTAGGAAAG 
63 200 
FoxA2 F: TGGTCACTGGGGACAAGGGAA 
R: GCAACAACAGCAATAGAGAAC 
59 289 
AQP5 F: ACTGCCACAGCTCAGACCTCA 
R: AACGCCCAACCCGAATACC 
58 267 
CC10 F: GCCTCCAACCTCTACCATGA 
R: CTCTTGTGGGAGGGTATCCA 
55 241 
Oct 4 F: GCCTTGCAGCTCAGCCTTAA 
R: CTCATTGTTGTCGGCTTCCTC 
54 127 
GAPDH F:  TGTGTCCGTCGTGGATCTGA 
R:  CCTGCTTCACCACCTTCTTGA 
59 76 
Key: FoxA2: forkhead box A2; SPC: surfactant protein C; SPA: surfactant protein A; 
AQP5: aquaporin 5; CC10: Clara cell 10; Oct4: Octamer 4. GAPDH: Glyceraldehyde 
3-phosphate dehydrogenase 
3.8.3 Polymerase chain reaction (PCR) amplification 
 
1µg total RNA in a final volume of 20µl was reverse-transcribed into cDNA 
using the Thermoscript reverse transcription-polymerase chain reaction (RT-PCR) 
system (Invitrogen Ltd., Paisley UK).  Oligo (dt) 20 was used to prime RT reactions, 
which enabled the same cDNA to be PCR-amplified with different sites of gene-
specific primers. Denaturing of the RNA template and primer was done by incubation 
at 65oC for 5 minutes and later placed on ice while adding the master mix to the 
reaction. The master mix contains the following; 4µl of 5X cDNA synthesis buffer 
(250mM Tris acetate pH 8.4, 375 mM potassium acetate, 40 mM magnesium acetate, 
stabilizer), 1 µl of 0.1 M dithiothreitol (DTT) (a reducing agent for the RTase), 40 U 
RNase Out (an RNase inhibitor), 1 µl RNase free water, 2 µl of 10mMdNTP mix and 
15U/ µl ThermoScript RT. The reaction mixes were then transferred into a thermal 
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cycler (Perkin Elmer GeneAmp PCR System 2400; AB Applied Biosystems, 
Warrington, UK) and incubated at 50οC for 30 min followed by 85oC for 5 min. 
Negative controls were performed in the absence of cDNA template.  The positive 
control was total whole lung RNA (Ambion, Inc.). cDNA samples were stored at -
20oC prior to use. 
 
 
Each reaction contained 50 µl of mix. In the 50µl PCR reaction mix, the final 
concentration of MgCl2 and dNTP (Promega, UK) were 3 and 10mM, respectively.   
DNA amplification was performed in an Eppendorf Thermal Cycler (Eppendorf AG, 
Hamburg, Germany): double-stranded DNA denaturation and the activation of Taq 
DNA Polymerase (Fermentas, Life Sciences, UK ) was carried out at 94oC for 10 min, 
followed by 40 cycles of template denaturation at 94oC (5sec), primer annealing at 
56oC and primer extension at 72oC (30sec).   
 
 3.8.4 Agarose gel electrophoresis 
 
PCR products were separated on 2% (w/v) agarose gel (made up with 1 X 
TAE buffer (Tris Acetate EDTA) (Sigma Aldrich, UK) which contains 0.4M Tris 
acetate, 10 mM EDTA (ethylenediaminetetraacetic acid), pH 8 and visualized by 
ethidium bromide fluorescence (Sigma Aldrich, UK) and size of products 
approximated using 50bp and 100bp ladders (Fermentas, Life Sciences, UK).  Digital 
images of ethidium bromide-stained gels were captured using the Bio-Rad (Hemel 
Hempstead, UK) Fluor-S MultiImager system. 
 
 
3.9 Viability assays 
 
Live/Dead assay is a simple and fast method to differentiate between live and 
dead cells seen morphologically in situ, especially cells within the encapsulated beads.  
Alamar blue assay is found to be more sensitive to quantify the number of viable cells 
within beads as it measures fluorescence changes that are believed to be more 
accurate and sensitive than any other assays using absorbance reader. 
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 3.9.1 Live/Dead assay 
 
In situ live and dead cells can be visualized using the the LIVE/DEAD® 
Viability/Cytotoxicity Assay Kit (Molecular Probes, Invirtogen ,UK) that provides a 
two-colour fluorescence cell viability assay based on the simultaneous determination 
of live and dead cells with two probes that measure two recognized parameters of cell 
viability, intracellular esterase activity and plasma membrane integrity. Live cells are 
distinguished by the presence of ubiquitous intracellular esterase activity, determined 
by the enzymatic conversion of the virtually non-fluorescent, cell-permeant calcein 
AM to the intensely fluorescent calcein. The polyanionic dye calcein is well retained 
within live cells, producing an intense uniform green fluorescence (EX/EM ~495 
nm/~515 nm). EthD-1 enters cells with damaged membranes and undergoes a 40-fold 
enhancement of fluorescence upon binding to nucleic acids, thereby producing a 
bright red fluorescence in dead cells (EX/EM ~495 nm/~635 nm). EthD-1 is excluded 
by the intact plasma membrane of live cells. The determination of cell viability 
depends on these physical and biochemical properties of cells.  A 4 mM EthD-1 and 2 
mM calcein AM solution (Molecular Probes, Invitrogen, UK) diluted in PBS was 
added to live cells or alginate beads and incubated at room temperature for 30 
minutes, in the dark. After incubation, the solution was aspirated and a small amount 
of PBS was added to the cells to prevent dehydration.  The cells and beads were then 
photographed within 30 minutes using an inverted IX70 (Olympus, Southall, UK) 
fluorescent microscope to visualize the proportion of live and dead cells. 
 
3.9.2 Alamar blue assay 
 
Alamar blue, or The CellTiter-Blue® Cell Viability Assay (Promega 
Corporation, USA), provides a homogeneous, fluorescent method for monitoring cell 
viability. The assay is based on the ability of living cells to convert a redox dye 
(resazurin) into a fluorescent end product (resorufin). Dead cells rapidly lose 
metabolic capacity and, thus, do not generate a fluorescent signal. Viable cells retain 
the ability to reduce resazurin into resorufin, which is highly fluorescent. The 
CellTiter-Blue® Reagent is a buffered solution containing highly purified resazurin 
(blue).  The spectral properties of CellTiter-Blue® Reagent change upon reduction of 
intrinsic fluorescence until it is reduced to resorufin, which is pink and highly 
fluorescent (exitation 579nm/ emission 584nm). The absorbance maximum of 
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resazurin is 605nm and that of resorufin is 573nm. Either fluorescence or absorbance 
may be used to record results; however, fluorescence is the preferred method because 
it is more sensitive.  The cell viability assay solution was diluted to a final 
concentration of 1:5 with the appropriate culture medium.  100 µl of the solution was 
added to 96 well plates and incubated for 2 hours at 37oC in 5% (v/v) CO2.  For the 
measurement of fluorescence, the solution was transferred to a 96 white well plate 
(VWR Ltd., UK) and read using a microtitre plate fluorometer (MFX, Dynex 
Technology, Findland) with the excitation wavelength being at 530-570 nm and 
emission at 580-620 nm.  A standard curve was generated using the amount of total 
metabolic activity produced from the same cultured cells proportional to the number 
of viable cells.  For the final data analysis, the fluorescence values were normalized to 
the standard value of metabolic activity determined by the Alamar blue assay.   
 
3.10 Flow cytometry 
 
Flow cytometry was used to analyse and quantify the proportion of cells 
immunolabelled for expression of SPC (surfactant protein C), a specific marker of 
type II pneumocytes, and AQP5 (Aquaporin 5), a marker of type I pneumocytes, in 
the differentiated murine ES cells.  In this study, a single colour experiment was used. 
The antibody of interest was conjugated with FITC (fluorescein isothiocyanate) and 
excitation at 488nm and emission at 518nm were detected in the FL-1 (fluorescence-
1) channel. 
 
Conjugated single cells were analysed using a Beckman Coulter Epic Altra 
(Coulter Corporation, Florida, USA).   
 
3.10.1 Calibration and suitable controls 
 
Before running any samples, routine alignment and calibration is essential. 
For the calibration procedure, Calibrite™3 beads (Becton Dickinson, UK) were used 
prior to analysis and are suitable for FITC (fluorescein isothiocyanate)/PE 
(Phycoerythrin)/ PerCP (Peridinin-chlorophyll-protein complex) and 7-AAD 
calibration. The beads were used to adjust instrument settings, set the fluorescence 
compensation and check the instrument sensitivity before analysis. Background auto-
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fluorescence occurs naturally in cells and was accounted for in these experiments by 
running a sample of cells without any staining and drawing a dot plot of FSC 
(forward scatter channel) vs SSC (side scatter channel) (size vs granularity). A region 
termed R1 in the density plot was drawn around the discreet cell population of 
interest based upon size and granularity (gated). The differentiated ES cells typically 
have high granularity but vary in size. Cell control samples (negative control) were 
undifferentiated murine ES cells conjugated with the same antibodies of interest (anti-
SPC or anti-AQP5).   
 
3.10.2 Data analysis 
 
Data were further processed using Expo32 MultiCOMP software.  A single 
parameter histogram shows the number of events (cell counts) on the y-axis over the 
measurement parameter (relative fluorescence intensity) on the x-axis.  Finally, data 
from the samples were analysed over the negative control to determine the percentage 
of the total population formed by the positive phenotype. 
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CHAPTER 4 
ENHANCED DIFFERENTIATION OF ALVEOLAR 
EPITHELIAL CELLS FROM HUMAN AND MURINE 
EMBRYONIC STEM CELLS USING CONDITIONED 
MEDIUM 
 
ABSTRACT 
Stem cells offer an attractive cell source for various medical applications, 
including tissue engineering, cell and gene therapy, but the derivation of specific 
differentiated phenotypes in sufficient numbers for clinical use is a major challenge. 
Colleagues have previously shown that lung epithelial cells can be generated from 
murine and human embryonic stem (ES) cells following administration of a cocktail 
of growth factors to the growth medium, exposure to cell extracts or co-culture.  
However, these techniques require laborious culture conditions and, therefore, still 
pose difficulties for the large-scale derivation of pulmonary epithelial cells.  In this 
study, the differentiation of human and murine ES cells into pulmonary epithelial 
cells, specifically type II pneumocytes, was demonstrated following culture in 
medium conditioned by a human type II pneumocyte tumour cell line (A549).  
Following, 10 days growth in conditioned medium, differentiated human ES cells 
showed expression of surfactant protein C and its mRNA, markers for type II 
pneumocytes, and transmission electron microscopy revealed the typical morphology 
of type II pneumocytes, with lamellar bodies and apical microvilli. Interestingly, 
similar differentiation occured in murine ES cells. These findings demonstrate a new, 
relatively economical means to produce human and murine ES cell-derived 
pneumocytes that lends itself to scale up.  Identification of key factors driving 
pneumocyte differentiation by proteomic analysis of the conditioned medium will 
allow modification of the medium to up-regulate the process further.  
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4.1 INTRODUCTION 
 
 The use of stem cells in regenerative medicine could play a major role in the 
repair of a variety of lung diseases.  However, due to the very low rates of cellular 
proliferation and turnover in vivo, the cellular and architectural complexity of the 
respiratory tract and the lack of an intensive research effort, lung stem cells remain 
poorly understood compared to those of other major organ systems (Neuringer and 
Randell, 2004).  
 
Progress towards the development of the individual components of engineered 
lung to date has been encouraging particularly in the production of lung epithelial 
cells. Previous studies have shown that human and murine ES cells could be 
differentiated into pulmonary epithelial cells, specifically type II pneumocytes (Ali et 
al, 2002; Rippon et al., 2004; Coraux et al., 2005; Qin et al., 2005; Van Vranken et 
al., 2005; Rippon et al., 2006; Samadikuchaksaraei et al., 2006; Wang et al., 2007).  
However, the success rate is still very low and limited and, therefore, still poses 
difficulties for the large-scale expansion of the differentiation of pulmonary 
epithelium from stem cells for potential therapeutic applications.  Furthermore, the 
differentiated cells do not remain viable for a long time in culture and no reports exist 
that demonstrate functional and phenotypically stable cells in prolonged culture. 
 
Although previous researchers have made significant progress in producing 
pure populations of pulmonary epithelium, up to 99% pure populations of type II 
pneumocytes in the case of Wang and co-workers (2007), and reaching the point of in 
vivo implantation of engineered tissues in animal models, the production of 
engineered tissue that meets the requirements of clinical application is still a long way 
off.  
 
In this study, a novel means is presented for the differentiation of human and 
murine ES cells into pulmonary epithelial cells, specifically type II pneumocytes, by 
culture in medium conditioned by the human type II pneumocyte (A549) cell line.   
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4.2 AIM AND HYPOTHESIS 
 
 The aim of this study was to develop an efficient 2D culture method for the 
differentiation of murine and human ES cells using A549-conditioned medium. 
 
 The hypothesis being tested was that A549-conditioned medium upregulates 
the differentiation of pneumocytes from human and murine ES cells in 2D culture 
condition. 
 
4.3 MATERIALS AND METHODS  
4.3.1 Maintenance of human ES cells 
 
The human ES cell line H1 was obtained from the WiCell Research Institute 
(Madison, WI, USA). Human ES cells were maintained on mitotically inactivated 
primary murine embryonic fibroblasts in human ES cell medium, comprising 
Knockout DMEM medium, 20% (v/v) Knockout Serum Replacement, 1mM L-
glutamine, 0.1mM B-mercaptoethanol, 1% (v/v) non-essential amino acids, 
supplemented with 4ng/ml human basic fibroblast growth factor (bFGF) (all supplied 
by Invitrogen Ltd., Paisley UK).  H1 cells were passaged every 7-10 days by 
incubation in 1 mg/ml collagenase IV for approximately 15 min at 37oC followed by 
scraping.   
 
4.3.2 Maintenance of murine ES cells 
 
The E14Tg2a murine ES cell line (American Type Culture Collection, 
Virginia, USA; # CRL-1821) was cultured in DMEM high glucose / no sodium 
pyruvate (Invitrogen, UK), supplemented with 10% (v/v) fetal bovine serum (PAA, 
UK), 100 U/mL penicillin and 100 µg/mL streptomycin, 2 mM L-glutamine, 0.1 mM 
2-mercaptoethanol (all supplied by Invitrogen, UK) and 1000 U/mL LIF (Milipore, 
Chemicon Upstate, UK).  The murine ES cell line was routinely passaged on 0.1% 
(w/v) gelatin (Sigma Aldrich, UK)-coated tissue culture plastic in a humidified 
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incubator set at 37oC and 5% (v/v) CO2. Undifferentiated murine ES cells (<p20) 
were passaged with trypsin-EDTA (Invitrogen, UK) every 2 or 3 days and fed every 
day.  
 
4.3.3 A549-conditioned medium 
 
A549 is a human type II pneumocyte tumour cell line (A549: American Type 
Culture Collection, Virginia, USA; # CCL 183).  The cells were grown in F12 K 
(Invitrogen, UK) supplemented with 10% (v/v) FBS (PAA, UK) and 2mM L-
glutamine (Invitrogen, UK) to confluence in T75 flasks (Orange Scientific, Braine-
l’Alleud, Belgium) for 2-3 days.  On day 3, the conditioned medium was collected 
from the flasks, passed through a 0.22µm filter to remove cell debris and kept at -
80oC for long storage. 
 
4.3.4 Differentiation of human ES cells 
 
Undifferentiated human ES cells were removed from the feeder layer by 
treatment with collagenase IV (Invitrogen, Life Technologies, Paisley, UK) which 
resulted in cell clumps.  In order to test the effects of differentiating the human ES 
cells with and without the stage of embryoid body (EB) formation, these cell clumps 
were divided into two.  One group of cell clumps was cultured in suspension for EB 
formation in bacterial Petri dishes (Sterilin, Bibbt Sterilin Ltd, Stone, Staffs, UK), as 
described previously (Samadikuchaksaraei et al., 2006).  Cells in the other group 
were cultured as monolayers and allowed to adhere to T75 flasks (Orange Scientific, 
Braine-l’Alleud, Belgium). 
 
To enhance the differentiation specifically of type II pneumocytes, both the 
human EBs in suspension and the cells grown in monolayer were cultured in the 
A549-conditioned medium. Parallel control cultures were set up where cells of the 
two groups were grown in basic medium without conditioning (F12K medium with 
15% (v/v) FBS).  The EBs were fed every 4-5 days and the monolayer culture every 
2-3 days and the monolayer cultures were passaged every 5-6 days on reaching 90% 
confluence.  Differentiated human ES cells from both the EB and monolayer cultures 
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were treated with collagenase IV and collected for analysis at 10, 20 and 30 days of 
culture in A549-conditioned medium.  Changes in cell structure and morphology 
were evaluated during the course of culture and recorded using an inverted 
microscope (Olympus, Southall, UK) equipped with a colour CoolPix 950 digital 
camera (Nikon, Kingston-upon-Thames, UK).  Parallel cultures of differentiating EBs 
and monolayers in A549-conditioned or basic medium were set up in 4 or 8 chamber 
slides for 30 days (Nalge Nunc International, Rochester, USA) for subsequent 
immunocytochemistry. 
 
4.3.5 Differentiation of murine ES cells 
 
As for human ES cell culture, undifferentiated murine ES cell colonies were 
removed by treatment with trypsin-EDTA (Invitrogen, UK) which resulted in cell 
clumps.  The cell clumps were cultured in suspension for EB formation in bacterial 
Petri dishes (Sterilin, Bibbt Sterilin Ltd, Stone, Staffs, UK), as described previously 
(Ali et al., 2002).  The EBs were cultured in maintenance medium (without LIF). To 
enhance the differentiation specifically of type II pneumocytes, after EB formation in 
suspension, they were cultured in the A549-conditioned medium. The EBs were fed 
every 4-5 days. Differentiated EBs were collected for analysis at 10, 20 and 30 days 
of culture in A549-conditioned medium.   
 
4.3.6 Immunocytochemistry 
 
Cells attached on chamber slides were washed twice in 10mM phosphate-
buffered saline (PBS; Invitrogen Ltd., Paisley UK; pH 7.2) and fixed with 4% (w/v) 
paraformaldehyde for 30 min at room temperature.  Following a rinse in PBS, the 
cells were incubated with normal rabbit or goat serum (1:25), as appropriate, for 30 
minutes at room temperature as a blocking agent.  The primary polyclonal antibodies 
used were raised against pro-surfactant protein C (SPC),  surfactant protein B (SPB), 
Clara cell 10kDa protein (CC10) and aquaporin 5 (AQP5) (Table 4.1). The cells were 
incubated with these antibodies at appropriate dilutions overnight at 4oC.  The 
following day, cells were washed again with PBS twice and respective secondary 
antibodies (Table 4.1), labelled with FITC, were applied for 1 hour at room 
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temperature.  Nuclei were counterstained with Vectashield with propidium iodide (PI) 
or 4’, 6 diamidino-2-phenylindole (DAPI) (Vector Laboratories, Peterborough, UK).  
The images were viewed and recorded using an inverted microscope (Olympus, 
Southall, UK) equipped with a colour CoolPix 950 digital camera (Nikon, Kingston-
upon-Thames, UK).   
 
Table 4.1.  Antibodies for immunocytochemistry 
Primary 
antibodies 
Dilution  Source Secondary  
antibodies 
Dilution Source 
Rabbit anti-
human pro-SPC  
1:1000 Chemicon 
AB3786 
Goat anti rabbit 
Ig G  
1:200 Chemicon 
AP132S 
Goat anti-SPB 
(M-20) 
 
1:200 Santa Cruz 
Sc-7703 
Donkey anti 
goat IgG  
1:200 Santa Cruz 
Sc-3853 
Goat anti-AQP5  
(G-19) 
 
1:200 Santa Cruz 
Sc-9890 
Donkey anti 
goat IgG  
1:200 Santa Cruz 
Sc-3853 
Goat anti-CC10 
(T-18) 
 
1:200 Santa Cruz 
Sc-9772 
Donkey anti 
goat IgG  
1:200 Santa Cruz 
Sc-3853 
Key: SPC: surfactant protein C; SPB: surfactant protein B; AQP5: aquaporin 5; 
CC10: Clara cell 10kDa protein. 
 
4.3.7 Transmission electron microscopy (TEM) 
 
Differentiated human ES cells grown as EBs were rinsed in PBS.  Cells grown 
as monolayers in T75 flasks were treated with collagenase IV, spun at 1250 rpm for 5 
minutes and washed once in PBS.  The EBs and cell suspensions were washed in 
buffer containing 0.1M phosphate and 0.1M sucrose, rinsed in PBS twice and then 
fixed in 3% (v/v) glutaraldehyde in cacodylate buffer (pH 7.2) for 30 min.  The 
details of this process are provided in Chapter 3 (section 3.5.4). 
 
Differentiated human ES cells grown as EBs were rinsed in PBS.  Cells grown 
as monolayers in T75 flasks were treated with collagenase IV, spun at 1250 rpm for 5 
minutes and washed once in PBS.  The EBs and cell suspensions were washed in 
buffer containing 0.1M phosphate and 0.1M sucrose, rinsed in PBS twice and then 
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fixed in 3% (v/v) glutaraldehyde in cacodylate buffer (pH 7.2) for 30 min.  The 
details of this process are provided in Chapter 3 (section 3.5.4). 
 
4.3.8 RNA isolation and Reverse Transcriptase-PCR 
 
To determine phenotype, RT-PCR was performed on samples taken at days 10, 
20 and 30 of human ES cell differentiation in the A549-conditioned medium.  Total 
RNA isolation was carried out using RNAeasy kit (Qiagen Ltd., West Sussex, UK) 
according to the manufacturer’s protocol.  The subsequent process is described in 
detail in Chapter 2. Primers were designed using Primer Express 2 software (Applied 
Biosystems, Warrington, UK).  RT-PCR primer sequences are shown in Table 4.2 
(human) and Table 3.1 (murine). 
 
Table 4.2  RT-PCR primer sequences (human ES cells) 
Gene Primer sequence (5’ – 3’) Annealing 
temp. (ºC) 
Amplicon 
size (bp) 
SPC F: CGGGCAAGAAGCTGCTGCTTCT 
R: CTCTCCCCAAGCTCCCATTG 
56 66 
SPB F:  GGCTGAGTCACACCTGCT 
R:  GGCTTTGGCACCAGAACT 
57 124 
CC10 F:  TACCTATCCCACCAAGCCAATG 
R;  AAGGGCAGGGCAAGGG 
58 69 
AQP5 F: CAATCTGGCCGTCAACGC 
R: TCCACCACCATGGCCTG 
62 60 
Oct 4 F: TCTGCAGAAAGAACTCGAGCAA 
 
R: AGATGGTCGTTTGGCTGAACAC 
55 128 
GAPDH F:  GTTCGACAGTCAGCCGCATC 
R:  GGAATTTGCCATGGGTGGA 
54 182 
 
Key: SPC: surfactant protein C; SPB: surfactant protein B; AQP5: aquaporin 5; 
CC10: Clara cell 10kDa protein; Oct4: Octamer 4. GAPDH: Glyceraldehyde 3-
phosphate dehydrogenase 
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PCR products were separated on 2% (w/v) agarose gel and visualized by 
ethidium bromide fluorescence and size of products approximated using 50bp and 
100bp ladders (Fermentas).  Digital images of ethidium bromide-stained gels were 
captured using the Bio-Rad (Hemel Hempstead, UK) Fluor-S MultiImager system. 
 
4.3.9 Flow cytometry analysis for murine ES cell differentiation 
 
Human embryoid bodies at day 20 of growth in conditioned or maintenance 
medium were collected for flow cytometry analysis.  The EBs were resuspended a 
few times to break them up and obtain single cells. Then the cells were centrifuged at 
1,000 rpm for 5 minutes and the cell pellet was washed once with PBS and 
centrifuged again.  Cell pellets were then fixed in 4% (v/v) paraformaldehyde (Sigma 
Aldrich, UK) for 20 min at room temperature.  While fixing, cells were resuspended a 
few times again to get single cells and sieved using a cell strainer, 40 µm in size 
(VWR International Ltd., UK).  The cells were then centrifuged at 1,000 rpm for 5 
minutes, rinsed in PBS and centrifuged again. The cells were then divided into two 
tubes, for FACS with either pro-SPC or AQP5 antibodies, using FITC-labelled 
secondary antibodies. After rinsing the cells twice in PBS (Invitrogen, UK), they 
were incubated for 15 min at room temperature in blocking agent comprising 5% 
(v/v) goat or rabbit serum diluted in PBS and 0.1% (v/v) Triton-X (Sigma-Aldrich). 
After blocking, cells were incubated with polyclonal anti rabbit pro-SPC antibodies 
(1:500) and polyclonal anti goat AQP5 antibody (1:300) (both from Chemicon, 
Upstate, UK) for 2 hours.  Cells were rinsed twice with PBS and incubated with 
secondary antibodies, rabbit anti goat (pro-SPC) and goat anti rabbit (AQP5) IgG 
1:300 (both from Chemicon, Upstate, UK), both conjugated with FITC.  After 
washing with PBS once, the cells were analysed using a Beckman Coulter Epic Altra 
(Coulter Corporation, Florida, USA).  Data were further processed using Expo32 
MultiCOMP software. 
 
 
 
 
 109
4.4 RESULTS  
 
4.4.1 Morphological changes in human ES cells 
 
Human EBs grown in maintenance medium, showed the typical morphology 
of the three germ layers beginning from day 5 in culture. After 10 days, the EBs 
started forming cysts with the fluid filled cavities being clearly seen under light 
microscopy. Human ES cells cultured in SAGM showed mixed morphological 
changes and a heterogeneous cell population.  At day 10 in culture, hEBs were seen 
to attach to the Petri dish and start growing with a morphology resembling that of 
fibroblasts (Figure 4.1a and b) and neuron-like cells (Figure 4.1c). Later in culture, 
the differentiated cells looked flatter and more epithelium-like (Figure 4.1d) and 
projections like sprouts appeared (Figure 4.2a and b).  These finger-like outgrowths 
that connected neighbouring colonies seemed similar in appearance to endothelial 
cells (Figure 4.2c and d).   
 
In A549-conditioned medium, the EBs started showing the differentiation of 
the germ layers from day 2 in culture (Figure 4.3a).   From day 6 in conditioned 
medium, the hEBs showed an outgrowth from the periphery (Figure 4.3b) and some 
evidence of cells attaching to the Petri dish.  These cells, cultured in 2-D, became 
flattened and after a few days formed confluent layers (Figure 4.3c).  The cultures 
also contained structures with the cobblestone appearance of epithelial cells. By the 
end of day 30, cells from the EBs tended to form ring-like structures on the Petri dish 
(Figure 4.3d and e) with numerous cells showing the thin, membranous morphology 
of type I pneumocytes.  
 
4.4.2 Morphological changes of murine ES cells 
 
Similar changes to those seen in human ES cell cultures were observed for 
murine ES cells.  The murine EBs showed formation of the typical three germ layers 
from day 2-3 when cultured in A549-conditioned medium (Figure 4.4a and b).  The 
EBs were seen to be attached to the Petri dish and also formed the cobblestone 
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appearance similar to that seen in human ES cell cultures (Figure 4.4c)  However, by 
the end of day 30, the cells showed clear formation of endothelial cells in contrast to 
human ES cell that showed formation of ring-like structures (Figure 4.4d and e). 
 
4.4.3 Immunocytochemistry 
 
Immunoreactivity for markers of distal airway epithelium was detected in 
differentiated human ES cells after 30 days culture in SAGM (Figure 4.5a) and A549-
conditioned medium (Figure 4.5b-e).  proSPC expression was observed in cells 
grown in SAGM (Figure 4.5a) and A549-conditioned medium (Figure 4.5b-e).  
Expression of SPB, CC10 and AQP5 (Figure 4.6a-d) was observed in human ES cells 
grown in A549-conditioned medium.  
 
Similar results for SPC expression were detected in differentiated murine ES 
cells after 15 days culture in A549-conditioned medium that showed positive proSPC 
expression (Figure 4.6e).   
 
4.4.4 Transmission electron microscopy (TEM) 
 
Subcellular organelles were virtually absent from undifferentiated human ES 
cells (Fig. 4.7a) but were abundant in all differentiated cells examined, in both human 
and murine ES cell cultures.  Human ES cells cultured in SAGM showed mitotic 
activity (Fig. 4.7b) and the typical features of pneumocytes (Fig. 4.7c-f).   For human 
ES cells in grown in A549-conditioned medium, frequent gap junction complexes 
were seen, with desmosomes at the margins of neighbouring cells, indicating cell-cell 
communication between epithelial cells (Fig. 4.8a-d). However, these features were 
not observed in SAGM culture. The presence of these organelles, that are important 
for the interaction between epithelial cells, suggests that the cells formed functional 
units.  Other typical characteristics that were seen included microvilli and lamellar 
bodies, indicative of differentiated type II pneumocytes (Fig. 4.8a-e). Mitotic activity 
was also observed indicating cell proliferation and differentiation (Fig 4.8e). Other 
cytoplasmic contents of respiratory epithelial cells that were seen were rough 
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endoplasmic reticulum, mitochondria, multivesicular bodies and lysosomes (Fig.4.9a-
e).   Some of the cells showed typical features of Clara cells, with abundant 
endoplasmic reticulum and electron-dense granules with numerous mitochondria and 
rare cells seemed to contain a mixture of organelles from Clara and type II cells, 
perhaps representing some kind of intermediate cell (Fig. 4.9b and c).   Others had 
cilia, indicative of epithelium of proximal airways (Fig. 4.9f).   
 
Similar morphological features were also observed in the differentiated 
murine ES cells (Fig. 4.10a and b) except for the electron dense granules indicating 
Clara cell formation that were not detected. 
 
4.4.5 RT-PCR 
RT-PCR was performed on day 10, 20 and 30 of human and murine ES cell 
differentiation in the A549-conditioned medium.  Expression of SPC, SPB, CC10 and 
AQP5 mRNAs was detected at all 3 stages of culture, with the levels of SPC mRNA 
being noticeably higher than that of the others (Fig. 4.11) in human ES cells.    
 
Expression of SPC and AQP5 RNAs was also detected in murine ES cells 
grown in A549-conditioned medium (Fig. 4.12).  Oct 4 RNA expression at day 0 of 
culture in conditioned medium confirmed the pluripotency of both human (Fig. 4.11) 
and murine (Fig. 4.12) ES cells. 
 
4.4.6 Flow cytometry for murine ES cell differentiation  
 
The 2D scatter plot figure shows that the differentiated cells were of a similar 
cell size and formed a homogeneous population (Figure 4.13a, allowing a single 
gating; Figure 4.13b as a negative control).  The analysis from the scatter plot 
histogram shows that the positive SPC expression at day 20 of culture in A549-
conditioned medium was 32.41%±2.1 (mean±SD) (Figure 4.13c and d) and 4.4%±2 
for AQP5 expression (Figure 4.13d and e).  
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4.5 DISCUSSION  
 
In this study, it was shown that differentiation from both human and murine 
ES cells of mature cells with the phenotype of type II pneumocytes can be achieved 
using medium conditioned by a human lung adenocarcinoma (A549) cell line.  In 
addition, this differentiation occurred whether or not the ES cells were taken through 
the stage of embryoid body formation.  Previously, colleagues and others have 
reported the derivation of mature type II pneumocytes from both murine and human 
ES cells using a range of methods that has been previously described (Ali et al, 2002; 
Rippon et al., 2004; Coraux et al., 2005; Qin et al., 2005; Van Vranken et al., 2005; 
Rippon et al., 2006; Samadikuchaksaraei et al., 2006).  Although successful in 
upregulating the differentiation of the required phenotype, these approaches involved 
complex culture conditions, for example administration of cocktails of growth and 
soluble factors and formation of embryoid bodies, and resulted in only low yields of 
pneumocytes.  Recently, Wang and co-workers (2007) have developed a reliable 
transfection and culture procedure, which facilitates, via genetic selection, the 
differentiation of human ES cells into an essentially pure (>99%) population of type 
II pneumocytes. They were able to demonstrate the pure population within 15 days of 
differentiation. However, these differentiated type II cells survive for at least 2 days 
in culture in the absence of G418.   In the present study, it was shown that the human, 
as well as murine, differentiated cells maintain their phenotype in prolonged culture 
even after a few passages. 
 
The well-known property of mammalian cells to adapt and remodel in 
response to physiological and environmental cues has often been used to drive 
differentiation of embryonic and other stem/progenitor cells toward required lineages 
by co-culturing them with mature cells or tissues (Buttery et al., 2001; Kaufman et al., 
2001; Mummery et al., 2002; Song et al., 2002; Buzanska et al., 2002; Brizzolara et 
al., 2002; Alexanian et al., 2003; Fair et al., 2003; Gerstenfeld et al., 2003; Miura et 
al., 2003 ; Sui et al., 2003 ; Ball et al., 2004 ; Hwang et al., 2004; Bentz et al., 2006; 
Vats et al., 2006; Lee et al., 2007).  For pneumocytes, primary cells are extremely 
difficult to obtain in useable numbers and they do not retain their phenotype for long 
in culture (Dobbs et al., 1990).  A549 is a human pulmonary adenocarcinoma cell line 
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that is held to be representative of distal airway epithelial cells (Fox et al., 2001).  In 
previous studies comparing A549 with primary human airway epithelial cells, both 
cell types have been shown to exhibit similar characteristics in culture in terms of the 
secretion of inflammatory mediators (Kwon et al., 1994; Mitchell et al., 1994).  Thus, 
it was postulated that this readily available and easy to maintain cell line can release 
growth factors that could promote the differentiation of human ES and murine ES 
cells and the results suggest that this is indeed the case. 
 
Although focus has been placed on the differentiation of type II pneumocytes 
in this study, to follow on from previous work by colleagues (Ali et al., 2002;  
Coraux et al., 2005; Qin et al., 2005; Rippon et al., 2006; Samadikuchaksaraei et al., 
2006; Van Vranken et al., 2006), it was possible to detect a variety distal epithelial 
phenotypes in the resultant cultures.   
 
A study done by Samadikuchaksaraei et al. (2006), reported the derivation of 
mature type II pneumocytes from human ES cells using a commercially available 
medium, SAGM (small airway growth medium).  The results showed minor 
morphological changes observed when the embryoid bodies or differentiated ES cells 
were transferred to the SAGM medium.  Although successful in producing the 
required phenotype, this approach resulted in only a low yield of pneumocytes (about 
5%).  In contrast, the present study showed a mixed and heterogeneous differentiation 
population. The formation of neuron-like cells and of tubular structures was observed 
before the morphology of type I and II pneumocytes developed in culture.  This 
observation is probably due to the differentiation medium, SAGM that contains a 
cocktail of growth and soluble factors that enhance the differentiation of other type of 
lineages. However, in this study we were able to show the formation of more than 
30% type II pneumocytes visualized by flow cytometry analysis in murine ES cells. 
This is a very promising result as previously the best rate of differentiation into type 
II pneumocytes, for human or murine ES cells was around 10%. Unfortunately, it was 
not possible to quantify the differentiation of human ES cells into type II 
pneumocytes due to limited numbers of cells available. One of the challenges to be 
met in any follow-up to this study is to quantify the degree of type II pneumocyte 
differentiation accurately.  
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Using A549-conditioned medium to drive differentiation also resulted in the 
formation of type I and II pneumocytes that formed tight junction complexes.  In the 
developing lung and during recovery from lung injury, most of the cell-cell interfaces 
consist of type I cells in direct contact with other type I cells (Mason et al., 1997).  
There are also numerous areas where type II cells are in contact with type I cells 
(Adamson et al., 1991; Danto et al., 1994; Mason et al., 1997).  Sites of cell-cell 
contact contain a number of different structures including gap junctions (Goodenough 
et al., 1996; Nicholson et al., 1997; Simon et al., 1998).  Gap junctions contain 
complexes of channels that interconnect cells in a tissue.  This enables the direct 
transfer of small signalling molecules and metabolites from the cytoplasm of one cell 
to another (Abraham et al., 2001). 
 
Previous studies have shown that cell-cell interaction, such as that which 
exists between distal mesenchyme and type II pneumocytes in vivo, is essential for 
the maintenance of the mature differentiated state of the respiratory epithelium 
(Griffin et al., 1993 ; Mollard et al., 1998; Nandkumar et al., 2002).  Epithelial-
mesenchymal interactions provide the necessary differentiative cues for lung 
development (Shannon et al., 2004) and have been shown to promote organotypic 
differentiation of functional engineered proximal airway constructs (Paquette et al., 
2003).  The formation of gap junctions demonstrated in this study suggests that the 
recapitulation of in vivo cell-cell interaction is necessary as a first step in generating 
functional distal lung tissue construct.    
 
Although small and distal airway epithelial cells were obtained in this study, 
many challenges still remain.  Proteomic analysis of the constituents of the 
conditioned medium will give better understanding of the mechanisms promoting the 
differentiation of the specific phenotypes and, furthermore, will allow identification 
of the key factors driving pneumocyte differentiation so that a medium can be 
designed to give further upregulation of the process without any risk of carry over of 
any potentially hazardous factors secreted by the A549 cells.  Conditioned media are 
known to contain a variety of proteins, some of which have been shown to stabilize 
any added growth factors (Levenstein et al., 2005).  Recently, Huang et al., (2006) 
have identified 14 human proteins in medium conditioned by A549 cells using mass 
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spectrometry and database research.  These proteins include peptidyl–prolyl cis–trans 
isomerase A, manganese superoxide dismutase, peroxiredoxin 1, 
phosphatidylethanolamine-binding protein, glutathione S-transferase P, PGP9.5, alpha 
enolase, phosphoglycerate mutase 1, galectin-1 and dihydrodiol dehydrogenase 
(DDH).   The next step is to find the significant growth factors and proteins from the 
proteiomic analysis that will enhance the differentiation of lung epithelial cell.  
 
4.6 CONCLUSION 
 
In conclusion, it was demonstrated that differentiation of human and murine 
ES cells to pulmonary epithelium, primarily type II pneumocytes, can be upregulated 
by growing the cells in medium conditioned by A549 cells, a human lung carcinoma 
cell line.  These findings suggest that this medium is a suitable and better culture 
medium to deliver both human and murine ES cell differentiation. Following 
proteomic analysis, this conditioned medium could provide a relatively cheap means 
to scale-up production of human and murine ES cell-derived pneumocytes and 
establish cell lines.  Such a human line could replace A549 cells as the major 
respiratory cell source for in vitro pharmacological and toxicological testing.  In 
addition, the cells could be used as an in vitro and in vivo system for studying lung 
development, regeneration and repair as well as representing an important step 
towards producing functional respiratory epithelial cells or tissues for implantation.  
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 Figure 4.1 
At day 10 in SAGM culture, the human EBs attached to the Petri dish and 
started forming mixed culture populations, including fibroblast-like cells (a 
and b) and neuron-like cells (c) (n=3). After 15 days in culture the 
differentiated cells looked flatter and more epithelium-like (d) (n=3). 
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Figure 4.2 
Projections from the differentiated human ES cell colonies were observed (a 
and b).  These long finger-like sprouts may have indicated early formation of 
endothelial cells or connections between neighbouring colonies (c and d) 
(n=3).   
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Figure 4.3 
In A549-conditioned medium, at the early stage the EBs showed formation 
of the germ layers (a) and some started to attach to the Petri dish (b).  The 
attached cells grew flattened in shape and, after a few days, formed confluent 
monolayers (c) with cobblestone appearance (n=3).  At the end of day 30, the 
cells formed ring-like structures on the Petri dish (d and e) (n=2). 
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Figure 4.4 
The formation of the typical three germ layers; endoderm, mesoderm and 
ectoderm (Joza et al., 2001; Dang et al., 2002; Koika et al., 2007) day 2-3 
murine EBs was observed when cultured in A549-conditioned medium (a and 
b) (n=5).  Also the cobblestone appearance of the monolayer culture was also 
observed (c). At the end of day 30, the cells showed formation of endothelium-
like cells (d and e) (n=3). 
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Figure 4.5 
Differentiated human ES cells at day 30 in SAGM culture condition (a) and in 
A549-conditioned medium (b-e) showed positive proSPC expression [positive 
FITC-green (Fluorescein isothiocyanate) expression counterstained nuclei with 
PI-red (propodium iodide)] (n=4).   
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Figure 4.6 
Expression of SPB (a), CC10 (b), AQP5 (c and d) was detected in human ES 
cells cultured in A549-conditioned medium at day 30 [positive FITC-green 
expression nuclei counterstained blue with DAPI (4',6-diamidino-2-
phenylindole)] (n=3). Differentiated murine ES cells at day 15 in A549-
conditioned medium showed proSPC expression (positive FITC-green 
[Fluorescein isothiocyanate] expression), nuclei counterstained blue with DAPI 
(e) (n=3).   
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Figure 4.7 
TEM showed undifferentiated human ES cells with no obvious cytoplasmic 
organelles (a). Human ES cells cultured in SAGM showed mitotic activity 
(b) with obvious chromatin (black arrow) probably in the late anaphase 
process. Other important features which indicate type II pneumocyte 
formation are the numerous microvilli (mv) (c-f) and lamellar bodies (LB) 
(d-f) (n=1). 
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Figure 4.8 
Human ES cells cultured in A549-conditioned medium showed frequent gap 
junction complexes (a), with desmosomes (blue arrow) at the margins of 
neighbouring cells (a,c). Other typical characteristics that were seen include 
microvilli (mv) (a-c), mitochondria (mc) (c) and lamellar bodies (LB) (c).  
Mitotic activity with obvious chromatin (black arrow) was also observed, 
probably indicating the late anaphase process (e) (n=2). 
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Figure 4.9 
Other cytoplasmic contents that were observed in the human ES cells 
cultured in A549-conditioned medium are numerous multivesicular bodies 
(mvb) (a), lamellar bodies (LB) (b,c), the rough endoplasmic reticulum (rer) 
(c), mitochondria (mc) (c),  lysosomes (d) and microvilli (mv) (e).   Features 
of Clara cells were also observed including abundant electron-dense granules 
(gr) (c,d).   Other cells contained cilia bodies (f), indicative of the epithelium 
of proximal airways (n=2).   
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Figure 4.10  
Murine ES cells cultured in A549-conditioned medium showed morphological 
changes similar to those observed in human ES cells, with formation of lamellar 
bodies (LB) (a) and microvilli (mv) (b), typical features of type II pneumocytes 
(n=1). 
 126
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 
RT-PCR results on day 10, 20 and 30 of human ES cell differentiation in A549-
conditioned medium show expression of SPC, SPB, CC10 and AQP5 mRNAs 
(n=3). Positive Oct 4 expression confirmed the pluripotency of the human ES cells 
at day 0 in the conditioned media. 
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Figure 4.12 
Expression of SPC and AQP5 RNAs was detected in murine ES cells 
grown in A549-conditioned medium (n=5). Positive Oct 4 expression 
comfirmed the pluripotency of the murine ES cells at day 0 in 
conditioned medium. 
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Figure 4.13 
The 2D scatter plot [SS (side scatter) vs FS (Forward Scatter)] showed the 
differentiated murine ES cells to be a homogeneous population (a). The 
scatter plot analysis showed as single parameter histogram, quantified the 
SPC-expressing cells as 32.41%±2.1 (mean±SD) of the population (c and d) 
and AQP5 as 4.5%±2 (mean±SD) (d and e) (b = negative control) (n=2).   
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CHAPTER 5 
 
ENCAPSULATION OF HUMAN EMBRYONIC STEM 
CELLS SUPPORTS PROLONGED FEEDER-FREE 
MAINTENANCE 
___________________________________________________ 
 
ABSTRACT 
 
Most methods for maintaining human ES cell pluripotency require the use of 
human or animal feeder cell layers, the most common being murine embryonic 
fibroblasts.  Herein, it is demonstrated that encapsulation of human ES cells in 1.1% 
(w/v) calcium alginate hydrogel resulted in the maintenance of their undifferentiated 
state for periods of up to 260 days.  However, these cells were able to differentiate 
when they were subsequently cultured in a conditioned environment. Following 
encapsulation, the human ES cell aggregates were found to express protein and gene 
markers of pluripotency and showed no evidence of the formation of any of the three 
germ layers. Immunocytochemistry and RT-PCR showed that the human ES cell 
aggregates expressed protein and gene markers characteristic of pluripotency 
including Oct-4, Nanog, SSEA-4, TRA-1-60 and TRA-1-81. At the ultrastructural level, 
the cells were arranged in closely packed clusters and showed no cytoplasmic 
organelles. In this study, a protocol was applied aimed at maintaining human ES cells 
in culture without passaging or embryoid body formation and without exposure to 
animal cells or proteins. 
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5.1 INTRODUCTION 
 
Current techniques for the culture of human ES cells are hindered by the need 
for high maintenance, comprising long, fragmented and labour-intensive processes. 
Specifically, the pluripotency of most human ES cell lines is maintained either 
through the use of feeder layers, usually murine or human fibroblasts (Amit et al., 
2003), or in feeder-free conditions through the use of matrigel or laminin (Xu et al., 
2001), or through the use of conditioned or supplemented media (Cheng, et al., 2003).  
In addition, human ES cell colonies can be maintained and passaged in two-
dimensional (2D) culture by mechanical scraping following enzymatic treatment 
(Amit et al., 2000).   
 
These culture techniques are not only laborious, tedious and involve operator 
decisions and they also involve a high risk of animal pathogenic contamination. Khoo 
et al.  (2005), demonstrated the spontaneous differentiation of embryoid bodies (EBs) 
grown in different glucose concentrations supplemented with bFGF for up to 104 
days. Morphological analysis of these EBs demonstrated the development of the three 
germ layers. At the end of 104 days, the EBs had differentiated into cartilage and 
cells of the murine mesodermal lineage, as evidenced by the expression of POU5F1, 
nestin, Foxa2, onecut1, neurod1, Pax6 and insulin. In a study by Xu et al. (2001), 
human ES cells were cultured in feeder-free conditions in which undifferentiated cells 
were maintained until at least passage 46. Amit et al. (2003) reported an animal-free 
and serum-free culture system, based on a feeder layer derived from human foreskin, 
where human ES cells maintained their ES cell features following prolonged culture 
of 70 passages. Furthermore, Li et al. (2005), cultured human ES cells in defined, 
non-conditioned serum-free medium supplemented with growth factors, which 
retained their characteristics following prolonged culture of at least 62 passages.  
 
However, a different approach has been used successfully on murine ES cells 
that comprised encapsulation in alginate ‘microbeads’ in order to mass produce EBs 
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(Magyar et al. 2001). Specifically, undifferentiated murine ES cells were 
encapsulated in 1.1% (w/v) alginate resulting in the formation of discoid colonies that 
further differentiated to cystic EBs and spontaneously beating cells within the beads. 
More recently, an integrated bioprocess was developed that utilizes alginate hydrogel 
encapsulation of murine ES cells to form 3D mineralized constructs without the need 
for passaging or handling of the cells (Randle et al., 2007).   
 
In this study, it was demonstrated for the first time that human ES cells 
encapsulated in alginate hydrogels can be maintained in the undifferentiated state for 
more than 260 days while still retaining their pluripotent capabilities without any 
enzymatic treatment, mechanical expansion or manipulation in a feeder-free 
environment. Murine ES cells encapsulated into 1.1% (w/v) alginate resulted in 
inhibited differentiation at the morula-like stage without cystic EB formation.The 
lack of passaging, the feeder-free conditions, the ease of operation and the minimal 
labour involved suggest that this approach is well-suited to automation and scale-up. 
 
5.2 AIM AND HYPOTHESIS 
 
 The aim of this study was to develop a 3D culture system that is efficient for 
the maintenance of ES cells in the pluripotent state.  The hypothesis tested was that 
encapsulation of human ES cells in alginate hydrogel maintains their undifferentiated 
state and pluripotency during prolonged culture. 
 
5.3 MATERIALS AND METHODS 
 
5.3.1 Feeder layer 
  5.3.1.1 Primary murine embryonic fibroblasts (MEFs) 
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Briefly, a female mouse (strain Swiss MF1) was sacrificed in her 13th day of 
pregnancy by schedule I killing. Then the embryos were pulled out and their viscera 
removed. Embryo carcasses were finely minced in trypsin/EDTA solution (0.05% 
(w/v) trypsin/0.53 mM EDTA in 0.1 M PBS without calcium or magnesium; Gibco 
Invitrogen, Life Technologies, Paisley, UK) and seeded in culture flasks in high-
glucose DMEM supplemented with 10% (v/v) heat-inactivated FBS, 0.1 mM MEM 
non-essential amino acids solution, 100 U/ml penicillin, 100 µg/ml streptomycin (all 
from Gibco Invitrogen, Life Technologies, Paisley, UK). When the cells reached 
confluence, the fibroblasts were harvested and frozen in MEF freezing medium 
containing 60% (v/v) high-glucose DMEM, 20% (v/v) heat-inactivated FBS (all from 
Gibco Invitrogen, Life Technologies, Paisley, UK) and 20% (v/v) Dimethyl sulfoxide  
Hybri-Max® (DMSO) (Sigma-Aldrich, Dorset, UK).  According to the protocol from 
WiCell Research Institute Inc, Madison, the ideal passage for the human ES cell 
growth is passage 3 to 4 of the MEF.   
 
The thawed MEFs were grown on a T75 flask (Orange Scientific, Braine-
l'Alleud, Belgium) and after 4-5 days the cells reach confluency. The MEFs were 
mitotically inactivated with mitomycin C before being used as a feeder layer. For 
mitotic inactivation, mitomycin C, at a concentration of 10% (w/v), was added to the 
culture medium and the cells were incubated in this medium for 2 hours at 37˚C. The 
inactivated cells were then trypsinized (0.05% (w/v) trypsin/0.53 mM EDTA in 0.1 M 
PBS without calcium or magnesium; Gibco Invitrogen, Life Technologies, Paisley, 
UK) and were either frozen or transferred to 6 well plates as a feeder layer for human 
ES cell growth.  The MEFs were frozen in the MEF freezing medium (protocol from 
WiCell Research Institute Inc, Madison, July 2000). 
5.3.1.2 Feeder-free culture 
 
For feeder-free culture, human ES cells were grown on 6-well plates coated 
with laminin IV (kind gift from Jonathan Jones, Northwestern University, Chicago) 
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and one uncoated plate.  The plates with laminin IV were incubated for at least 15 
min at 37˚C.  
 
5.3.2 Culture of human ES cells 
 
The human ES cell line H1 was obtained from the WiCell Research Institute 
(Madison, WI, USA).  Human ES cells were maintained on mitotically inactivated 
primary MEFs in human ES cell medium, comprising KNOCKOUT D-MEM, with 
high glucose and sodium pyruvate without L-glutamine, 20% (v/v) KNOCKOUT SR 
(serum) (all from Gibco, Invitrogen, Life Technologies, Paisley UK ) supplemented 
with 2mM L-glutamine, 0.1 mM non-essential amino acids solution, 0.1mM 2-
mercaptoethanol and 4ng/ml human recombinant basic fibroblast growth factor 
(bFGF) (all from Gibco, Invitrogen, Life Technologies, Paisley UK). H1 cells were 
passaged every 7–10 days by incubation in 1 mg/ml collagenase IV (Gibco Invitrogen, 
Life Technologies, Paisley, UK for approximately 15 min at 37ºC followed by 
scraping. 
 
5.3.2.1 Culture of undifferentiated cells 
 
Inactivated primary MEFs were seeded for at least one day before thawing of 
undifferentiated human ES cells in the medium described above. The day after, 
undifferentiated human H1 cells were thawed out and seeded on MEFs and the 
protocol provided by the supplier was used to grow the cells in an undifferentiated 
state. The content of the culture medium was described in Chapter 3. The cells were 
fed every two days. 
 
The growth rate of these cells was found to be much slower than that of 
murine ES cells. As inactivated MEFs died after 7-10 days in culture, human ES cells 
were transferred onto a new feeder layer every 7 - 10 days. After thawing of cells, it 
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took 4-6 weeks before a sub-confluent culture was obtained and the cells could be 
split. The cells grew and maintained their undifferentiated state only when they were 
in a colony. Single cells did not grow. Occasionally, some colonies underwent 
spontaneous differentiation. In this case, the undifferentiated colonies were cloned. 
 
5.3.2.2 Formation of embryoid bodies 
 
The protocol suggested by the Geron Corporation (Menlo Park, CA, USA) 
(www.geron.com) was employed in order to direct human ES cells to form embryoid 
bodies (EBs). Undifferentiated cells were treated with 1mg/ml collagenase IV (Gibco 
Invitrogen, Life Technologies, Paisley, UK) and were collected in clumps. Cell 
clumps were cultured in suspension in bacterial Petri dishes (Sterilin, Bibbt Sterilin 
Ltd, Stone, Staffs, UK) in human ES cell medium consisting of the same ingredients 
in the culture medium mentioned above but without adding human recombinant basic 
fibroblast growth factor (bFGF).  
 
5.3.3 Encapsulation of human ES cells in alginate hydrogels 
 
Undifferentiated, days 4–5, human ES cells were collagenized and re-
suspended in 1.1% (w/v) low viscosity alginic acid (Sigma–Aldrich, Dorset, UK) and 
0.2% (v/v) bovine gelatin (Sigma-Aldrich) solution at room temperature (in PBS at 
pH 7.4). Using a peristaltic pump (Amersham Biosciences, Amersham, UK) from a 
drop height of 3 cm the cell-gel solution was passed through a 25-gauge needle 
(Becton Dickinson, Oxford, UK) into a sterile 100mM CaCl2 (Sigma Aldrich) 10mM 
N-(2-hydroxyethyl) piperazine-N-(2-ethane sulphonic acid) (HEPES; Sigma Aldrich, 
UK) solution pH7.4. Gelation was instant on contact with the CaCl2 solution resulting 
in the formation of spherical beads (approximately 2.5mm in diameter after swelling). 
The beads remained in the gently stirred CaCl2 solution for 6–8min at room 
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temperature. The beads were washed three times in PBS and were cultured in human 
ES cell maintenance medium (as described above) with a 3–4 day feeding cycle.  
 
Any changes in cell structure and morphology were evaluated and recorded 
using an inverted microscope (Olympus, Southall, UK) attached with a colour 
CoolPix 950 digital camera (Nikon, Kingston-upon-Thames, UK). The diameter of 
the aggregates was estimated using the scale from the analySISD (UK) software. 
 
5.3.4 Alginate bead dissolution 
 
The alginate beads were dissolved at different stages for further 
characterization in sterile buffer, containing 50 mM tri-sodium citrate dihydrate 
(Sigma-Aldrich), 77 mM sodium chloride (VWR International, Leicestershire, UK), 
and 10 mM HEPES (Sigma) in PBS, for 5 min while stirring gently at room 
temperature. The cells were recovered by centrifugation at 1200 rpm for 5 min and 
the cell pellet was washed with PBS and centrifuged again at 1000 rpm for 3 min. 
 
 
5.3.5 Viability assay 
 
A live/dead viability/cytotoxicity assay (Invitrogen, Life Technologies, 
Paisley, UK) was performed according to manufacturer’s instructions. Briefly, 
suspended cells were incubated at room temperature for 30 min in the dark with 4 
mM EthD-1 and 2 mM calcein AM solution in PBS followed by a PBS wash. 
Preparations were viewed under an IX70 fluorescence inverted microscope (Olympus, 
Southall, UK). 
 
5.3.6 Paraffin Embedding 
 
Day 110 alginate hydrogels were fixed with 4% (v/v) paraformaldehyde 
(PFA; VWR International, UK) for 30 min at room temperature and dehydrated in 
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increasing concentrations of ethanol followed by xylene (VWR International, UK) 
prior to embedding in paraffin as described in Chapter 3 (section 3.6.1).  The 
embedded samples were serially sectioned (5µm) onto Vectabond-coated glass slides 
(Vector Laboratories, Orton Southgate, UK). The dehydrated sections were immersed 
in a 10 mM tri-sodium citrate dihydrate buffer (pH 6.0; Sigma) prior to antigen 
retrieval by heating. 
 
5.3.6.1 Haematoxylin and eosin stain 
 
The paraffin from the 5µm sections was removed by immersion in xylene, 
decreasing ethanol concentrations and then tap water as described in Chapter 3 
(section 3.6.1.2). 
 
5.3.6.2 Alcian blue and Safranin O staining 
 
Two hundred day human ES cell aggregates that had spontaneously 
differentiated into whitish hard structures were fixed with 4% (v/v) paraformaldehyde 
(PFA; VWR International, UK) for 30 min at room temperature and embedded in 
paraffin.  The paraffin from the 5µm sections was removed by immersion in xylene 
(VWR International, UK), decreasing ethanol concentrations and then tap water as 
described in Chapter 3 (section 3.6.1.2). 
 
The sections were pre-treated with 3% (v/v) acetic acid (Sigma Aldrich, UK) 
and then were stained with 1% Alcian blue (Sigma Aldrich, UK) at pH 2.5 for 2 hour 
at room temperature and excessive stain was washed off in tap water.  Following a 
rinse once in distilled water, the stained slides were dipped in acetone (Sigma Aldrich, 
UK) 20 times and then in 1:1 acetone/xylene another 20 times, followed by clearing 
in xylene.  The slides were counterstained with Mayer’s haematoxylin (VWR 
International, UK) before mounting with DPX solution (VWR International, UK).   
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For safranin O staining, the sections were stained with 0.1% (v/v) safranin O 
solution (Sigma Aldrich, UK) for 5 min at room temperature.  Excessive stain was 
reeemoved with tap water, the sections rinsed once in distilled water and then dipped 
in acetone 20 times.  Following that, the slides were then dipped in 1:1 
acetone/xylene 20 times, followed by clearing in xylene. The slides were 
counterstained with Mayer’s haematoxylin before mounting with DPX solution 
(VWR International, UK).   
 
5.3.7 Immunocytochemistry 
 
De-paraffinized sections were incubated with 3% (v/v) blocking goat or rabbit 
serum (Vector Laboratories) for 30 min at room temperature in 0.05% (w/v) bovine 
serum albumin (BSA; Sigma Aldrich, UK) and 0.01% (w/v) NaN3 (Sigma Aldrich, 
UK) in PBS as primary diluents. The ES cell characterization kit (Chemicon, 
Millipore Upstate, UK) was used according to the manufacturer’s instructions. 
Specifically, the primary monoclonal antibodies used were murine anti-SSEA-4, anti- 
TRA-1-60, anti-TRA-1-81 and alkaline phosphatase (AP). Rabbit anti-Oct-3/4 
primary antibodies (Santa Cruz Biotechnology, UK) were used at a 1:300 dilution and 
incubated overnight at 4oC followed by two washes and incubation with secondary 
goat anti-rabbit antibodies conjugated with FITC (Santa Cruz Biotechnology, UK) at 
a dilution of 1:300 for 1h at room temperature in the dark.  
 
To assess differentiation into neurons, murine IgG monoclonal antibodies to 
neuron-specific enolase (NSE; Santa Cruz Biotechnology, Middlesex, UK) were used 
at a 1:300 dilution and incubated overnight at 4oC followed by two washes and 
incubation with the secondary goat anti-mouse antibodies conjugated with FITC 
(Santa Cruz Biotechnology) at a dilution of 1:300 in secondary diluent consisting of 
0.05% (w/v) BSA (Sigma Aldrich) for 1 h at room temperature in the dark for the 
detection of neuronal cells.  To assess differentiation into type II pneumocytes, 
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primary polyclonal rabbit antibodies raised against pro-surfactant protein C (SPC) 
(Chemicon Upstate, Milipore, UK) were applied to the sections at a 1:300 dilution, 
incubated overnight at 4oC followed by two washes and incubation with secondary 
goat anti-rabbit antibodies conjugated with FITC (Santa Cruz Biotechnology, UK) at 
a dilution of 1:300 at room temperature in the dark for 1h   (Table 5.1).  
 
Subsequently, the samples were washed twice in PBS and mounted using 
Vectashield counterstained with DAPI (Vector Laboratories, UK). Preparations were 
viewed under an IX70 fluorescence inverted microscope (Olympus UK Ltd., 
Southall). Negative controls were performed by omitting the primary antibodies to 
check for non-specific binding. The negative controls were used to allow 
identification of the exact position of the negative populations and to estimate the 
amount of non-specific binding of the monoclonal or polyclonal antibodies to cell 
surface antigens. For positive controls, human ES cells were grown on MEFs and 
immunostained using the same antibodies. 
Table 5.1. Antibodies for immunocytochemistry 
Primary 
antibodies 
Dilution  Source Secondary  
antibodies 
Dilution Source 
SSEA-4 1:50 Chemicon 
Upstate 
Goat anti 
mouse IgG 
1:200 Chemicon 
Upstate 
TRA1-60 1:50 Chemicon 
Upstate 
Goat anti 
mouse IgG 
1:200 Chemicon 
Upstate 
TRA1-81 1:50 Chemicon 
Upstate 
Goat anti 
mouse IgG 
1:200 Chemicon 
Upstate 
Oct-4 1:300 Santa Cruz 
Biotechnology 
Goat anti 
rabbit IgG 
1:300 Santa Cruz 
Biotechnology 
Rabbit anti-
human pro-
SPC  
1:300 Chemicon 
Upstate 
Goat anti 
rabbit Ig G  
1:300 Chemicon 
Upstate 
NSE 1:300 Santa Cruz 
Biotechnology 
Goat anti 
mouse IgG 
1:300 Santa Cruz 
Biotechnology 
Key: SSEA-4: Stage-specific embryonic antigen 4; TRA1-60- Tumour  Rejection 
Antigen-60; TRA1-80- Tumour Rejection Antigen-81; Oct-4- Octamer-4; SPC-
Surfactant protein C; NSE-Neuron-specific enolase. 
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5.3.8 Transmission electron microscopy (TEM) 
 
The human ES cell aggregates encapsulated within the alginate hydrogels 
were washed with PBS supplemented with 0.1 M phosphate and 0.1 M sucrose 
(Sigma Aldrich, UK) twice and then fixed in 3% (v/v) glutaraldehyde (BDH 
Laboratory Supplies, UK) in cacodylate buffer (pH 7.2; Sigma Aldrich, UK) for 30 
min. The rest of the process was described in Chapter 3 (section 3.5.4). 
 
5.3.9 RNA isolation and reverse transcriptase-PCR 
 
Total RNA isolation was carried out for 40, 60, 120, 170 and 260 days using 
the RNAeasy kit (Qiagen, UK) according to manufacturer’s instructions. A reverse-
transcription-polymerase chain reaction (RT-PCR) was used to synthesize cDNA 
from 1 µg total RNA in a final volume of 20 µl. The rest of the process was described 
in Chapter 3 (section 3.8.1).  Primers were designed using Primer Express 2 software 
(Applied Biosystems, Warrington, UK) and are shown in Table 5.2. PCR products 
were separated on 2% (w/v) agarose gel and visualized by ethidium bromide (Sigma 
Aldrich, UK). The size of products was correlated to 50 bp and 100 bp ladders 
(Fermentas). Digital images of ethidium bromide-stained gels were captured using the 
Bio-Rad (Hemel Hempstead, UK) Fluor-S MultiImager system. 
 
 
Table 5.2. List of PCR primers 
Gene Primer sequence (5′–3′) Annealing temp. (°C) 
Amplicon 
size (bp) Ref. 
Oct-4 F: TCTGCAGAAAGAACTCGAGCAA 54 127 – 
 
R: AGATGGTCGTTTGGCTGAACAC 
   
Nanog F: TGCAGTTCCAGCCAAATTCTC 55 91 – 
 
R:CCTAGTGGTCTGCTGTATTACATT
AAGG    
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Gene Primer sequence (5′–3′) Annealing temp. (°C) 
Amplicon 
size (bp) Ref. 
 
Sox2 
 
F: CCATCCACACTCACGCAAA 
 
57 
 
204 
 
– 
 
R: GCAAAGCTCCTACCGTACCACT 
   
Tert1 F: ATCCCCAGATTCGCCATTGT 61 112 – 
 
R: CACTCCAAATTCCCAGAGCTCC 
   
UTF F:TACAAGTTCCTTAAAGACAAGTTTCGC 62 83 – 
 
R: CCCATGAGCTTCCGGATCT 
   
Rex2 F: CTCATTCATGGTCCCCGAGA 61 55 – 
 
R: CAACGAACGCTTTCCCACAT 
   
DPPA5 F: CTCAAACTTGCCGAAGCCA 59 55 – 
 
R: TTCACTTCATCCAAGGGCCTA 
   
Enolase F: GTTCAATGTCATCAATGGCG 62 477 Yoo et al., 2005 
 
R: GTGAACTTCTGCCAAGCTCC 
   
AFP F: TGAAAACCCTCTTGAATGCC 62 492 Chen et 
al., 2007 
 
R: TCTTGCTTCATCGTTTGCAG 
   
MAP2 F: GCATGAGCTCTTGGCAGG 55 192 Chen et 
al., 2007 
 
R: CCAATTGAACCCATGTAAAGCC 
   
mFGF12 F: AAGATGAAGAGCGGCACCAA 60 122 – 
 
R: TTCATGGATGCACTGGAGTCAG 
   
GAPDH F: GTTCGACAGTCAGCCGCATC 54 182 – 
 
R: GGAATTTGCCATGGGTGGA 
   
Key: Oct4: Octomer 4; Tert1: human telomerase reverse transcriptase 1; UTF: 
unicode transformation format; Rex2: RNA exonuclease 2 homolog; DPPA5: 
developmental pluripotency associated 5; AFP: alpha fetoprotein; MAP2: 
microtubule associated protein-2; mFGF12: murine fibroblast growth factor 12; 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase. 
 
 
 142
5.3.10 A549-conditioned medium  
 
A549 cells were grown in a medium comprising F12 K (Invitrogen, UK) 
supplemented with 10% (v/v) FBS (Invitrogen, UK) and 2 mM L-glutamine 
(Invitrogen, UK). The cells were grown to confluence in T75 flasks (Orange 
Scientific, Braine-l’Alleud, Belgium) for 2–3 days. On day 3, the conditioned 
medium was collected from the flasks, passed through a 0.22 mm filter (Sigma) to 
remove cell debris and stored at 4 ºC prior to use and, for prolonged storage, at -80oC. 
 
5.3.11 SAGM media 
 
Another differentiation media that was used in this study, the SAGM media 
(Biowhittaker, Watersville, MD; marketed in the UK by Cambrex, Wokingham, UK) 
that was designed for the growth of mature distal lung epithelium and work by 
colleagues (Ali et al., 2002; Samadikuchakarei et al., 2006; Rippon et al., 2006) 
previously showed that culture in this medium enhances the differentiation of human 
and murine ES cells into alveolar epithelial cells.   
 
SAGM consists of a basal medium (Small Airway Basal Medium, SABM 
(Biowhittaker, Watersville, MD; marketed in the UK by Cambrex, Wokingham, UK). 
To make SAGM, the following factors are added: 0.5 mg/ml bovine serum albumin, 
5µg/ml insulin, 10 µg/ml transferrin, 30 µg/ml bovine pituitary extract, 0.5 µg/ml 
epinephrine, 6.5 ng/ml tridothyronin, 0.1 ng/ml retinoic acid, 0.5 µg/ml 
hydrocortisone, 0.5 ng/ml human epidermal growth factor, 0.05 mg/ml gentamicin 
sulphate and 0.05 mg/ml amphotericin B.  
 
5.3.12 Differentiation of human ES cells 
 
To verify the pluripotency of the encapsulated human ES cells, following 
decapsulation, as described above, the cells were directed towards the differentiation 
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of the endodermal lineage, specifically pneumocytes. Briefly, the decapsulated human 
ES cells at day 110 were cultured with SAGM media for a period of 21 days (the 
conditioned medium was replaced every 3 days) at which point the cells were 
evaluated for their differentiation to the pneumocyte lineage using TEM and 
Immunocytochemsitry.  
 
5.3.13 From 3D decapsulation to 2D culture 
 
To analyze the differentiation capability of the encapsulated cells, the beads 
were collected at different time point, at day 110 and 210 and were then dissolved and 
depolymerised according to the previous protocol.   The de-capsulated single cells 
were plated onto 8 chamber slides (VWR International Ltd., UK) in basic 
maintenance medium to grow as monolayer or 2D. 
 
5.4 RESULTS 
5.4.1 Morphology 
The undifferentiated human ES cells encapsulated in alginate hydrogels and 
cultured for extended periods of time (in excess of 260 days) without any passaging 
or enzymatic and mechanical manipulation were evaluated morphologically, 
phenotypically (surface and molecular) and functionally (pluripotency). As a control, 
human ES cells were cultured on feeders (MEFs) (Figure 5.1a) and in feeder-free 
conditions (laminin) (Figure 5.1b). Following removal from feeder and feeder-free 
culture, aggregate bodies were formed (before the formation of embryoid bodies). 
Each alginate bead contained approximately 5–7 aggregates (Figure 5.1c and d) 
following the encapsulation. The size of the aggregates in the beads initially varied as 
a consequence of the different size of colonies in monolayer culture. Following 1 day 
of culture, the diameters of the human ES cell aggregates were estimated using the 
scale from the analySISD software captured from the light microscope. The diameters 
of the human ES cell aggregates ranged between 50 mm and 80 mm. At day 10 in the 
early stage of encapsulation, some aggregates showed outgrowths that were finger-
like in shape (Figure 5.2a and b).  This morphological change was taken to be 
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indicative of spontaneous differentiation in 3D culture.  However, such projections 
were not observed as the culture progressed and the shape of the aggregates remained 
oval or elongated as seen at day 210 (Figure 5.2c). The same aggregates were 
decapsulated and cultured in 2D. Typical ES cell differentiation was observed, with 
the spontaneous formation of fibroblast-like and neuron-like cells growing out from 
the colony (Figure 5.2d).  
 
As the culture progressed, the human ES cell aggregates increased in size, up 
to around 400–500 mm, in diameter, without ever exceeding the size of the alginate 
beads, as shown in Figure 5.3a. Morphologically, the 110-day-old aggregates 
resembled day 4 embryoid bodies. These human ES cell aggregates were spherical or 
oval in shape with closely packed cells; however, there were no morphological 
indications of the formation of germ layers or of any cystic cavities from day 30 to 
day 210 in culture (Figure 5.4a-f). Furthermore, when the alginate hydrogels were 
dissolved in order to obtain the human ES cell aggregates for further characterization, 
the aggregates retained their cohesiveness and were not disrupted by the 
decapsulation process, as shown in Figure 5.5a (Figure 5.5b as a control showing 2 
day old aggregates).    
 
5.4.2 Haematoxylin and eosin stain 
 
110 day old aggregates were sectioned until their core to investigate the 
morphological characteristics of the tightly packed cells. The cells were found to be 
tightly packed and very homogeneous (Figure 5.4d).  There was no formation of 
typical tissue-like structures such as the teratoma features that indicate the formation 
of the three germ layers. 
 
5.4.3 Live/Dead assay 
To verify that excessive cell death within the encapsulated human ES cell 
aggregates was not an issue; a live/dead stain was performed at day 110 during the 
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culture. As shown in Figure 3.3b, the tightly packed cells within the aggregates were 
viable, even when the aggregates reached a d of 400–500 mm. Furthermore, cell 
viability levels did not decrease with prolonged culture, even after 260 days of culture.  
 
5.4.4 Immunocytochemistry 
 
The expression of pluripotency markers was assessed by 
immunocytochemistry.  In a similar manner to that used for the histology analysis, at 
day 110 of culture, the alginate hydrogels were dissolved, the human ES cell 
aggregates were released and the expression of Oct-4, SSEA-4, TRA-1-60 and TRA-
1-81 was evaluated (Figure 5.6a-d). As shown in Fig. 5.6a, expression of the nuclear 
transcription factor Oct- 4 was strong at 110 days of culture. In addition, the surface 
antigens, including SSEA and TRA, were also strongly expressed in the human ES 
cell aggregates (Fig. 5.6b-d). The positive controls (insets – a’, b’ c’, and d’) 
demonstrated that the expression of the pluripotency markers in the human ES cell 
aggregates at day 110 of culture was comparable to that of day 1 human EBs, whereas 
the negative controls (insets – a’’, b’’, c’’, and d’’) confirmed the specificity of the 
immunostaining.  
 
5.4.5 RT-PCR 
 
The gene expression profiles of pluripotency markers at various time points, 
as well as germ layer markers, in the encapsulated human ES cells was assessed using 
the reverse-transcription-polymerase chain reaction (RT-PCR), as shown in Figure 
5.7. Figure 5.7a shows that the results confirmed the expression, at significant and 
constant levels, of Oct-4 and Nanog RNAs throughout the culture time up to 260 days. 
Expression of RNAs for Sox2, h-TERT, UTF1, Rex2 and DPPA5 was also observed, 
albeit with varying intensity and duration. Specifically, Sox2 RNA expression was 
strong up to day 120, decreased at day 170 and then was not detected at day 260. In 
contrast, expression of Tert1 RNA was detected throughout the culture time, whereas 
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that of UTF and Rex2 RNAs followed a similar pattern to Sox2 RNA. Finally, 
expression of DPPA5 RNA was low and present until day 170. In addition to the 
expression by the encapsulated human ES cells of the pluripotency markers, there 
was a lack of expression of germ layer markers (Figure 5.7b). Specifically, RNAs for 
AFP (endoderm-derived marker) and MAP2 (ectoderm-derived marker) were not 
expressed throughout the culture period of 260 days, whereas as enolase RNA 
(murine mesoderm-derived marker) was only slightly expressed at day 260 of culture 
and was not detected at day 170. Finally, to examine for possible animal 
contamination, expression of the murine fibroblast gene, mFGF12, was assessed. As 
shown in Figure 5.7c, no expression of mFGF12 RNA was detected throughout the 
culture period indicating that no carry over of animal cells, specifically feeder 
fibroblasts, had occurred. 
 
5.4.6 Directed differentiation 
 
In order to verify that encapsulation did not affect the ability of the human ES 
cells to grow in traditional 2D conditions, at 110 day of culture the hydrogels were 
dissolved and the decapsulated human ES cell aggregates were plated onto 6-well 
plates in basic maintenance medium. The human ES cell aggregates attached to the 
plate and, after a few days, fibroblast-like structures started to grow outwards from 
the aggregates (Figure 5.8a). Furthermore, the cells were immunoreactive for TRA-1-
60 (Figure 5.8b) and alkaline phosphatase (Figure 5.8c and 5.8d) which suggests that 
they maintained their ES cell pluripotency. Having demonstrated that the cells in the 
human ES cell aggregates had maintained their undifferentiated state during their 
prolonged 3D culture, their ability to differentiate to specific mature phenotypes was 
then tested. Specifically, it was found that the human ES cell aggregates were able to 
differentiate into the chondrocytic lineage (Figure 5.9c), as indicated by positive 
staining for Safranin O (Fig. 5.9d) and Alcian Blue (Figure 5.9e). Differentiation 
towards the ectoderm germ layer was confirmed by the presence of differentiated 
neurons with typical dendrite morphology and immunoreactivity for neuron-specific 
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enolase (NSE) (Fig. 5.9a and b). Colleagues had previously illustrated the 
differentiation of murine (Ali et al., 2002) and human (Samadikuchaksaraei et al., 
2006) ES cells to type II pneumocytes and the same protocol was used to determine 
whether the encapsulated human ES cells were able to differentiate to an endodermal 
derivative.   The aggregates showed differentiation into endoderm, specifically type II 
pneumocytes, when cultured in SAGM, as indicated by their expression of surfactant 
protein C (Fig 5.9f). 
 
5.4.7 Transmission electron microscopy 
 
Transmission electron microscopy (TEM) was used for confirmation of 
phenotype at the ultrastructural level. The undifferentiated encapsulated human ES 
cells, which grew in clusters, lacked cytoplasmic organelles thereby confirming their 
undifferentiated state at day 110 in culture (Fig. 5.10a and b). In contrast, TEM 
revealed the presence of numerous lamellar bodies and apical microvillus formation, 
the typical morphology of type II pneumocytes (Fig. 5.10c), generated from 
decapsulated human ES cells at day 110 and directed to differentiate into type II 
pneumocytes by culture in SAGM. 
 
5.5 DISCUSSION 
 
In this study, a novel protocol was established for maintaining human ES cell 
pluripotency for extended periods of time by encapsulation in alginate hydrogels, 
which is feeder-free and does not require any passaging through mechanical or 
enzymatic treatment.  The encapsulated aggregates were originally small in size but 
increased as the culture continued. However, these aggregates were still intact within 
and did not escape the confines of the hydrogel for the duration of the culture periods. 
The aggregates formed were tightly packed with defined spherical borders, which 
were homogeneous in their composition.  For further characterization and 
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investigation of individual aggregates, each particular bead was decapsulated and 
embryoid body-like structures were released.  These aggregates in beads remained 
undifferentiated and pluripotent over prolonged periods of maintenance culture 
without any mechanical expansion or manipulation.   
 
There have been several reports of culturing human ES cells on scaffolds or 
hydrogels (Levenberg et al., 2003; Li et al., 2006; Mohr et al., 2006; Gerecht et al., 
2007). In agreement with the present observations, culture in 3D appeared to maintain 
human ES cells in an undifferentiated state (Li et al., 2006) for weeks without 
passaging (Mohr et al., 2006). Specifically, Gerecht and co workers (2007) 
encapsulated human ES cells in hyaluronic acid hydrogels and the human ES cells 
remained undifferentiated, preserved their normal karyotype and maintained their 
differentiation capacity in EB formation. 
 
Gene expression analysis by RT-PCR revealed significant levels of RNAs for 
Oct-4 and Nanog in the aggregates cultured for 40, 60, 120, 170 and 260 days.  Oct4 
and Nanog are transcription factors that are essential for the maintenance of 
pluripotency in both human and murine ES cells (Stewart et al., 2006, Cai et al., 
2006). The mechanisms involved in the regulation of Nanog are not fully understood, 
although recent reports suggest a pivotal role for the transcription factors Oct3/4 and 
Sox2, which have adjacent binding sites within the Nanog promoter region (Kuroda 
et al., 2005; Rodda et al., 2006).  There was also expression of Sox2, h-TERT, UTF1, 
Rex2 and DPPA5. However, expression was limited to day 120 for Sox2, UTF1 and 
Rex2.   According to Cai et al. (2006), expression of these pluripotency factors should 
occur irrespective of the culture conditions, number of passages and methods of 
derivation and propagation and as long as undifferentiated human ES cells are present. 
The surface antigens, including SSEA and TRA, are useful markers for 
undifferentiated human ES cells because their level of expression is down regulated 
as human ES cells differentiate (Cai et al., 2006).  
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It is demonstration of a combination of these core pluripotency markers that 
can serve to assess reliably the state of human ES cells as it is clear that no single 
marker is fully sufficient (Cai et al., 2006).  It is also believed that the observations of 
the pluripotent state in prolonged culture are due to some elimination of the use of the 
inhibition factors that suppresses the lineage formation. Upregulation of any of the 
factors, in particular Oct4 and Nanog, will maintain the stability of the ES cells but 
once down-regulation and turn-over occurs, the undifferentiated phenotype will be 
suppressed (Rao and Zandstra, 2005) and differentiation will take place. Furthermore, 
the lack of expression of the ectoderm and murine mesoderm phenotypes proved that 
the aggregates maintained their pluripotency while inhibiting the turn-over of the 
differentiation proteins.  
 
This result is similar to results from Wang et al., (2005) and Stojkovic et al., 
(2005). They reported the use of fibroblast-like structures derived from spontaneously 
differentiated human ES cells that permit continuous growth of undifferentiated and 
pluripotent human ES cells.  A similar observation was made in this study.  The 
advantage over the previous study is that the spontaneously formed fibroblast-like 
cells were originally from 3D culture and the growth in 2D supports the growth of 
undifferentiated ES cells.   
 
Having demonstrated that the cells in the human ES aggregates had 
maintained their undifferentiated state during prolonged culture, their ability to 
differentiate to a specific mature phenotype was then tested.   The ability to form into 
all the germ layers is essential for human ES cell characterization and pluripotency 
(Peura et al., 2006). 
 
This work indicates, for the first time, that encapsulation of human ES cells 
allows their maintenance for up to 260 days without passaging or any chemical or 
enzymatic treatment in the undifferentiated state. Consequently, this presents the 
opportunity for long-term, feeder-free and non-labour-intensive culture of human ES 
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cells that could standardize culture conditions and be amenable to scale-up. The 
pluripotency and functionality of the long-term encapsulated human ES cells, 
following decapsulation, were demonstrated by their ability to differentiate into 
pneumocytes and chondrocytes in the absence of EB formation.  
 
5.6 CONCLUSION 
 
In this study it was demonstrated that;  
1) human ES cell encapsulation is superior to conventional culture on feeder layers 
with the encapsulated cells retaining their ‘stemness’ well over 260 days in culture 
without the need for manipulation or passaging,  
2) the decapsulated cells (even after 200 days in culture) are able to differentiate into 
cells with characteristics of lung-specific epithelium, chondrocytes and neurons in 
vitro.  
 
Recently, Chen et al. (2006) showed that spontaneous differentiation to cells 
expressing germ cell markers can be achieved without going through the stage of EB 
formation.  In this study, EB formation was shown not to be the only pathway for 
initiating human ES cell differentiation.  Understanding the molecular mechanisms 
governing human ES cell self-renewal will facilitate the design of a better protocol 
and improved systems for culturing undifferentiated human ES cells.  This novel 
protocol for human ES cell feeder-free culture can be automated, requires no 
interference and can be easily scaled-up using bioreactors with potentially significant 
implications for future therapeutic applications.  
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Figure 5.1  
Human ES cells growing on (a) feeder MEFs (n=10) and (b) feeder-free laminin 
(n=2) and (c&d) in alginate beads (n=10). 
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Figure 5.2  
(a&b) In the early stage of encapsulation, some aggregates showed finger-like 
outgrowths.  (c&d) In prolonged culture, the shape of the aggregates remained 
oval or elongated as seen at day 210 (c). After decapsulation and culture in 2D, the 
aggregates showed spontaneous differentiation (d) with a morphology similar to 
that of a routinely cultured ES cell colony (n=5). 
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Figure 5.3  
110 day old human ES cell aggregates resembling a day 4 embryoid body without 
formation of germ layers or cystic cavities. (a) Tightly packed cells within the 
aggregates were viable, even when the aggregates reached a size of 400–500 mm 
(b) Live cells are distinguished by the presence of ubiquitous intracellular esterase 
activity, producing a bright green fluorescence (n=3). 
 154
 
 
 
 
 
 
 
 
Figure 5.4 
Human ES cell aggregates without formation of three germ layers; 
endoderm, mesoderm and ectotoderm (Joza et al., 2001; Dang et al., 2002; 
Koika et al., 2007) and embryonic cavities observed at day 30 (a), 130 (b), 
160 (c and d), 180 (e) to 210 (f) of culture immediately following 
decapsulation (n=7). 
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Figure 5.5 
The human ES cell aggregates maintained their cohesiveness after decapsulation.  
Aggregates at day 130 (a) after decapsulation appear similar to 2 day old 
aggregates (b) (n=7). 
a b 
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Figure 5.6 
At day 110 of culture, the alginate beads were dissolved and the human ES cell 
aggregates were released. Immunoreactivity for Oct-4 (a), SSEA-4 (b), TRA-
1-60 (c) and TRA-1-81 (d) was observed. The positive controls (insets – a’, b’ 
c’, and d’) demonstrate expression of the pluripotency markers in day 1 human 
EBs, whereas the negative controls (insets – a’’, b’’, c’’, and d’’) confirmed the 
specificity of the immunostaining by showing no staining when primary 
antibodies were omitted (n=3).  
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Figure 5.7 
RT-PCR results confirmed expression at significant and constant levels of 
Oct-4 and Nanog RNAs throughout the culture time up to 260 days.  Sox2, 
h-TERT, UTF1, Rex2 and DPPA5 RNAs (a) were also expressed (n=4). 
There was a lack of expression of germ layer markers; specifically AFP 
(endoderm-derived marker) and MAP2 (ectoderm-derived marker) were 
not expressed throughout the culture period of 260 days (b). No expression 
of mFGF12 was detected throughout the culture period which indicates no 
possible animal contamination (c). 
 
 158
 
 
 
 
 
 
 
 
 
 
Figure 5.8 
Beads at 110 days of culture were dissolved and the human ES cell aggregates 
attached to the culture plate. After a few days, fibroblast-like structures started to 
grow outwards from the aggregates (a).  The colonies were immunoreactive for 
TRA-1-60 (b) and alkaline phosphatase (c and d), which suggested that they 
maintain their ES cell pluripotency (n=3). 
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Figure 5.9 
Human ES cell aggregates were also able to differentiate into neurons 
with typical dendrite morphology (a&b), chondrocytic lineage (c), as 
indicated by the Safranin O (d) and Alcian Blue (e) staining, and 
pneumocytes, shown by their immunoreactivity for SPC (green; nuclei 
were counterstained with propidium iodide; red)(f) (n=3). 
a b 
c d 
e f 
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Figure 5.10 
TEM showed that undifferentiated encapsulated human ES cells, which grew 
in clusters, lacked cytoplasmic organelles (a and b).  In contrast, 
decapsulated human ES cells at day 110 directed to differentiate into type II 
pneumocytes showed numerous lamellar bodies and apical microvillus 
formation when culture in SAGM medium, the typical morphology of type II 
pneumocytes (c) (n=1).  
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CHAPTER 6 
 
DIFFERENTIATION OF MURINE EMBRYONIC STEM 
CELLS INTO ALVEOLAR EPITHELIAL CELLS: 3D 
CULTURE MODEL OF THE PULMONARY EPITHELIAL 
MICROENVIRONMENT 
_____________________________________________________________________ 
 
ABSTRACT 
 
Recent studies have developed protocols for the generation of alveolar 
epithelial cells, the component of the gas-exchange unit of the lung that is crucial for 
survival, from murine and human embryonic stem (ES) cells.  These include culturing 
murine ES cells in commercially available medium, conditioned medium or co-
culture systems.  Colleagues have proved previously that co-culture of murine 
embryoid bodies with embryonic mesenchyme from distal murine lung promotes 
differentiation of pulmonary epithelium from murine ES cells. Co-culture systems 
have been used widely to study the effect of cells that represent the native 
microenvironment. Such systems aim to create an environment that mimics the 
complex three dimensional (3D) structure in the human body.  In this study, a 3D 
lung model was developed by co-culturing encapsulated murine ES cells with A549 
cells in tissue culture flasks.  Alginate hydrogels are highly biodegradable and are 
widely used for creating a 3D microenvironment for culturing cells. Single murine ES 
cells were encapsulated in alginate and the consequent floating beads were placed in 
direct contact with a monolayer culture of A549 cells.   It was possible to show not 
only that the differentiation of pulmonary epithelial phenotypes was upregulated but 
also that the stem cells formed tissue with a morphology reminiscent of the distal 
airways of the lung. 
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6.1 INTRODUCTION 
 
ES cells are pluripotent cells that have the potential to develop and 
differentiate into cells of any of the three germ layers.  Co-culture of embryonic and 
other stem or progenitor cells with mature cells or tissues has been used increasingly 
to drive and enhance the differentiation towards required lineages (Vats et al., 2006).  
For the lung, the ability of lung mesenchyme to direct the phenotype of the 
epithelium has long been known from developmental studies and creating an in vitro 
milieu to mimic the in vivo situation, by grafting fetal distal lung mesenchyme 
underneath the proximal epithelium, was shown to redirect its differentiation 
(Shannon, 1994; Shannon et al., 1998).  
 
The results of these experiments demonstrated that phenotypic differentiation 
in the epithelium of the recombinants appeared to be wholly dependent on the cell 
phenotype used (i.e. mesenchyme) and that the entire respiratory epithelium has 
significant plasticity at early stages of development (Shannon et al., 1998).  
 
On the bases of these observations, colleagues (Vranken et al., 2005) devised 
a co-culture method to drive murine ES cell differentiation towards pulmonary 
epithelium.  They allowed murine ES cells to differentiate spontaneously into 
embryoid bodies (EBs) and then cultured the cells for 5 or 12 days with pulmonary 
mesenchyme from embryonic day 11.5 or 13.5 murine embryos, in direct contact or 
separated by a membrane. The results showed epithelium-lined channels in directly 
co-cultured EBs and expression of cytokeratin and thyroid transcription factor 1, an 
early developmental marker in pulmonary epithelium and surfactant protein C (SP-C) 
in some of the epithelial cells.  Indirect co-culture of EBs with lung mesenchyme 
resulted in a 14-fold increase in SP-C gene expression (Vranken et al., 2005).    This 
work confirmed the propensity of ES cells to respond to chemical and/or physical 
signals sent out by other cells in co-culture and differentiate. 
 
Co-culture is a culture model system that has the great advantage of 
mimicking the natural physiological situation, the principle of which is to restore the 
in vitro cell-to-cell interaction signals presents in vivo (Corlu et al., 1997).  In the 
previous chapter, it was shown that A549-conditioned medium enhances the 
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differentiation of alveolar epithelial cells from ES cells both as embryoid bodies and 
in encapsulation.  However, the differentiation of the ES cells induced by direct 
exposure to both the soluble factors secreted by the pulmonary cells and the physical 
contact has not yet been investigated. 
 
6.2 AIM AND HYPOTHESIS 
 
In this study, the aim was to devise a culture protocol for the differentiation of 
murine ES cells into an engineered 3D model of a distal lung tissue construct in vitro, 
when exposed directly to A549 cells.  
 
It was hypothesized, therefore, that this co-culture system induces the 
differentiation of ES cells to a similar, or perhaps greater, degree to that obtained with 
the conditioned medium method.   
 
6.3 MATERIALS AND METHODS 
 
6.3.1 Maintenance of murine ES cells 
 
The E14Tg2a murine ES cell line (ATCC, USA) was cultured in DMEM high 
glucose / no sodium pyruvate (Invitrogen, UK), supplemented with 10% (v/v) fetal 
bovine serum (PAA), 100 iu/mL penicillin and 100 µg/mL streptomycin, 2 mM L-
glutamine, 0.1 mM 2-mercaptoethanol (all supplied by Invitrogen, UK) and 1000 
U/mL LIF (Chemicon, UK).  The murine ES cell line was routinely passaged on 0.1% 
(w/v) gelatin (Sigma, UK)-coated tissue culture plastic in a humidified incubator set 
at 37oC and 5% (v/v) CO2. Undifferentiated murine ES cells (<p20) were passaged 
with trypsin-EDTA (Invitrogen, UK) every 2 or 3 days and fed every day.  
 
6.3.2 Culture of A549 cells  
 
A549 is a human type II pneumocyte tumour cell line (A549: American Type 
Culture Collection, Virginia, USA; # CCL 183).  The cells were grown in F12 K 
supplemented with 10% (v/v) FBS and 2mM L-glutamine to confluence in T75 flasks 
(Orange Scientific, Braine-l’Alleud, Belgium) for 2-3 days.  The cell line had to be 
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split every 2-3 days as they reached confluency very quickly. The cells were fed 
every 2 days. 
 
6.3.3 Encapsulation of murine ES cells 
 
Murine ES cells were encapsulated as single cells from undifferentiated 
colonies. About 2x104 single cells were encapsulated.  Undifferentiated murine ES 
cell colonies were removed by treatment with trypsin-EDTA (Invitrogen, UK) and 
resuspended a few times, which resulted in single cells.  The alginate hydrogel 
consisted of 1.1% (w/v) low viscosity alginic acid (Sigma-Aldrich, UK) and 0.1% 
(v/v) bovine gelatin (Sigma, UK) (all dissolved in PBS, pH 7.4) solution in room 
temperature. Using a peristaltic pump (Amersham Biosciences, Amersham, UK) from 
a drop height of 30mm the cell-gel solution was passed through a 25-gauge needle 
(Becton Dickinson, Oxford, UK) into a sterile 100mM CaCl2 (Sigma Aldrich) 10mM 
N-(2-hydroxyethyl) piperazine-N-(2-ethane sulphonic acid) (HEPES; Sigma) solution 
(pH7.4). Gelation was instant on contact with the CaCl2 solution resulting in the 
formation of spherical beads (approximately 2.5mm in diameter after swelling). The 
beads remained in the gently stirred CaCl2 solution for 6–8min at room temperature.   
The beads were washed three times in PBS before putting into T75 flasks with the 
A549 cell line. These beads were cultured in T75 flasks with the A549 cells and fed 
every 2-3 days for the duration of 20 days.  Any changes in the structure and 
morphology of the encapsulated cells were evaluated and recorded using an inverted 
microscope (Olympus, Southall, UK) attached with a colour CoolPix 950 digital 
camera (Nikon, Kingston-upon-Thames, UK). 
 
6.3.4 Alginate bead dissolution 
 
A sterile depolymerization buffer was used to dissolve the beads that 
consisted of Ca2+-depletion solution with 50 mM tri-sodium citrate dihydrate (Fluka, 
UK), 77 mM sodium chloride (BDH Laboratory supplies, UK) & 10 mM HEPES), as 
described in Chapter 3.  The solution with dissolved beads was centrifuged at 1250 
rpm for 5 minutes and the pellet was washed once with PBS and centrifuged again, at 
1000 for 3 minutes. 
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6.3.5 Co-culture with A549 cells 
 
A549 cell lines were cultured in T75 flasks (Orange Scientific, Braine-
l’Alleud, Belgium) as previously described.  About 300 beads were placed in the T75 
flask and co-cultured with the A549 cells.  The encapsulated cells floated just above 
the A549 cell line.  The cells were fed every 2 days and any morphological changes 
were noted each day.  Samples of beads were collected at day 10, 15 and 20 for 
further analysis and characterization. 
 
6.3.6 A549-conditioned medium 
 
As a control for the co-culture system, the method of using A549-conditioned 
medium and maintenance medium (basic control) (section 3.2.2.2) was used.  A549-
conditioned medium was collected as described in Chapter 3 (section 3.3.2). Any 
morphological changes of the encapsulated cells were noted each day.  Samples of 
beads were collected at day 10, 15 and 20 for further analysis and characterization. 
 
6.3.7 Fixation and cryosectioning 
 
Sampled beads were fixed in 4% (w/v) paraformaldehyde (Sigma Aldrich, 
UK) overnight at 4oC.  After rinsing the beads with PBS twice, they were incubated 
with 30% (w/v) sucrose (Sigma Aldrich, UK) at 4ºC overnight. The next day, beads 
were washed twice with PBS and placed in OCT compound (VWR International Ltd, 
UK) in a 50ml centrifuge tube (VWR International Ltd, UK). The intact beads 
together with the OCT compound in the centrifuge tube were then immersed in 
isopentane (Sigma Aldrich, UK) suspended in liquid nitrogen for 1-2 minutes until 
the OCT compound solidified. The frozen beads were kept in -80ºC overnight or at 
least 1 hour before sectioning in a cryostat (Bright Instrument Company LtD, 
Huntingdon, England) at a thickness of 7µm.  Sections were picked up on poly-l-
lysine-coated glass slides (VWR International Ltd., UK) and kept in slide box at -
20ºC for long storage. 
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6.3.8 Immunocytochemistry 
 
The 7µm sections were place with a few drops of PBS to prevent dehydration 
prior to the immunostaining process.  They were permeabilized with 0.1% (v/v) 
Triton X-100 (Sigma-Aldrich, UK).  Following a rinse in PBS, the sections were 
incubated with normal rabbit serum (1:25) for 30 minutes at room temperature as a 
blocking agent.  Primary rabbit polyclonal antibodies against pro-surfactant protein C 
(SP-C) were applied at a dilution of 1:1000 (Millipore, Chemicon, Upstate, UK) and 
left overnight at 4oC.  The following day, cells were washed again with PBS twice 
and incubated with secondary goat anti rabbit IgG antibodies (1:200) (Millipore, 
Chemicon, Upstate, UK), conjugated with FITC for 1 hour at room temperature.  To 
stain actin, cells were washed twice with PBS and incubated with Phalloidin (Sigma 
Aldrich) conjugated with Rhodamine at room temperature for another 30 minutes. 
Nuclei were counterstained with Vectashield with 6 diamidino-2-phenylindole 
(DAPI) (Vector Laboratories, Peterborough, UK).  Images were viewed and recorded 
using an inverted microscope (Olympus, Southall, UK) equipped with a colour 
CoolPix 950 digital camera (Nikon, Kingston-upon-Thames, UK).   
 
6.3.9 Haematoxylin & eosin stain 
 
Beads were fixed in 4% (w/v) paraformaldehyde (Sigma Aldrich, UK) 
overnight at 4ºC as described in Chapter 3 (section 3.6.1.2).  Frozen beads in OCT 
compound were sectioned at 7µm thickness and placed on a poly-l-lysine coated glass 
slides (VWR International Ltd., UK).  The 7µm sections were stained as described in 
Chapter 3 (3.6.1.2). Images were captured and recorded using an upright microscope 
Olympus BH-2 (Olympus, Southall, UK) equipped with Axio Cam MRct camera 
(Carl Zeiss Ltd., UK).   
 
6.3.10 Transmission electron microscopy (TEM) 
 
The collected beads were washed in buffer containing 0.1M phosphate and 
0.1M sucrose, rinsed in PBS twice and then fixed in 3% (v/v) glutaraldehyde in 
cacodylate buffer (pH 7.2) for 30 min as described in Chapter 3 (section 3.5.4).  
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Ultrathin sections were observed in a Philips CM10 transmission electron microscope 
(Amsterdam, The Netherlands). 
 
6.3.11 RNA isolation and reverse transcriptase-PCR 
 
Total RNA isolation was carried out using the RNAeasy kit (Qiagen, UK) 
according to the manufacturer’s instructions. A reverse-transcriptase-polymerase 
chain reaction (RT-PCR) was used to synthesize cDNA from 1 mg total RNA in a 
final volume of 20 ml. The rest of the process was described in Chapter 3 (section 
3.8).  Primers were designed using Primer Express 2 software (Applied Biosystems, 
Warrington, UK) and are shown in Chapter 3 (Table 3.1). PCR products were 
separated on a 2% (w/v) agarose gel and visualized by ethidium bromide (Sigma 
Aldrich, UK). The size of the products was correlated to 50 bp and 100 bp ladders 
(Fermentas, UK). Digital images of ethidium bromide-stained gels were captured 
using the Bio-Rad (Hemel Hempstead, UK) Fluor-S MultiImager system. 
 
6.3.12 From 3D decapsulation to 2D culture 
 
 To analyze the functionality of the differentiated murine ES cells in the co-
culture system, the beads were dissolved and depolymerized according to the 
previous protocol (2.3.2).   The de-capsulated individual cells were then plated onto 
T75 flasks to grow in basic maintenance medium which consists of F12 K medium 
supplemented with 10% (v/v) FBS and 2mM L-glutamine as monolayers or 2D 
cultures and later transferred to 8 chamber slides (VWR International Ltd., UK) for 
immunocytochemical analysis.   
 
The monolayer cells cultured in the chamber slides were fixed in 4% (w/v) 
paraformaldehyde (Sigma Aldrich, UK) for 30 min and immunostained with proSPC 
antibodies according to the previous protocol (Chapter 3, section 3.7). 
 
6.4 RESULTS 
 
6.4.1 Morphological changes of encapsulated murine ES cells 
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The encapsulated cells within the beads looked scattered, equally distributed 
and discrete.  After 8 days in the co-culture system, the single cells started forming 
small aggregates within the beads (Figure 6.1a). The aggregates observed were 
elongated in shape and very dense in number within the beads. At the end of day 20 
in culture, the aggregates had grown larger in size and some of them had escaped into 
the culture medium (Figure 6.1b).  As a control, encapsulated murine ES cells 
cultured in A549-conditioned medium were used to compare the differentiation 
without the physical presence of the cell line.  The encapsulated cells showed 
aggregation at day 10 in culture.  The aggregates looked more oval than the sharp and 
elongated shape observed in the co-culture system.  However, the density of 
aggregates appeared similar in both culture systems.  Morphologically, the cell 
number and degree of aggregation appeared to increase over time. 
 
6.4.2 Histology 
 
Cross-sections of the beads in the co-culture system at day 11 showed discretely 
distributed cell aggregates with connective tissue-like structures that looked as though 
they were holding the aggregates within the beads (figure 6.2a, b and c).  This 
observation is in contrast with the morphology of the cells differentiated in beads in 
A549-conditioned medium (Figure 6.2d).  The tree-like structures in the co-cultured 
beads gave the impression that they were branching out towards the periphery (Figure 
6.3a, b), as is seen in cross sections of normal lung (Figure 6.3c).  Cell aggregates 
grown in A549-conditioned medium were more dispersed and some accumulated at 
the periphery of the beads.  
 
 
6.4.3 Immunocytochemistry 
 
Aggregates within the beads were stained with phalloidin conjugated with 
rhodamine to visualize actin within the cells (Figure 6.4a).  The actin stain revealed 
large numbers of cells in close contact within each particular aggregate.  
Immunoreactivity for proSPC was detected by immunocytochemistry in the 
differentiated murine ES cells co-cultured with A549 cells at day 15 (Figure 6.4b).  
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Similar results were obtained for differentiated murine ES cells after 15 days culture 
in A549-conditioned medium.   
 
6.4.4 Transmission electron microscopy (TEM) 
 
The ultrastructure of the murine ES cells co-cultured with A549 cells showed 
many typical features of type II with abundant lamellar bodies and formation of 
microvilli. The concentric lamellar bodies seen in the type II pneumocyte-like cells 
were particularly well preserved.  Some of the cytoplasmic lamellar bodies could be 
seen escaping from the epithelial layer or the surface microvilli (Figure 6.5a).  This 
may reflect the mechanism by which the final secretory product is segregated in 
lamellar bodies that are destined to be secreted in to the alveolar space to become part 
of the surfactant lining layer.  
 
Many cells in aggregates showed evidence of active protein synthesis 
indicated by the presence of abundant, engorged rough endoplasmic reticulum (rER) 
(Figure 6.5a-d).  The rER was typically composed of numerous electron-dense 
cytoplasmic organelles and there was prominent Golgi apparatus as well as numerous 
mitochondria and lamellar bodies. Junction complexes were also seen, with 
desmosomes at the margins of neighbouring cells, indicating cell-cell communication 
between the epithelial cells (Figure 6.6a-d). The presence of these organelles, that are 
important for the interaction between epithelial cells, suggested that the cells formed 
functional units.  
 
   Although the ES cells were encapsulated, it did not prevent their direct 
differentiation and the formation of the functional apparatus for secreting protein-
surfactant complexes that characterize the mature pulmonary epithelial phenotype. 
 
The ultrastructural changes observed in ES cells differentiated in beads in the 
co-culture system were similar those obtained with the A549-conditioned medium 
with the formation of type I and type II pneumocyte and other related cytoplasmic 
organelles, as described in Chapter 7 (7.4.5). In contrast, no cytoplasmic organelles 
were seen in encapsulated ES cells grown in the basic maintenance medium. 
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6.4.5 RT-PCR 
 
To study gene expression in the differentiated murine ES cells, RT-PCR was 
performed on cells at days 10 and 20 of either co-culture or growth in conditioned 
medium.  Expression of Foxa2, SPC and AQP5 mRNAs was detected at days 10 and 
20 in both co-culture and conditioned medium (Figure 6.7). Interestingly, the levels 
of SPC mRNA expression were noticeably higher at day 10 than at day 20 for both 
culture conditions.   However, the expression of the AQP5 phenotype was found to be 
similar for all samples, times and culture conditions. 
 
6.4.6 From 3D decapsulation to 2D culture 
 
Decapsulated cells grown as monolayers in T75 flasks showed homogeneous 
flat and cobble stoned shape.  After 3 days, the homogeneous cells reached 
confluency and were ready to be split.  These cells were then grown in F12K medium 
supplemented with 15% (v/v) FBS (without A549-conditioned medium).  
Interestingly, the morphology and phenotype of these cells were maintained 
following decapsulation after 14 days or 2 passages in monolayer culture.  These 
findings were confirmed using immunostaining that showed proSPC expression 
confirming retention of the type II pneumocyte phenotype (Figure 6.8a, b). 
 
6.5 DISCUSSION 
 
In Chapter 4 and 5, it was shown that culture of murine ES cells in A549-
conditioned medium enhances their differentiation into pulmonary epithelial cells.  
The present chapter demonstrates another simple differentiation protocol for ES cells 
by providing direct access to the soluble factors secreted by A549 cells through co-
culture. This method not only upregulated the differentiation pathway towards distal 
airway epithelium, as occurred with A549-conditioned medium, but also gave rise to 
additional morphological features.  Although the differentiation occured in a very 
limited space within the beads, the cells were still able to direct themselves towards 
not only the pulmonary epithelial cell phenotype but also forming distal branches and 
to synthesize and secrete proteins that play an important role in the regulation of the 
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alveolar space.  Thus, this protocol is more efficient than using conditioned medium 
in promoting the formation of structures similar to those seen in ex vivo lung tissue. 
 
Three key features distinguished the differentiatated murine ES cells obtained 
using this A549 cell co-culture system from those derived using A549-conditioned 
medium.  Firstly, the formation of branching, tree-like structures extending towards 
the periphery of the beads and the space in between the cell aggregates indicated that 
some form of directed 3D organization of cells had occurred within the alginate beads.  
Secondly, the ultrastructure of the cells that had differentiated towards distal 
pulmonary epithelium was indicative of a high level of functional activity.  In 
addition, there was evidence, in the form of desmosomes, that inter-connected 
epithelial sheets had formed, as occurs in vivo. Recreating in vitro the complexity and 
intricate branching of the distal portion of the lung presents a major challenge to 
tissue engineers (Vranken et al., 2005).  However, the results from the present study 
suggest that the combination of providing a 3D support for cell growth, in  the form 
of alginate,  with the soluble and, possibly, physical factors provided by the A549 cell 
line is a promising means to generate organized lung epithelium from ES cells.  
 
As well as providing a matrix for the in vitro differentiation of ES cells 
towards pulmonary epithelium, the alginate hydrogel could be used for delivery of the 
ES cell-derived pneumocytes and/or 3D lung tissue for cell therapy.  Alginate 
hydrogel can be used as a microcarrier system (Orive et al, 2006) as it is both 
biodegradable and biocompatibility and could facilitate functional tissue growth in 
order to integrate the engineered cells/tissue so that they can produce the appropriate 
biomechanical and functional properties of the lung. 
 
The levels of gene expression for different markers of distal airway epithelium 
were roughly similar in murine ES cells grown in either direct co-culture with A549 
cells or in A549-conditioned medium.  In both cases, the highest expression was seen 
at day 10 and had decreased by day 20 in culture.  This pattern of gene expression 
was similar to that shown in Chapter 4 for ES cells taken through EB formation and 
cultured in A549-conditioned medium.  The gene expression pattern indicating the 
formation of distal airway epithelium especially that of SPC, was detected as early as 
day 10 in co-culture. 
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An advantage of using the 3D approach described in this chapter, with the ES 
cells encapsulated in beads, is that it allows co-culture in close proximity, something 
that can not easily be achieved in conventional co-culture set ups, such as those using 
membrane inserts or transwell systems.  Furthermore, the method provides an 
additional degree of control as the diffusion rate and size of molecules secreted by the 
co-cultured cells may be modulated by adjusting the pore size of the alginate 
hydrogel.   
 
To demonstrate the stability of the type II pneumocyte-like phenotype derived 
from murine ES cells, the differentiated cells were decapsulated from the beads and 
grown in monolayer.  These cells were cultured in basic, unconditioned medium for a 
few passages.  Immunocytochemistry showed that the cells maintained both their 
SPC-expressing phenotype and homogeneous morphology.  This result compares well 
with those obtained in studies using other methods, such as genetic modification that, 
although it gave high yields (>99%) of SPC-expressing cells, the cells survive for 
only 2 days without the presence of G418 Neomycin antibiotic (Wang et al., 2007).  
 
6.6 CONCLUSIONS 
  
The results of this study are the first to provide evidence that co-culture of 
encapsulated murine ES cells with a lung epithelial cell line promotes the formation 
of pulmonary epithelial cells, specifically type II and type I pneumocytes, in 
structures that resemble distal lung.  Thus, this approach may have applications in the 
construction of ‘lung-like’ tissue constructs for therapeutic and research applications. 
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Figure 6.1 
After 8 days in co-culture with A549 cells, the single murine ES cells 
encapsulated in alginate started to form numerous small, elongated aggregates 
(a) as seen under the inverted microscope. By the end of day 20, the aggregates 
had grown larger and filled up the entire bead (b) (n=3). 
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Figure 6.2 
Examination of the histology of cross sections of fixed beads at day 11 of co-
culture with A549 cells revealed the formation of tree-like structures from the 
differentiating murine ES cells that branched out towards the periphery of the 
beads (a-c).  In contrast, the ES cells grown in A549-conditioned medium 
showed only aggregates at the same day (day 11) (d) (n=3).  
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Figure 6.3 
Haematoxylin and eosin staining of cross sections of fixed beads showed 
discrete distribution of the aggregates of differentiated murine ES cells following 
10 days of co-culture with A549 cells.  There are some connective tissue-like 
structures (arrows) that appear to be holding the aggregates together (a, b) (n=3). 
(c) Shows a similarly stained section of adult murine lung for comparison. 
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Figure 6.4 
Phalloidin (Rhodamine-red) attachment showed the distribution of actin revealing 
that the cells grew in close contact and formed aggregates or colonies at day 15 in 
the co-culture system (a).  Immunocytochemistry showed the presence of SPC 
(FITC-green) in the differentiated murine ES cells at day 15 of co-culture with 
A549 cells (b).  Nuclei were counterstained blue with DAPI (n=3). 
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Figure 6.5 
TEM demonstrated the typical features of type II cells with formation of 
lamellar bodies and microvilli (a), engorged rough endoplasmic reticulum 
(rER) (b) and abundant electron dense lamellar bodies (LB) (c,d) (n=2). 
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Figure 6.6 
TEM showed typical electron-dense cytoplasmic organelles related to 
surfactant component metabolism, including rough endoplasmic reticulum 
(rER), Golgi apparatus (G) and numerous mitochondria (m) and lamellar 
bodies (LB) (a-d). Junction complexes were also seen, with desmosomes 
(arrow, b) at the margins of neighbouring cells, indicating cell-cell 
communication between epithelial cells (n=2). 
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conditioned 
medium 
Figure 6.7 
RT-PCR results for murine ES cells at days 10 and 20 of co-culture 
with A549 cells (Co-culture) or growth in A549-conditioned medium 
(Conditioned medium). Expression of mRNAs for Foxa2 (endoderm), 
SPC (type II pneumocytes) and AQP5 (type I pneumocytes) was 
noticeably higher at day 10 in both the culture conditions. However, the 
expression of AQP5 phenotype was constant over time and in both 
culture conditions (n=3). 
Key: Foxa2; forkhead transcription factor; SPC: surfactant protein C; 
AQP5: aquaporin 5; GAPDH: Glyceraldehyde 3-phosphate 
dehydrogenase; +ve: adult lung mRNA, -ve: water 
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Figure 6.8 
De-capsulated murine ES cells were plated back onto T75 flasks following 
20days co-culture with A549 cells to grow in 2D culture for 10 days/2 passages. 
After 3 days, the cells had formed homogeneous flat and cobblestoned 
monolayers typical of epithelium (a).  Using immunostaining, it was possible to 
show expression of proSPC (green) confirming retention of the type II 
pneumocyte phenotype (b).  Nuclei were counterstained with DAPI (n=3). 
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CHAPTER 7 
 
DIFFERENTIATING ALVEOLAR EPITHELIAL CELLS 
FROM MURINE EMBRYONIC STEM CELLS IN  
STATIC 3D CULTURE 
_____________________________________ 
 
ABSTRACT 
 
The most common concept underlying tissue engineering is to combine a 
scaffold or matrix, living cells and/or biologically active molecules to form a 'tissue-
engineered construct' to promote the repair and regeneration of tissues.  The lung is a 
particularly difficult target for tissue engineering in view of its structural complexity 
and cellular heterogeneity.  Encapsulation of animal cells into alginate hydrogels has 
been used with a large number of different cell types, including murine embryonic 
stem (ES) cells. In this study, single murine ES cell suspensions were encapsulated in 
alginate hydrogel solution using the method devised earlier for human ES cells 
(Chapter 3).  The beads were cultured in static conditions for up to 30 days.  They 
were maintained in 2 types of medium; murine ES cell maintenance medium without 
LIF as a control and A549-conditioned medium that were shown to promote 
pneumocyte differentiation from both human and murine ES cells (Chapter 4).  It was 
found that the cells in alginate beads differentiated into pneumocyte-like cells, 
identified by immunocytochemistry, ultrastructure and RT-PCR assessment of gene 
expression.  The results of this study appear to be promising and feasible for the 
derivation of pneumocytes in encapsulation in static 3D condition from murine ES 
cells. Although the concept of alginate encapsulation of cells has been around for 
more than 20 years, the current study represents the first application of the technology 
to the differentiation of murine ES cells. 
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7.1 INTRODUCTION 
 
In recent years, tissue engineered artificial organs, generated from autogenic 
and allogeneic cells, have posed a promising alternative treatment for a wide range of 
end-stage diseases where tissue or organ transplantation is the only remaining option 
but is limited by the availability of donor organs (Magyar et al., 2001). Alginate 
hydrogel was first used to encapsulate pancreatic islet cells for the treatment of 
diabetes (Lim and Sun, 1980).  Since then, it has been used for various applications 
such as in biomedical, medical, drug delivery and tissue engineering.   The alginate 
system provides an interesting and attractive model to study due to its 
biodegradability and biocompatibility and has the possibility of being used for in vivo 
techniques for cell transplantation. A major advantage of using such encapsulation 
technology for cell therapies is that it could eliminate the need for 
immunomodulatory protocols or immunosuppressive drugs and permit the long term 
de novo delivery of therapeutic products in an either local or systemic manner (Orive 
et al., 2002). In vivo, the encapsulated living cells can be separated from the body’s 
immune system by a semi-permeable structure which allows gas and nutrient 
exchange.  With the aim of mimicking the body’s environment, this 3D support for 
cells also delivers cell-inducing substances e.g cytokines, growth factors, matrix 
metalloproteinases and genetic material (Baroli, 2007). 
 
The differentiation of ES cells is initiated, in most protocols, by embryoid 
body (EB) formation that resembles embryonic formation in vivo but the 
differentiation process is limited due to variation in the sizes of the EBs and 
differentiation state of the various component cells (Magyar et al., 2001).  
Furthermore, the formation of cystic EBs after a few days in culture complicates the 
differentiation process.  This study brought together work done in Chapters 3 and 4 
and aimed to establish an efficient, robust ES cell differentiation protocol that 
bypasses the uncontrolled differentiation associated with EB formation by 
encapsulating murine ES cells in alginate hydrogel solution.  Although differentiation 
of ES cells in encapsulation has been used to derive certain specific lineages, 
including cartilage, bone (Bryant and Anseth, 2002; Elisseeff et al., 2000; Martens et 
al., 2003), pancreatic cells (Lim ans Sun, 1980; Sun et al., 1996), to date, no study has 
used this approach in the differentiation of stem cells into lung epithelial cells.  
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Following on from previous work (Chapter 4), A549-conditioned medium was used 
to enhance the differentiation of ES cells towards type II pneumocytes.  Thus, the 
current study formed the basis for the large scale expansion of murine ES cell 
differentiation to airway epithelium in a bioreactor system.   
 
7.2 AIM AND HYPOTHESIS 
 
 The aim of this study is to develop a 3D culture system that is efficient for the 
differentiation of murine ES cells towards pulmonary epithelium. 
 
 The hypothesis examined in this study is that the A549-conditioned medium 
mimics the in vivo condition of the lung for the differentiation of murine ES cells in a 
3D static microenvironment. 
 
 
7.3 MATERIALS AND METHODS 
 
 
7.3.1 Maintenance of murine ES cells                                                                                                              
 
The E14Tg2a murine ES cell line (American Type Culture Collection, 
Virginia, USA; # CRL-1821) was cultured in DMEM high glucose / no sodium 
pyruvate (Invitrogen, UK), supplemented with 10% (v/v) fetal bovine serum (PAA, 
UK), 100 iu/mL penicillin and 100 µg/mL streptomycin, 2 mM L-glutamine, 0.1 mM 
2-Mercaptoethanol (all supplied by Invitrogen, UK) and 1000 U/mL ESGRO (LIF) 
(Chemicon, UK).  The murine ES cell line was routinely passaged on 0.1% (v/v) 
gelatin (Sigma-Aldrich, UK)-coated tissue culture plastic in a humidified incubator 
set at 37oC and 5% (v/v) CO2. Undifferentiated murine ES cells (<p20) were passaged 
with trypsin-EDTA (Invitrogen, UK) every 2 or 3 days and fed every day.  
 
7.3.2 Encapsulation of murine ES cells 
 
Undifferentiated murine ES cell colonies were removed by treatment with 
trypsin-EDTA (Invitrogen, UK) and resuspended a few times, which resulted in 
single cells.  The alginate hydrogel consisted of 1.1% (w/v) low viscosity alginic acid 
(Sigma-Aldrich, UK) and 0.1% (v/v) bovine gelatin (Sigma, UK) (all dissolved in 
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PBS, pH 7.4) solution in room temperature. Using a peristaltic pump (Amersham 
Biosciences, Amersham, UK) from a drop height of 3 cm the cell-gel solution was 
passed through a 25-gauge needle (Becton Dickinson, Oxford, UK) into a sterile 
100mM CaCl2 (Sigma Aldrich) 10mM N-(2-hydroxyethyl) piperazine-N-(2-ethane 
sulphonic acid) (HEPES; Sigma) solution (pH7.4). Gelation was instant on contact 
with the CaCl2 solution resulting in the formation of spherical beads (approximately 
2.5mm in diameter after swelling). The beads remained in the gently stirred CaCl2 
solution for 6–8min at room temperature.   The beads were washed three times in 
PBS before putting into either basic ES cell maintenance medium or A549-
conditioned medium.  The beads were collected at day 10, 20 and 30 for further 
analysis. 
 
Any changes in the structure and morphology were evaluated and recorded 
using an inverted microscope (Olympus, Southall, UK) with a colour CoolPix 950 
digital camera (Nikon, Kingston-upon-Thames, UK) attached. The diameter of the 
aggregates was estimated using the scale from the analySISD (UK) software. 
 
7.3.3 A549-conditioned medium 
 
A549 cells were grown in F12 K medium supplemented with 10% (v/v) FBS 
and 2mM L-glutamine to confluence in T75 flasks (Orange Scientific, Braine-
l’Alleud, Belgium) for 2-3 days.  On day 3, the conditioned medium was collected 
from the flasks, passed through a 0.22µm filter to remove cell debris and kept at -
80oC for long storage.   
 
7.3.4 Viability assay 
 
Live/Dead assay is a two colour fluorescence assay that determines live cells 
and dead cells.  Live cells have intracellular esterases that convert non-fluorescent, 
cell permeable calcein acetoxymethyl (calcein AM) to calcein that fluoresces green.  
Dead cells have damaged membranes. The ethidium homodimer-1 (EthD-1) enters 
damaged or dead cells and produces bright red fluorescence when bound to nucleic 
acids.  A 4 mM EthD-1 and 2 mM calcein AM solution (Molecular Probes, Invitrogen, 
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UK) was diluted according to the manufacturer’s protocol in PBS and added to cells 
in alginate beads and incubated at room temperature for 30 minutes, in the dark. After 
incubation, the solution was aspirated and a small amount of PBS was added to the 
cells to prevent dehydration.  The cells were then photographed within 30 minutes 
using inverted IX70 (Olympus, Southall, UK) fluorescent microscope to visualize the 
proportion of live and dead cells. 
 
7.3.5 Alginate bead dissolution 
 
A sterile depolymerization buffer was used to dissolve the beads that 
consisted of Ca2+-depletion solution with 50 mM tri-sodium citrate dihydrate (Fluka, 
UK), 77 mM sodium chloride (BDH Laboratory supplies, UK) & 10 mM HEPES, as 
described in Chapter 2.  The solution with dissolved beads was centrifuged at 1250 
rpm for 5 minutes and the pellet was washed once with PBS and centrifuged again, at 
1000 for 3 minutes. 
 
7.3.6 Fixation and cryosectioning 
 
The collected beads were fixed in 4% (w/v) paraformaldehyde (Sigma Aldrich, 
UK) overnight at 4oC.  After rinsing the beads with PBS twice, they were incubated 
with 30% (w/v) sucrose (Sigma Aldrich, UK) at 4ºC overnight. The next day, beads 
were washed twice with PBS and placed in OCT compound (VWR International Ltd, 
UK) in a 50ml centrifuge tube (VWR International Ltd, UK). The intact beads 
together with the OCT compound in the centrifuge tube were then immersed in 
isopentane (Sigma Aldrich, UK) suspended in liquid nitrogen for 1-2 minutes until 
the OCT compound solidified. The frozen beads were kept in -80ºC overnight or at 
least 1 hour before sectioning in a cryostat (Bright Instrument Company LtD, 
Huntingdon, England) at a thickness of 7µm.  Sections were picked up on poly-l-
lysine coated glass slides (VWR International Ltd., UK) and kept in slide box at -
20ºC for long storage. 
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7.3.7 Immunocytochemistry 
 
Sections were place with a few drops of PBS to prevent dehydration prior to 
the immunostaining process.  They were permeabilized with 0.1% (v/v) Triton X-100 
(Sigma-Aldrich, UK).  Following a rinse in PBS, the sections were incubated with 
normal rabbit or goat serum (1:25), as appropriate, for 30 minutes at room 
temperature as a blocking agent.  Primary rabbit polyclonal antibodies against pro-
surfactant protein C (SPC) were applied at a dilution of 1:1000 (Milipore, Chemicon, 
Upstate, UK) and left overnight at 4oC.  The following day, cells were washed again 
with PBS twice and incubated with secondary goat anti rabbit IgG antibodies (1:200) 
(Millipore, Chemicon, Upstate, UK), conjugated with FITC for 1 hour at room 
temperature.  To stain actin, cells were washed twice with PBS and incubated with 
Phalloidin (Sigma Aldrich) conjugated with Rhodamine at room temperature for 
another 30 minutes. Nuclei were counterstained with Vectashield with 6 diamidino-2-
phenylindole (DAPI) (Vector Laboratories, Peterborough, UK).  Images were viewed 
and recorded using an inverted microscope (Olympus, Southall, UK) equipped with a 
colour CoolPix 950 digital camera (Nikon, Kingston-upon-Thames, UK).   
 
7.3.8 Haematoxylin and eosin stain 
 
The 7µm cryosections were stained as described in Chapter 3 (section 3.6.1.2). 
Images were captured and recorded using an upright microscope Olympus BH-2 
(Olympus, Southall, UK) equipped with Axio Cam MRct camera (Carl Zeiss Ltd., 
UK).   
 
7.3.9 Transmission electron microscopy (TEM) 
 
The intact beads were washed in buffer containing 0.1M phosphate and 0.1M 
sucrose, rinsed in PBS twice and then fixed in 3% (v/v) glutaraldehyde in cacodylate 
buffer (pH 7.2) for 30 min, as described in Chapter 3 (section3.5.4).  Ultrathin 
sections were observed in a Philips CM10 transmission electron microscope 
(Amsterdam, The Netherlands). 
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7.3.10 RNA isolation and reverse transcriptase-PCR 
 
Total RNA isolation was carried out using the RNAeasy kit (Qiagen, UK) 
according to the manufacturer’s instructions. A reverse-transcriptase-polymerase 
chain reaction (RT-PCR) was used to synthesize cDNA from 1 mg total RNA in a 
final volume of 20 ml. The rest of the process was described in Chapter 3 (section 
3.8).  Primers were designed using Primer Express 2 software (Applied Biosystems, 
Warrington, UK) and are shown in Chapter 3 (Table 3.1). PCR products were 
separated on a 2% (w/v) agarose gel and visualized by ethidium bromide (Sigma 
Aldrich, UK). The size of the products was correlated to 50 bp and 100 bp ladders 
(Fermentas, UK). Digital images of ethidium bromide-stained gels were captured 
using the Bio-Rad (Hemel Hempstead, UK) Fluor-S MultiImager system. 
 
7.3.11 From 3D decapsulation to 2D culture 
 
 To analyze the functionality of the differentiated murine ES cells in alginate 
beads, the beads were dissolved and depolymerized according to the previous 
protocol (5.3.5).   The de-capsulated single cells were then plated onto T75 flasks to 
grow as monolayers or 2D culture and later transferred to 8 chamber slides (VWR 
International Ltd., UK) for immunocytochemical analysis.  These cells were grown in 
basic medium which consists of F12 K medium supplemented with 10% (v/v) FBS 
and 2mM L-glutamine. The monolayer cells cultured in the chamber slides were fixed 
in 4% (w/v) paraformaldehyde (Sigma Aldrich, UK) for 30 min and immunostained 
with proSPC antibodies according to the above protocol (7.3.7). 
 
 
7.4 RESULTS 
 
 
7.4.1 Differentiation of murine ES cells in 3D static culture 
 
Gel bead formation occurs as soon as the alginate gel gets in contact with the 
calcium chloride solution. About 2x104 cells were encapsulated in each bead.  These 
beads were cultured in T75 flasks and feed every 2-3 days for 30 days.  At the 
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beginning of culture (day 1 to day 7), the entrapped cells remained as single cells.  
After 10 days it was clear that they had started aggregating.  The encapsulated cells 
looked scattered and discrete within each bead.  The size of the hypodermic needle of 
25G determined the size of each bead that ranged from 2.3-2.5mm in diameter.  
These beads were divided into two groups, one group was cultured in medium 
conditioned with A549 cells to enhance differentiation and ES cell maintenance 
medium was used as a basic control.  The maintenance medium contained the same 
ingredients as the EB medium but without LIF.     
 
After 10 days in conditioned medium, the single cells started forming small 
aggregates within the beads (Figure 7.1a). In the cryosections of fixed beads, it was 
possible to see small aggregates at day 10 that were dispersed and some were visible 
at the periphery of the beads. At this time, the size of the aggregates ranged from 100-
150 µm measured from analySISD (UK) software.  At the end of day 30 in culture 
(Figure 7.1a-e), the aggregates had grown larger in size and some of them had 
accumulated at the border of the beads.  Similar observations were made for the 
controls, with single cells starting to aggregate after 10 days in culture, except that the 
aggregates were more spherical with dense cells in the middle, possibly 
corresponding to degenerating or apoptotic cells. 
 
7.4.2 Viability test 
The viability of the murine ES cells in situ was evaluated using a Live/Dead 
viability test.  The in situ test showed between 80-90% viability on days 5 and 10 
conditioned medium but decreased from day 15 onwards (Figure 7.2 a, a’,a’’).  Beads 
in maintenance medium showed aggregation and the aggregates were still viable until 
day 30 in culture (Figure 7.2 b, b’, b’’).   
 
 
7.4.3 Haematoxylin and eosin stain 
 
The formation of cell aggregates was obvious from the appearance of cross-
sections of the beads.  Static culture at day 12 in conditioned medium resulted in 
increased size of the aggregates that accumulated around the border of the beads and 
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not many cells at the core (Figure 7.3 a, b).  It is likely that this reflected migration 
towards the border due to there being less gas and nutrient exchange within the beads.  
As the aggregates survived longer in culture, they grew bigger in size and some 
showed branching or budding out (Figure 7.3 c, d).  This morphology was 
reminiscent of that of early lung morphogenesis in vivo.  
 
7.4.4 Immunocytochemistry 
 
To test the level of type II pneumocyte differentiation within the beads, the 
sections were stained with antibodies against pro-SPC, counterstained with phalloidin, 
to show the actin cytoskeleton, and DAPI, for the nuclei (Figure 7.4a).  Cells in the 
small aggregates were immunoreactive for SPC antibody and filled the entire beads 
by day 15 (Figure 7.4b). The larger aggregates also showed positive SPC expression 
at day 15 conditioned medium.  
 
7.4.5 Transmission electron microscopy (TEM) 
 
The cell ultrastructure seen on TEM corresponded with the histology results 
that demonstrated the migration of aggregates towards the surface of the beads.  TEM 
analysis showed that the migrated cells formed a thin, monolayer surface that 
elongated and stretched along the whole spherical structure of the bead (Figure 7.5 a, 
b).  This observation was observed at day 15 cultured in conditioned medium. 
 
Interestingly, the cells or aggregates that grew just below the outer layer of 
cells showed signs of degeneration (figure 7.5 a).  This was probably due the layers 
on the surface forming a sealed boundary that prevented gas exchange and nutrient 
transport into and out of the beads.  However, the aggregates within the beads showed 
differentiation into type I and II penumocytes with typical features being observed 
(Figure 7.6 b-d; 7.7 a-d; 7.8 a-c).  Other cytoplasmic organelles seen included rough 
endoplasmic reticulum (RER), Golgi apparatus, numerous mitochondria and the oval 
to round electron bodies of lysosomes (Figure 7.6d; 7.7a-d).  The mix of lysosomal 
and lamellar bodies observed was taken to indicate the transformation from one 
structure to another to form a functional organelle (Figure 7.8 a-c). As in the co- 
culture system (Chapter 6), engorged RER and protein secretion was observed from 
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the static cultures.  As a comparison, no obvious cytoplasmic organelles formation 
could be detected in beads cultured in the maintenance medium (Figure 7.6a). 
 
7.4.6 Reverse transcriptase-PCR 
 
RT-PCR results confirmed the differentiation of endoderm (FoxA2) as well as 
SPC (type II) and AQP5 (type I) pneumocytes cultured in conditioned medium.  
Expression of SPC mRNA was observed at day 10 in culture and reduced at day 20.  
Expression of SPA and AQP5 RNAs was maintained at a similar level throughout the 
whole culture period (Figure 7.9).  In contrary, mRNA expression for cells cultured in 
basic medium does not show these genes expression. 
 
7.4.7 From 3D decapsulation to 2D culture 
 
The decapsulated cells grown in 2D had a homogeneous flat and cobblestoned 
appearance.  After 2 days, the homogeneous cells reached confluency and were ready 
to be split.  Interestingly, the morphology and phenotype of these cells were well 
maintained following decapsulation.  These findings were confirmed using 
immunocytochemistry that showed positive proSPC expression in cells grown in 2D 
culture (Figure 7.10 a, b). 
 
 
7.5 DISCUSSION 
 
In the previous chapter, it was shown that culture of murine and human ES 
cells in A549-conditioned medium enhances their differentiation into pulmonary 
epithelial cells.  In this chapter, it was possible to demonstrate that 3D culture of 
encapsulated murine ES cells can be combined with exposure to A549-conditioned 
medium to enhancing their differentiation to endoderm and lung epithelial cells.  This 
study is the first to show the differentiation of murine ES cells in encapsulation into 
pulmonary epithelial cells. 
 
 
 Alginate hydrogel is a three dimensional scaffold that serves as a physical 
support for the growth and differentiation of cells.   This 3D scaffold is a cross-linked 
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polymer matrix capable of absorbing large amounts of medium and nutrients (Mikos 
et al., 2006).   Furthermore, the alginate microenvironment is biocompatible, 
conducive to ES cell differentiation and maintains differentiated cellular function 
(Orive et al., 2003).   
 
Transmission electron microscopy (TEM) demonstrated that encapsulated 
murine ES cells in conditioned medium differentiated into type I pneumocytes with 
flat and microvillus cell formation. The epithelial cells formed a network, with many 
long and short microvilli, with cells underneath that contained very numerous 
lamellar bodies. It was possible to show that the differentiation of encapsulated 
murine ES cells occurred as early as day 10 according to data obtained from RT-PCR 
and TEM analyses.  These results for RNA (surfactant protein C; SPC) and 
ultrastructure corresponded to those obtained with immunocytochemistry that 
demonstrated that the cell aggregates expressed proSPC.  In this study, cryosectioning 
was preferred to paraffin-embedding (from Chapter 4) for immunocytochemistry 
analysis.  This was because cryosectioning is a simple and straightforward protocol 
that gives better antigen preservation without having to go through the antigen 
retrieval procedure. In addition, dewaxing and the subsequent in the paraffin-
embedding technique can easily wash off thin sections.  However, cryosections do not 
give as good morphological preservation as can be obtained with paraffin-embedding. 
 
RT-PCR results also confirmed the expression of RNAs for endoderm (Foxa2) 
as well as aquaporin 5 (AQP5; marker for type I pneumocytes) and surfactant protein 
C and A (SPA). The surfactant-associated proteins, SPA, SPB, SPC, and SPD, are 
believed to play important roles in surfactant synthesis, storage, secretion and 
functions (Clark et al., 1995; Weaver and Whitsett. 1991).   
 
TEM and histological analyses showed that individual cells and cell 
aggregates grown in conditioned medium penetrated towards the surface layer of the 
alginate beads.  The pores of the beads are large enough to accommodate living cells 
and allow release of growth factors and so the cells may penetrate them and 
proliferate (Hutmacher, 2001). Furthermore, the hydrogel is derived from naturally 
occurring polymers and mimics many features of extracellular matrix.  Thus, it may 
have the potential to direct the migration, growth and organization of cells during 
 192
tissue regeneration and stabilization of encapsulated and transplanted cells 
(Balakrishnan and Jayakrishnan, 2005). Another possible reason why the cells 
migrate to the surface of the beads may be because of limited nutrients and metabolite 
transport that causes less diffusion and infusion within the beads.   
 
There was evidence that the migrated cells stretched in a layer right around 
the surface of the beads.  The cells or aggregates just underneath showed degenerative 
changes,  the most prominent being the formation of mutivesicular bodies, lysosomes 
and well developed concentric lamellar bodies that were abundant.  The identification 
of proSPB and proSPC in the mutivesicular bodies indicates that these organelles also 
participate in the synthesis of surfactant components in lamellar bodies (Voorghout et 
al., 1992; Voorhout et al., 1993; Brasch et al., 2004; Brasch et al., 2002; Johnson et 
al., 2002).  The mechanism of multivesicular body fusion and lamellar body 
formation is unknown, although it is believed that the process also includes, as an 
intermediate form, the composite body or immature lamellar body.  Some studies also 
suggest a close spatial and likely temporal relationship of this organelle with lamellar 
bodies (Wasano and Hirakawa, 1994).  
 
Lamellar bodies differ from lysosomes but resemble a number of other 
lysosome-related organelles in that they are specialized for storage and secretion 
rather than degradation of their contents (Weaver et al, 2002).  Some studies have 
indicated that, in addition to surfactant, the lamellar bodies also contain enzymes that 
are normally of lysosomal origin (Chander and Fisher, 1990).  A study by Hook and 
Gilmore (1982) suggested that lamellar bodies are derived from a source similar to 
that of lysosomes, although the precise site of origin is uncertain. 
  
All these observations indicate the existence of an early developmental 
process in the differentiation of ES cells towards pulmonary epithelium, including the 
formation of mature or progenitor cells that mimic the in vivo formation of the 
secretory pathway.   
 
To demonstrate the stability of the SPC-expressing phenotype, the 
differentiated cells were decapsulated from the beads and grown in monolayer.  
Immunostaining of SPC in the cells showed that they maintained their phenotype and 
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homogeneous morphology over at least 20 days of culture.  This result confirms the 
stability of SPC expression and indicates that these pneumocyte-like cells are indeed 
phenotypically stable in vitro.   
 
 The use of murine ES cells encapsulated in 1.1% alginate, as described in this 
chapter, could be optimized and then validated for human ES cell culture.  This 
system was used as a baseline for comparing the efficiencies of static and bioreactor 
culture systems in enhancing the differentiation of pulmonary epithelial cells.  
 
7.6 CONCLUSION 
 
The current study represents the first application of encapsulation technology 
to the differentiation of murine ES cells into distal epithelial lung cells. ES cells have 
the ability to differentiate and expand in unlimited numbers when exposed to 
appropriate culture conditions.  In this study, it was shown that ES cell differentiation 
and expansion can occur in encapsulation under static culture conditions.  This 
technique is simple, scalable and could be used in bioreactors to generate high 
densities of specialized cells in the future.  The differentiation into endoderm and 
alveolar epithelial cells has potentially significant implications for future therapeutic 
applications. It is hoped that stem cell microencapsulation may be used in transplant 
settings to offer relief to patients suffering from respiratory diseases.  
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Figure 7.1 
Single cells were encapsulated (a) and after 10 days (b) the single cells 
started to form small aggregates that grew larger over time, as shown on days 
20 (c), 25 (d) and 30 (e) in A549-cultured medium (n=5). 
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Figure 7.2 
A high level of viability (live cells-green, dead cells-red) was seen in cells 
observed at days 5 and 10 of culture in conditioned medium, but was found to 
decrease from day 15 onwards [Figure 5.2 a (phase), a’(green-live cells), 
a’’(red-dead cells].  Cells grown in beads in maintenance medium (control) 
formed aggregates and were still viable (green) until day 30 in culture (Figure 
5.2 b, b’, b’’) (n=3). 
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Figure 7.3 
Cross-sections of beads cultured in conditioned medium showed (a, b) large cell 
aggregates accumulated around the border of the beads and there were not many 
cells at the core.  As showed from haematoxylin and eosin staining, the 
aggregates survived longer in culture, they grew bigger in size and some showed 
branching or budding (c, d) (n=5).   
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Figure 7.4 
Immunocytochemistry showed that cells within beads grown in A549-
conditioned medium expressed pro-SPC (immunostaining: FITC-green) at day 
15.  Sections were stained with phalloidin (red) to show actin in the 
cytoskeleton and DAPI (blue) for the nuclei (a).  Small aggregates were 
formed at day 10 that filled entire beads by day 15 (b) (n=3). 
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Figure 7.5 
TEM showed that the cells in beads cultured in conditioned medium 
migrated to the surface of the beads formed a thin monolayer surface that 
stretched along the whole surface of the bead (a, b) while the cells 
underneath showed signs of degeneration (dg) (n=2). 
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Figure 7.6 
No obvious formation of cytoplasmic organelles was seen in cells grown in 
beads for 15 days in the maintenance medium (control) (a). In contrast, the 
typical features of type II with abundant lamellar bodies (LB) and type I 
pneumocytes with microvillus formation (mv) were observed, in encapsulated 
murine ES cells grown in A549-conditioned medium for 15 days (b-d) (n=2).  
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Figure 7.7 
(a-d) TEM revealed the presence of a range of cytoplasmic organelles in 
encapsulated murine ES cells grown in A549-conditioned medium, including 
lamellar bodies (LB), rough endoplasmic reticulum (rER), Golgi apparatus 
(G), numerous mitochondria (mc) and oval to round electron-dense bodies of 
lysosomes (Ly) (n=2).   
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Figure 7.8 
(a-c) On TEM, a mixture of lysosomal (Ly), multivesicular bodies (arrow) 
and lamellar bodies (LB) was observed indicating a form of transformation 
from one structure to another to form a functional organelle (n=2). 
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Figure 7.9 
RT-PCR results confirmed the differentiation of endoderm (FoxA2 RNA) as 
well as that of pneumocytes; SPC RNA (type II) and AQP5 RNA (type I).  The 
expression of SPC was observed at day 10 culture in conditioned medium and 
had reduced by day 20 while expression of SPA and AQP5 was maintained 
throughout the whole culture period (n=3).   
Key: GAPDH- Glyceraldehyde 3-phosphate dehydrogenase; +ve :whole lung 
RNA; -ve: water; FoxA2: forkhead box A2; SPC: surfactant protein C; SPA: 
surfactant protein A; AQP5: Aquaporin 5.  
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Figure 7.10 
(a,b) Alginate beads were dissolved and the decapsulated single cells were grown 
as monolayer in basic maintenance medium showed homogeneous flat and 
cobblestoned shape. Immunostaining demonstrated expression of proSPC (FITC-
green) (b) (n=2). 
 
 204
 
 
 
 
 
 
 
 
 
PHASE 3: 3D INTEGRATED STEM 
CELL BIOPROCESSING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 205
 
 
 
 
 
CHAPTER 8 
 
AN INTEGRATED 3D BIOREACTOR SYSTEM TO 
DIFFERENTIATE MURINE EMBRYONIC STEM CELLS 
INTO ALVEOLAR EPITHELIAL CELLS 
___________________________________________________________ 
 
ABSTRACT 
 
Stem cell therapies and tissue engineering strategies are required for the clinical 
treatment of respiratory diseases. Protocols have been developed for the generation of 
pneumocytes, the epithelial component of the gas-exchange unit that is crucial for 
survival, from murine and human ES cells.  In this study, it was shown that 
encapsulation of murine ES cells in 1.1% (w/v) alginate solution followed by culture 
in a conditioned medium within a rotating wall bioreactor system (HARV) 
upregulated their differentiation into endoderm, specifically type I and II 
pneumocytes. The yield of differentiated type II pneumocytes was approximately 
50%, as shown by flow cytometry analysis. Differentiation was further characterized 
by expression of surfactant proteins C, aquaporin 5 (AQP5) and Clara cell secretory 
protein (CC10) and their corresponding mRNAs.  Transmission electron microscopy 
(TEM) revealed the typical morphology of type II pneumocytes, with lamellar bodies 
and microvilli.  On TEM study, it was also possible to observe type I and type II 
pneumocyte differentiation as early as day 7.   In contrast, cells differentiated in the 
same medium but in static culture started to degenerate and show signs of apoptosis 
over the same period of time. The differentiated ES cells survived and secreted 
surfactant proteins during encapsulation as well as after decapsulation.  This was 
observed on both transmission and scanning EM where the lamellar bodies showed 
exocytosis of secreted protein. This work shows that an integrated, automated and 
scalable bioprocess can be used to enhance the production of pneumocytes from ES 
cells with potential clinical applications.  
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8.1 INTRODUCTION 
 
 In Chapter 7, it was shown that encapsulated murine ES cells grown in static 
conditions were able to differentiate into endoderm and, specifically, type II 
pneumocytes when cultured in A549-conditioned medium. However, the use of a 
static cultivation system provides only a limited area for the differentiation process to 
occur as the cells can not receive sufficent nutrients and waste transport is impeded. 
In this chapter, murine ES cells were encapsulated in the same way but were 
cultivated in a rotating bioreactor system, also known as the HARV (high aspect ratio 
vessel) bioreactor, in order to try to enhance and scale-up the differentiation of 
murine ES cells into type I and II pneumocytes.  
 
The HARV bioreactor is a rotating-wall vessel that has been used widely in 
3D tissue engineering approaches. It can simulate microgravity and was developed by 
NASA.  Within this rotating wall vessel, cells/cell aggregates experience a low fluid 
and shear stress environment that supports high-density and large scale three 
dimensional (3D) cell cultures compared with routine 2D cell culture flasks 
(Goodwin et al., 1992; Becker et al., 1993).  This vessel also provides adequate and 
controlled supplies of oxygen and nutrients (Gao et al., 1997) that support the growth 
of 3D cell aggregates (Saarinen et al, 2003).   Thus, the HARV bioreactor has become 
a common low-shear culture venue for studying cellular aggregation and the 
formation of 3D tissue-like cell assemblies or bodies. These bodies are demonstrably 
more differentiated, have increased size and exhibit behaviour more similar to actual 
in vivo tissue than those cultured in either 2D flasks or other bioreactors (Granet et al., 
1998; Klement et al., 2004). By mimicking natural tissue with higher fidelity, culture 
in rotating wall bioreactor permits more accurate evaluations of protein interactions, 
gene expression and signalling pathways (Lelkes et al., 1998; Sanford et al., 2002; 
DiLoreto et al., 2006; Johnson et al., 2006). 
 
As the encapsulated murine ES cells cultivated in the HARV bioreactor 
experience low fluid shear stress they are maintained in conditions that are essentially 
free from turbulence (Schwarz et al., 1992; Jessup et al., 1993; Freed and Vunjak-
Novakovic, 1995, 1997).  Oxygenation is provided by a permeable silicon rubber 
membrane through the stationary inner cylinder, allowing the passive exchange of 
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gases to and from the medium, whereas the outer cylinder is impermeable and rotates 
at a controlled rate.  The free falling of the beads inside the bioreactor as a result of 
gravity can be balanced by the centrifugal forces due to the rotation of the outer-
cylinder, thus establishing suspension culture environment for the alginate beads 
(Pollack et al., 2000; Hammond and Hammond, 2001). 
 
This one step protocol is an efficient 3D integrated bioreactor process towards 
producing high proportions of murine ES cells rapidly differentiated to alveolar 
epithelial cells for lung tissue engineering applications.  In the future, it is hoped that 
stem cell microencapsulation may be used in transplant settings to offer relief to 
patients suffering from respiratory diseases. 
 
8.2 AIMS AND HYPOTHESIS 
 
 The aims of this study were, firstly, to develop a single step culture technique 
to enhance and scale-up the differentiation of murine ES cells into alveolar epithelial 
cells using a HARV bioreactor and, secondly, to design a system that mimics the 
conditions that exist in vivo in the lung.   
 
The hypothesis was that the perfusion airlift bioreactor system increases the 
growth of A549 cells as a model for the differentiation of ES cells towards an 
alveolar epithelial phenotype. 
 
8.3 MATERIALS AND METHODS 
 
8.3.1 Culture of murine ES cells 
 
The E14Tg2a murine ES cell line (ATCC) was cultured in DMEM high 
glucose without sodium pyruvate (Invitrogen, UK), supplemented with 10% (v/v) 
fetal bovine serum (PAA, UK), 100 iu/mL penicillin and 100 µg/mL streptomycin, 2 
mM L-glutamine, 0.1 mM 2-mercaptoethanol (all supplied by Invitrogen, UK) and 
1000 U/mL LIF (Chemicon, UK).  The cells were routinely passaged on 0.1% (w/v) 
gelatin (Sigma Aldrich, UK)-coated tissue culture plastic in a humidified incubator 
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set at 37oC and 5% (v/v) CO2. Undifferentiated murine ES cells (<p20) were passaged 
with trypsin-EDTA (Invitrogen, UK) every 2 or 3 days and fed every day.  
 
8.3.2 Encapsulation of murine ES cells 
 
Undifferentiated murine ES cells were passaged with trypsin-EDTA 
(Invitrogen, UK)  and cell pellets were re-suspended in 1.1% (w/v) low viscosity 
alginic acid (Sigma, UK) and 0.1% (v/v) gelatin (Sigma) solution in room 
temperature (in PBS at pH 7.4).  Using a peristaltic pump (Amersham Biosciences, 
UK) from a drop height of 3 cm the cell-gel solution was passed through a 25-gauge 
needle (Becton Dickinson, UK) into a sterile 100 mM CaCl2 (Sigma) 10 mM N-(2-
hydroxyethyl) piperazine-N-(2-ethane sulfonic acid) (HEPES; Sigma) solution (pH 
7.4) accoding to previous protocol.  The beads were washed three times in PBS and 
were cultured in murine ES cell maintenance medium (as described in 7.3.2)  with a 
3-4 day feeding cycle.   
 
Any changes in the structure and morphology of the encapsulated cells were 
evaluated and recorded using an inverted microscope (Olympus, Southall, UK) 
attached with a colour CoolPix 950 digital camera (Nikon, Kingston-upon-Thames, 
UK). 
 
8.3.3 A549-conditioned medium 
 
A549 is a human type II pneumocyte tumour cell line (A549: American Type 
Culture Collection, Virginia, USA; # CCL 183).  The cells were grown in F12 K 
supplemented with 10% (v/v) FBS and 2mM L-glutamine (all supplied by Invitrogen, 
UK) to confluence in T75 flasks (Orange Scientific, Braine-l’Alleud, Belgium) for 2-
3 days.  On day 3, the conditioned medium was collected from the flasks, passed 
through a 0.22µm filter (Millipore, UK) to remove cell debris and kept at 4oC prior to 
use. 
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8.3.4 Differentiation of murine ES cells in a HARV 
 
After culturing the beads (containing approx. 30,000 cells per bead) for 24 
hours in maintenance medium, about 500 beads were transferred in 2 units of HARV 
vessels (Synthecon, USA).  The vessels were filled with 50ml of maintenance 
medium as a control or with 50 ml of A549-conditioned medium.  The rotating speed 
was maintained as 17 rpm (resolutions per minute) and cells were fed every 2-3 days.  
The beads were collected at different days for further characterization, for example 
days 5, 10, 15, 20, 25 for RT-PCR and at days 5, 7, 10, 15 for flow cytometry 
analysis.  
 
8.3.5 Fixation and cryosectioning  
 
Beads from day 20 conditioned medium were collected and fixed in 4% (w/v) 
paraformaldehyde (Sigma Aldrich, UK) overnight at 4ºC.  After rinsing beads with 
PBS twice, they were incubated with 30% (w/v) sucrose (Sigma Aldrich, UK) at 4ºC 
overnight.  The next day, beads were washed twice with PBS and OCT compound 
(VWR International Ltd, UK) were added.  The intact beads together with the OCT 
compound in a centrifuge tube (VWR International Ltd, UK) were immersed in 
isopentane (Sigma Aldrich, UK) suspended in liquid nitrogen for 1-2 minutes until 
the OCT compound solidifies.  The frozen beads were kept at -80ºC overnight or at 
least 1 hour before sectioning. The 7 µm thickness sections were picked up onto poly-
l-lysine-coated glass slides (VWR International Ltd., UK) and kept in slide box at -
20ºC for long-term storage. 
 
8.3.6 Hematoxylin and eosin stain 
 
Frozen beads in OCT compound were sectioned at 7µm thickness and placed 
on a poly-l-lysine coated glass slides (VWR International Ltd., UK).  The 7µm 
sections were stained as described in Chapter 2 (2.6.1.2). Images were captured and 
recorded using an upright microscope Olympus BH-2 (Olympus, Southall, UK) 
equipped with Axio Cam MRct camera (Carl Zeiss Ltd., UK).   
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8.3.7 Immunocytochemistry 
 
The 7 µm thin sections were place with a few drops of PBS to prevent 
dehydration prior to the immunostaining process.  They were permeabilized with 
0.1% (v/v) Triton X-100 (Sigma-Aldrich, UK).  Following a rinse in PBS, the 
sections were incubated with normal rabbit serum (1:25) for 30 minutes at room 
temperature as a blocking agent.  Primary rabbit polyclonal antibodies against pro-
surfactant protein C (SPC) were applied at a dilution of 1:1000 (Millipore, Chemicon, 
Upstate, UK) and left overnight at 4oC.  The following day, cells were washed again 
with PBS twice and incubated with secondary goat anti rabbit IgG antibodies (1:200) 
(Millipore, Chemicon, Upstate, UK), conjugated with FITC for 1 hour at room 
temperature.  To stain actin, cells were washed twice with PBS and incubated with 
Phalloidin (Sigma Aldrich) conjugated with Rhodamine at room temperature for 
another 30 minutes. Nuclei were counterstained blue with Vectashield with 6 
diamidino-2-phenylindole (DAPI) (Vector Laboratories, Peterborough, UK).  Images 
were viewed and recorded using an inverted microscope (Olympus, Southall, UK) 
equipped with a colour CoolPix 950 digital camera (Nikon, Kingston-upon-Thames, 
UK).   
 
8.3.8 Flow cytometry  
 
The beads from day 5, 7, 10 and 15 in conditioned medium and maintenance 
medium (as negative control) were depolymerized in sterile dissolution buffer 
consisting of 50 mM tri-sodium citrate dihydrate (Fluka, UK), 77 mM sodium 
chloride (BDH Laboratory supplies, UK), and 10 mM HEPES (Sigma) in PBS for 5 
minutes in a waterbath at 37ºC.  After centrifugation at 1,000 rpm for 5 minutes, the 
cell pellets were washed once with PBS and centrifuged again.  Cell pellets were then 
fixed in 4% paraformaldehyde (w/v) (Sigma Aldrich, UK) for 20 min at room 
temperature.  While fixing, cells were resuspended a few times to get single cells and 
sieved using a cell strainer, 40 µm in size (VWR International Ltd., UK).  The cells 
were then centrifuged at 1,000 rpm for 5 minutes, rinsed in PBS and centrifuged 
twice again. The cells were then divided into two tubes, for immunolabelling with 
either pro-SPC or AQP5 antibodies both conjugated with FITC. After rinsing twice in 
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PBS (Invitrogen, UK), the cells were incubated in blocking agent comprising 5% 
(v/v) goat or rabbit serum, as appropriate, diluted in PBS and 0.1% (v/v) Triton-X 
(Sigma-Aldrich)  for 15 min at room temperature. After blocking, cells were 
incubated with polyclonal anti-rabbit pro-SPC antibodies (1:500) and polyclonal anti-
goat AQP5 antibody (1:300) (both from Chemicon, Upstate, UK) for 2 hours.  Cells 
were rinsed twice with PBS and incubated with goat anti-rabbit (pro-SPC) or rabbit 
anti-goat (AQP5) IgG antibodies (both from Chemicon, Upstate, UK) diluted 1:300 in 
PBS, conjugated with FITC.  After washing with PBS once, the cells were analysed 
using a Beckman Coulter Epic Altra (Coulter Corporation, Florida, USA).  Data were 
further processed using Expo32 MultiCOMP software. 
 
8.3.9 Transmission electron microscopy 
 
The beads collected from the HARV were rinsed in PBS twice  and then 
washed in buffer containing 0.1M phosphate and 0.1M sucrose, rinsed in PBS twice 
and then fixed in 3% (v/v) glutaraldehyde in cacodylate buffer (pH 7.2) for 30 min.  
The details of this process are in Chapter 3 (section 3.5.4). Ultrathin sections were 
observed in a Philips CM10 transmission electron microscope (Amsterdam, The 
Netherlands). 
 
8.3.10 RNA isolation and Reverse Transcriptase-PCR 
 
RT-PCR was performed on samples taken at days 5, 10, 15, 20 and 25 of 
differentiation in the A549-conditioned medium and maintenance medium.  To 
dissolve the alginate beads for total RNA extraction, the beads were immersed in 
dissolving buffer as mentioned in material and methods (section 3.8). To facilitate the 
solubility the beads were gently shaken a few times for about 5 minutes in a water 
bath.  The dissolved beads in the buffer solution were centrifuged and the cell pellets 
were dislodged using lysis buffer (according to the manufacturer’s protocol).   Total 
RNA isolation was carried out using the RNAeasy kit (Qiagen, UK) according to 
manufacturer’s instructions. A reverse-transcription-polymerase chain reaction (RT-
PCR) was used to synthesize cDNA from 1 mg total RNA in a final volume of 20 ml. 
The rest of the process was described in Chapter 3 (3.8.3).  Primers were designed 
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using Primer Express 2 software (Applied Biosystems, Warrington, UK) and are 
shown in Chapter 3 (Table 3.1). PCR products were separated on 2% (w/v) agarose 
gel and visualized by ethidium bromide (Sigma Aldrich, UK). The size of products 
was correlated to 50 bp and 100 bp ladders (Fermentas, UK). Digital images of 
ethidium bromide-stained gels were captured using the Bio-Rad (Hemel Hempstead, 
UK) Fluor-S MultiImager system. 
 
 
8.3.11 Decapsulation from 3D cultivation 
 
To analyze the functionality of the differentiated murine ES cells in the 
HARV bioreactor system, the 10 day old beads in conditioned medium were 
dissolved and depolymerised according to the previous protocol.   The de-capsulated 
single cells were then plated onto T75 flasks in F12K supplemented with 15% (v/v) 
FBS (without conditioned medium) to grow as monolayers or 2D culture and later 
transferred to 8 chamber slides (VWR International Ltd., UK) for 
immunocytochemical analysis.  These cells were passaged a few times and grown for 
a period of 100 days in the basic medium (F12K supplemented with FBS). The 
monolayers cultured in the T75 flasks were harvested at day 10 and 100 for mRNA, 
TEM and flow cytometry analysis.   
 
 
8.3.12 Scanning electron microscopy (SEM) 
 
For SEM study, the decapsulated cells were cultured for 10 days on Petri 
dishes (Sterilin, Bibbt Sterilin Ltd, Stone, Staffs, UK). Just prior to fixing, the 
medium was removed and the cell cultures were washed in PBS twice and then fixed 
in 2.5 % (v/v) glutaraldehyde in cacodylate buffer (pH 7.2) for 30 minutes. The detail 
of this process was discussed in Chapter 3 (3.5.3).  
8.3.13 Lysotracker and FM1-43 
  
The application of the fluorescent dye LTG and FM143 to visualize 
exocytosis of surfactant was adapted and modified from previous protocols (Mair et 
al., 1999; Haller et al., 1998; Bertrand et al., 2006; Jennings et al., 2005).  As for 
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SEM, decapsulated cells were cultured in basic medium (F12K with 15% FBS) for 10 
days on Petri dishes (Sterilin, Bibbt Sterilin Ltd, Stone, Staffs, UK).  The Petri dishes 
were divided into two groups; one with unstimulated cells (control) and another with 
stimulated cells with ATP and isoproterenol (both from Sigma Aldrich, UK).  For dye 
loading, the cells were pre-incubated at 37°C in DMEM with LysoTracker® Green 
DND-26 (Invitrogen, UK) (LTG) at 50 nmol/litre for 30 min according to the 
manufacturer’s protocol. After 30 min, the medium was aspirated and ATP and 
isoproterenol (both from Sigma Aldrich, UK) were applied at a concentration of 10 
mmol/litre to the stimulated cells.  This method was used to stimulate alveolar type II 
cells because the additive actions of Ca21, PKC, and cAMP on surfactant secretion 
have been shown to yield maximum responses (Haller et al., 1998).  The unstimulated 
cells received maintenance medium (F12 K supplemented with 10% (v/v) FBS and 
2mM L-glutamine).  At the same time the fluorescent dye, FM 1-43 (Invitrogen, UK) 
at a concentration of 4 mmol/litre was added to both culture groups in order to 
visualize exocytosis of single lamellar bodies.  
 
LTG stains acidic vesicles and has previously been demonstrated to stain 
lamellar body-related vesicles selectively in primary culture rat alveolar type II cells 
(Haller et al., 1998).  In the presence of FM1-43 in the extracellular solution, lamellar 
bodies become highly fluorescent as soon as FM1-43 gets access to the lipid 
component of surfactant through the fusion pore (Frick et al., 2001). Any 
fluorescence changes were viewed and recorded using an inverted microscope 
(Olympus, Southall, UK) at the fluorescence excitation/emission maxima ~504/511 
nm equipped with a colour CoolPix 950 digital camera (Nikon, Kingston-upon-
Thames, UK).   
 
8.4 RESULTS 
 
8.4.1 Differentiation of murine ES cells in the HARV 
 
30,000 cells were encapsulated and cultivated in the rotating bioreactor 
(HARV) for the duration of 30 days in either A549-conditioned medium or, as a 
baseline control, maintenance medium.  Each vessel contained around 500 beads in 
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50ml of medium. The speed of rotation was maintained at 17rpm throughout the 
whole experiment. From morphological observation with different cell density in the 
beads, it was found that 30,000 cells is an ideal starting point in each bead as it gives 
high growth rate towards the end of the cultivation period.   
 
Aggregates were formed as early as day 5 of culture in both culture mediums.  
At day 10 of culture in the HARV, small cells aggregates were visible in both culture 
conditions (conditioned and maintenance medium) (Figure 8.1a, b).  The size of the 
aggregates increased (Figure 8.1c, d) and by day 20 (Figure 8.1e, f) the cells started to 
fill up the entire bead, clearly becoming cramped and crowded.  However, the 
encapsulated cells grown in maintenance medium formed very large aggregates with 
dark or dense areas at their core which indicated degeneration or apoptosis (Figure 
8.1f).   
 
8.4.2 Hematoxylin and eosin stain 
 
At day 15 of culture in A549-conditioned medium, huge cell aggregates were 
dispersed within the beads (Figure 8.2a and b).  In contrast with static culture, the 
aggregates accumulated around the periphery of the beads (as shown in chapter 7). 
The rotating movement of the vessel maintained adequate levels of gas and nutrient 
exchange inside and outside the beads. 
 
8.4.3 Immunocytochemistry 
 
In cross-section, the morphology of the cell aggregates was visible through to 
the core of the beads.  To test for type II pneumocyte differentiation within the beads 
grown in the conditioned medium, sections were immunostained with pro-SPC 
antibodies and counterstained with phalloidin to show the cytoskeleton and DAPI for 
the nuclei (Figure 8.2c).  From single cells, small aggregates had formed that filled 
entire beads by day 15. The aggregates showed immunoreactivity for pro-SPC 
expression at day 10 of culture in the HARV bioreactor.  
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8.4.4 Flow cytometry analysis 
 
The cell aggregates within the beads were depolymerized into single cells 
very carefully not to disrupt the cell membranes.  They were re-suspended carefully 
before fixation in 4% paraformaldehyde.  Two types of antibodies were used, one to 
proSPC for detection of type II pneumocytes and the other to AQP5 for 
immunolabelling of type I cells. Both types of antibodies were conjugated with FITC 
for flow cytometry analysis.  Positive immunoreaction was detected as early as day 5 
in cells grown in conditioned medium; 10.8%±1.9 (mean±SD) of the cells were 
positive for proSPC and 2.17%±0.76 for AQP5. At day 7 the proportion of cells 
expressing the markers had increased to 36.7%±1.39 for pro-SPC and 3.86%±1.34  
for AQP5 (Figure 7.3 a).  However, the highest proportion of pro-SPC expressing 
cells was detected at day 10 with a level of 51.1%±4.4 (Figure 7.3 b and c).  The 
AQP5 expression from day 5 to 15 appeared constant lying between 2.17%±0.76 and 
6.88%±1.18 (n=3). 
 
8.4.5 Transmission electron microscopy (TEM) 
 
As detected by TEM, differentiation of the ES cells to airway epithelium 
occurred as early as day 7 cultured in conditioned medium, in the HARV.  TEM 
examination revealed the typical features of type II pneumocytes with abundant 
lamellar bodies and type I cells with microvillus formation. As a control, TEM of ES 
cells cultured at the same 7 days in maintenance medium did not show any significant 
cytoplasmic organelles and apoptotic bodies were observed (Figure 8.4 a). 
 
The most striking and interesting finding was the presence of secretory 
proteins observed on engorged rough endoplasmic reticulum (rER).  Electron-dense 
cytoplasmic organelles that are typical of surfactant component metabolism were seen 
including the rough endoplasmic reticulum (rER), Golgi apparatus, numerous 
mitochondria and lamellar bodies (Figure 8.4 b and c) (Figure 8.5a-d).  Other 
cytoplasmic organelles seen were oval to round electron-dense bodies of lysosomes 
(Figure 8.5a) and electron-dense multivesicular bodies (Figure 8.5 c and d). There 
was also evidence of lipid droplets (Figure 8.5d).  However, no tubular myelin was 
detected.  
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The most important feature observed was the well developed, concentric 
lamellar bodies that were abundant and perhaps represent a form of surfactant 
secretion.  All these observations mimic the in vivo formation of the secretory 
pathway in pneumocytes. Another interesting finding was the observation of 
cytoplasmic lamellar bodies directed towards the surface of the epithelial layer or the 
surface microvilli (Figure 8.4d).  This suggests that the final secretory product is 
segregated as lamellar bodies that are destined to be secreted into the alveolar space 
to become part of the surfactant lining layer.   
 
Apart from the differentiated cells within the beads, some of the aggregates 
were large enough to escape and emerged from the surface of the alginate hydrogel.  
These aggregates were included in the TEM sections and the analysis showed that 
they contained abundant lamellar bodies that filled most of the cytoplasmic space 
(Figure 8.6a-d).  Another interesting feature was the observation of one particular cell 
that was stretched out giving the appearance of an alveolus-like unit (Figure 8.6d).   
 
To summarise the TEM observations, there were 3 zones within the cell 
aggregates grown in the conditioned medium that demonstrated the transformation of 
undifferentiated ES cells into type I and II pneumocytes.  The core zone showed 
undifferentiated cells with apoptotic bodies and other signs of degeneration.  The 
surrounding zone showed evidence of early differentiation consisting mostly of 
mitotic processes.  Lastly, the outer zone contained differentiated type II with 
lamellar bodies and type I pneumocytes with microvillus formation (Figure 8.7a); it 
could be clearly seen that the outer epithelial layer consisted of cells with short and 
long microvilli  (Figure 8.7a-c) with a sub-layer of cuboidal cells with abundant 
lamellar bodies (Figure 8.7 d and e).  
 
8.4.6 Reverse transcriptase-PCR 
 
It was observed that, after more than 10 days culture in both conditioned and 
maintenance medium, it was difficult to dissolve the alginate beads.  This is probably 
due to the secretion of extracellular matrix from the cells within the beads that had 
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covered the outer layer of the alginate.  However, after vigorous shaking in a water 
bath at 37oC, the cells could be recovered from the beads, although the alginate did 
not entirely dissolve.  The RT-PCR results confirmed the expression of endoderm 
(FoxA2 mRNA) as well as RNAs for SPC (marker for type II pneumocytes), AQP5 
(type I pneumocytes) and CCSP (Clara cells) in encapsulated murine ES cells 
cultivated in conditioned medium in the HARV integrated system (Figure 8.8).  These 
findings were observed as early as day 5 of culture.  Interestingly, the highest SPC 
RNA expression was observed at day 10 which corresponded with flow cytometry 
data that showed SPC expression by 51.08% of the cell population (Figure 8.3).    
  
8.4.7 Decapsulation from 3D cultivation 
 
To analyse the functionality of the differentiated cells, encapsulated cells from 
day 10 HARV conditioned medium were decapsulated and cultured as 2D in basic 
medium for up to 100 days. These cells were termed TII cells for ease of 
identification. TEM again confirmed the presence of the typical features of type II 
and type I pneumocytes with abundant lamellar bodies, microvilli and tonofilaments, 
lysosomes and mutivesicular bodies (Figure 8.9a-d).  The alveolar epithelium-like 
cells consisted mostly of spherical to cuboidal cells with surface microvilli and some 
features of tonofilaments characteristic of epithelial cells in vivo. 
 
The de-capsulated single cells (TII) were plated onto T75 flasks to grow as 
monolayers or 2D culture. The TII cell showed a homogeneous flat and cobblestone 
appearance (Figure 7.10a).  After 2 days, the homogeneous cells were confluent and 
ready to be passaged.  These cells were passaged a few times and grown for a period 
of 100 days in F12K medium supplemented with 15% (v/v) FBS (without conditioned 
medium).  Interestingly, the morphology and phenotype of these cells were 
maintained throughout the 100 day period.  The cells were frozen down and defrosted 
again a few times.  On recovery, they showed the same homogeneous morphology 
and phenotype.  These findings were confirmed using immunostaining and RT-PCR.  
Immunostaining showed proSPC expression (Figure 8.10b) and RT-PCR confirmed 
the presence of SPC RNA following a few passages (Figure 8.10c). 
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Flow cytometric analysis was carried out with antibodies to proSPC to 
identify type II pneumocytes and AQP5 for type I pneumocytes, both conjugated with 
FITC.  proSPC expression was detected in 40.09% ±0.14 (mean ±SD) of the cultured 
cells cells and whi;e immunoreactivity for AQP5 was found in 4.41% ±0.41 (Figure 
8.11a and b).    
 
8.4.8 Scanning electron microscopy (SEM) 
 
The monolayer TII cells contained thin cytoplasmic areas, corresponding to 
type I-like pneumocytes, and dome-shaped protrusions with the appearance of type II 
pneumocytes separated by septa believed to be junctional complexes (Figure 8.12a, c). 
The surface of the culture was covered with cells showing a homogeneous, flat and 
elongated morphology that looked like a polygonal network with numerous short 
microvilli (Figure 8.12a-c).  These junctional complexes between single cells 
indicated cell-to-cell interactions.  This observation corresponds with those made on 
TEM analysis that showed tight junctional complexes with desmosomes and 
tonofilaments.  Budding or protrusion from the surface of the lining cells was 
observed and may be evidence of lamellar bodies exocytosis of secreting protein to 
the external surface (Figure 8.12c, d, e).   
 
8.4.9 Lysotracker and FM1-43 
 
To examine functionality, the murine ES cell-derived pneumocytes were 
tested for protein-phospholipid complex or surfactant secretion via exocytosis seen 
under fluorescence microscopy and ultrastructure on TEM.   Intra-cellular lamellar 
bodies were stained with LysoTracker green (LTG) while those that had been 
exocytosed were stained with FM143 with the latter were seen in increased intensity 
after stimulation with ATP and isoproterenol (Figure 8.13a).  This method was used 
by Haller et al., and Mair et al., 1999 to measure the secretion via exocytosis of 
lamellar bodies.  This evidence corresponds with that obtained on TEM analysis that 
showed protrusion of lamellar bodies to the surface of murine ES cell-derived 
pneumocytes (Figure 8.13b-d).  
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8.5 DISCUSSION 
 
In this study, it was demonstrated that murine ES cells cultivated in HARV 
bioreactor with A540-conditioned medium were able to differentiate into a significant 
population of type II cells (approximately 50% of the total differentiating ES cells) 
and this phenotype is maintained for long periods after decapsulation and culture in 
monolayer conditions.  This study also shows the formation of abundant type I and 
type II pneumocytes that secrete surfactant proteins.  This study also showed the 
differentiation of murine ES cells in the HARV bioreactor as early as day 5-7 in 
conditioned medium, as shown by RT-PCR and TEM.  
 
 Previous studies have shown that culture of encapsulated murine ES cells 
under static conditions limits the exchange of nutrients and gas and the elimination of 
waste.  In order to survive, therefore, the cells migrate towards the surface of the bead.  
In a bioreactor environment, stem cell proliferation and differentiation increases in 
comparison with static culture as the mass transfer of important nutrients, such as 
oxygen, and carbon dioxide as a waste product are transported by active diffusion and 
flow.  This mass transport increases the diffusion of molecules and growth factors to 
the encapsulated stem cells and enhanced their differentiation when the beads were 
cultivated in the HARV bioreactor.  Over time, the individual cells in the beads 
became closer together and, at the right speed and rotation of the HARV will 
facilitates the formation of cell aggregation.  These aggregates rapidly increase in size 
and mass, forming tissue-like assemblies, many of which can become up to three 
orders of magnitude larger than those obtained from stationary flask cultures (Low et 
al. 2001). The solid body rotation in the enclosed fluid medium allows cellular 
particles to be suspended continuously by the equalization of gravity induced 
sedimentation against the constant upward forces provided by the rotation of the 
vessel (Nickerson et al., 2004). As they increase in mass, each body or tissue gains a 
more forceful gravitational pull on its structure, increasing shear stress and drag on 
the nascent tissue (Botta et al., 2006). 
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The pluripotency and capability of ES cells has long been established but for 
the differentiation, it is crucial to have significant quantities of differentiated cells as 
well as to maintain these cells phenotypically and homogeneity as progenitor cells. In 
recent years, attempts have been made to derive pneumocytes from both murine and 
human ES cells by administration of a cocktail of growth factors (Ali et al., 2002; 
Rippon et al., 2004; Samadikuchaksaraei et al., 2006; Rippon et al., 2006), co-culture 
with lung mesenchyme (Vranken et al., 2005), genetic selection (Wang et al., 2007) 
and extract-based cell reprogramming (Qin et al., 2005).  All these techniques require 
the use of growth factor administration, transfection and genetic selection, expensive 
cultures conditions and, therefore, still pose difficulties for the large-scale expansion 
of the differentiation of pulmonary epithelium cells.  Furthermore, the differentiated 
cells do not remain long in culture and no report has been made of the functionality 
and phenotypic stability of the derived cells in prolonged culture.  Recently, Wang et 
al., developed a reliable transfection and culture procedure, which facilitates, via 
genetic selection, the differentiation of human ES cells into an essentially pure 
(>99%) population of type II pneumocytes. They were able to demonstrate the pure 
population within 15 days of differentiation. However, it was not reported whether 
the differentiated type II cells survive for more than 2 days in culture in the absence 
of G418.    
 
RT-PCR results confirmed the differentiation of endoderm (Foxa2 RNA) as 
well as showing the expression of RNAs for SPC (marker for type II pneumocytes), 
AQP5 (type I pneumocytes) and Clara cell secretory protein (CC10; Clara cells) in 
encapsulated murine ES cells cultivated in conditioned medium in the integrated 
system. Surfactant-associated proteins, including SP-A, SP-B, SP-C, and SP-D, are 
believed to play important roles in surfactant synthesis, storage, secretion and 
functions (Clark et al., 1995; Weaver and Whitsett. 1991).  CC10 may contribute to 
the anti-inflammatory activities of the respiratory epithelium (Dodge et al., 1993; 
Singh et al., 1984,1988; Bedetti et al., 1987). 
 
These results correspond with those obtained from immunocytochemistry and 
also from flow cytometry that showed the largest proportion 51.1% ±4.44 of SPC 
expressing cells at day 10. SPC-expressing cells were detected as early as day 5, 
when they formed 10.8% ±1.9  of the total cell population. The proportion of cells 
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expressing AQP5 stayed low at between 2.17% ±0.76 and 6.88% ±1.18 from days 5 
to 15.  The trend of Graph 7.1 shows increased SPC expression over time 
corresponded to the RT-PCR results for SPC RNA being the highest at day 10.  
However, between days 10 to 15 conditioned medium the expression decreased.  
However, TEM examination of cells at day 10 conditioned medium showed abundant 
rough endoplasmic reticulum and evidence of lipid formation in the differentiating ES 
cells while in the beads. This observation was the first to be observed in the 
encapsulated ES cells and has not been reveal or detected in the previous studies.  
 
TEM revealed the formation of cyoplasmic organelles that are important for 
secreting proteins and phospholipids.  The abundant electron-dense organelles is 
evidence for the fusion of multivesicular bodies with lamellar bodies, which suggests 
that this event represents the final stage in the delivery of newly synthesized proteins 
to the lamellar bodies (Weaver et al., 2002).  
 
Surfactant phospholipids are synthesized in the endoplasmic reticulum, stored 
in lamellar inclusion bodies, the secretory organelle characteristic of the type II cell 
(Weaver et al., 2002), and finally secreted into the alveolar lumen by the process of 
regulated exocytosis (Mason and Voelker, 1998; Rooney, 1992). The phospholipid 
composition of isolated lamellar bodies is virtually identical to that of surfactant 
obtained by lung lavage (Rooney, 1992), and there is abundant evidence that 
surfactant phospholipids are secreted together with lamellar body contents (Chander 
and Fisher, 1990; Mason and Voelker, 1998; Rooney, 1992; Wright and Dobbs, 1991; 
Weaver et al., 2002; Gobran and Rooney, 2001). The evidence that shows typically 
composed electron-dense cytoplasms organelles of surfactant component metabolism 
such as the endoplasmic reticulum ER, Golgi apparatus, numerous mitochodria, 
multivesicular body, lysosomes and lamellar bodies was given by TEM.  The most 
important features here were the well developed concentric lamellar bodies that 
appear to be abundant.  
 
At this stage of differentiation, it is believed that the ES cells are deciding 
their stem cell fate.  Normally, ES cells growing in vitro will either differentiate 
degenerate or undergo apoptosis.  A homogeneous population of cells decided to 
differentiate into type II and I cells, the rest will either die or begin a programme that 
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will eventually terminate them. However, the observation of ES cells at the 
progressive stages of being undifferentiated to containing mitotic bodies through 
subsequent phases until the formation of adult lung epithelial cells is significant and 
bodes well for the future production of fully functional alveolar epithelial cells for 
tissue engineering applications.  More importantly these cells were shown to be stable 
phenotypically and able to function in vitro as they do in vivo, at least as far as 
exocytosis is concerned. 
 
According to Chevalier and Collet, 1972, the results of an electron 
microscopic autoradiography study using 3[H] leucine established that newly 
synthesized protein in type II cells was sequentially detected in the ER, Golgi and 
multivesicular and lamellar bodies. Another interesting finding in the present study 
was the observation of cytoplasmic lamellar bodies directing towards the surface of 
the epithelial layer or the surface microvilli.  
 
Type II cells are not only responsible for production and secretion of protein, 
but also responsible for the clearance of surfactant from the alveolar surface and 
reutilization for resecretion (Schaller-Bals et al., 2000). Before secretion, surfactant is 
stored in secretory granules called lamellar bodies (Askin et al., 1971; Chander and 
Fisher, 1990).  The exocytosis and endocytosis of surfactant is coupled in type II cells 
(Schaller-Bals et al., 2000). To show that the differentiated cells synthesize and 
secrete surfactant protein is a significant sign of the development and resolution of 
the normal lung epithelial cells in vitro that mimics the in vivo environment.  These 
cells also act as progenitor cells for degeneration and proliferation of new adult cells.   
 
The exocytosis of lamellar body contents proceeds via fusion between the 
limiting membrane of a lamellar body and the plasma membrane (Ryan et al., 1975), 
which lead to formation of an extrusion body at the apical surface of the cell. Once 
these secretory products are released into the alveolar space, the lamellar body is 
transformed into a highly ordered, calcium-dependent, lattice structure called tubular 
myelin, which is believed to be the precursor of the surface-active phospholipid 
monolayer at the air-liquid interface within the alveolus (Kikkawa, 1970).  However, 
in this study the formation of tubular myelin was not observed possibly due to the 
circulating movement and rotation of media in the HARV causing the material to be 
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disrupted.  This evidence suggests that the formation and development of murine ES 
cells into functional, secreting cells and progenitor cells is indeed the process 
enhanced by the infusion rate of the HARV bioreactor. 
 
 
To isolate the differentiated cells from degenerative and apoptotic cells, the 
aggregates were decapsulated and grown in monolayer.  These cells were cultured in 
unconditioned medium and, for up to 100 days in culture, the cells maintained their 
phenotype and homogeneous morphology. The observations from 
immunocytochemistry and RT-PCR analyses demonstrated the stability of SPC 
expression and indicated that these pneumocyte-like cells phenotypically stable in 
vitro.   
 
The process of exocytosis on the monolayer cells has been captured by 
scanning and electron microscopy.  To monitor the exocytose process, the fusion of 
lamellar bodies with the plasma membrane, that has been described by Haller et al., 
1998, was studied.  Lysotracker green accumulated in pre-exocytosis lamellar bodies.  
This is a fluorescent acidotropic probe for labelling and tracing acidic organelles in 
living cells. It has several important features, including high selectivity for acidic 
organelles and effective labelling of living cells at nanomolar concentrations. 
Lamellar bodies differ from lysosomes, but resemble a number of other lysosome-
related organelles, in that they are specialized for storage and secretion rather that 
degradation of their content (Weaver et al., 2002).   
 
LTG is freely permeated to cell membranes and accumulates in acidic 
compartments by a process involving diffusion and trapping by protonation (Haller et 
al., 1986).  Lamellar bodies are secretory granules and have a pH of 6.1 or below 
maintained by an energy-dependant process (Haller et al, 1998).  Accumulation of 
LTG in lamellar bodies yielded bright green fluorescence in unstimulated cells.  
During this time, cells in presence of FM 143 were weakly stained.  FM 143 is non-
fluorescent in aqueous solutions but emits fluorescence upon intercalating with lipids.  
After stimulation resulted in stained vesicles indicating the FM 143 entering the 
lamellar body through the exocytosis fusion pore and thus staining the lamellar body 
content (Haller et al, 1998) 
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The evidence of type I cells differentiation is also an important observation 
along with type II formation.  The epithelial lining is believed to be the major barrier 
to protein movement into or out of the alveolar space (Hasting et al., 1994).  This 
evidence was observed from the TEM study that shows the movement of secreting 
protein towards the space from the extracellular matrix.   
 
8.6 CONCLUSION 
 
In this study, it was possible to differentiate murine ES cells into pneumocyte-like 
cells (type I and II); i) quickly - as early as 5 days; ii) cheaply - without the use of 
growth factors; iii) reproducibly - many passages; iv) with phenotypic stability in 
either 2D or 3D culture; v) in significant quantities - about 51% of the total cell 
population; vi) with retention of function - secretion pattern mimic those in the in vivo 
environment.  This study presents a novel stem cell bio-process that represents an 
advance towards the engineering of a lung bio-device. 
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Figure 8.1 
At day 10, small cell aggregates were visible in beads cultured in either 
maintenance medium (a) or A549-conditioned medium (b). The size of the 
aggregates increased as seen in day 15 maintenance medium (c) and conditioned 
medium (d).  At day 20, the cell aggregates grown in beads in maintenance 
medium were very large with an additional dark or dense spot at the core which 
indicates degeneration or apoptosis (e).  Aggregates in beads cultured in A549-
conditioned medium started to fill the entire bead, becoming crowded and difficult 
to observe (f) (n=5).   
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Figure 8.2 
Haematoxylin and eosin stain of cells in day 20 beads cultured in the A549-
conditioned medium shows huge cell aggregates that were dispersed within the 
beads (a and b).  Immunocytochemistry demonstrated proSPC (FITC; green) 
expression counterstained with phalloidin to show actin (red) for cytoskeleton 
and DAPI for the nuclei (blue) at day 10 conditioned medium in a HARV 
bioreactor (c) (n=3).  
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Figure 8.3 
Flow cytometry detected proSPC-expressing cells, 10.8%±1.9 (mean±SD) of 
the total cell population and AQP5 2.17%±0.76 as early as day 5 of culture in 
conditioned medium. At day 7, the proportion had increasesd to 36.7%±1.39 
for proSPC expression and 3.86%±1.34 for AQP5 expression (a, b, c).  
However, the highest proportion of proSPC-expressing cells was detected at 
day 10 with 51.1%±4.4.  The proportion of cells expressing AQP5 form day 
5 to 15 varied between 2.17%±0.76 and 6.88%±1.18 (n=3). 
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Figure 8.4 
TEM revealed the presence of the typical electron-dense cytoplasmic organelles 
of surfactant metabolism, including rough endoplasmic reticulum ER (rER), 
Golgi apparatus (G), numerous mitochondria (mc) and lamellar bodies (LB) (b 
and c) at day 7 in conditioned medium cultivated in HARV. TEM of ES cells 
cultured in maintenance medium did not show any significant cytoplasmic 
organelles but apoptotic bodies (Ab) were observed (a). Another interesting 
finding of the differentiated cells within the bead was the observation of 
cytoplasmic lamellar bodies directing towards the surface of the epithelial layer or 
the surface microvilli (d) (n=2). 
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Figure 8.5 
Other cytoplasmic organelles observed on TEM of the 7 day old cells cultivated 
in conditioned medium in a HARV, included oval to round electron-dense bodies 
of lysosomes (Ly) (a) and electron-dense multivesicular bodies (mvb) (c and d). 
Lipid droplets (Lp) were also seen (d) (n=2).   
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Figure 8.6 
Aggregates that had escaped and emerged from the surface of the alginate 
hydrogel also demonstrated similar features with more abundant lamellar bodies 
filling most of the cytoplasmic space (a-d) with microvilli (mv), lamellar bodies 
(LB), lysosomes (Ly), multivesicular bodies (mvb), rough endoplasmic 
reticulum (rER) (n=2). 
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Figure 8.7 
Three zones could be distinguished in the cell aggregates that demonstrated the 
transformation of undifferentiated ES cells into type I and II pneumocytes (a).  The 
first zone consisted of undifferentiated cells. The second contained cells with mitotic 
processes (mito). The third zone had an outer epithelial lining that consisted of cells 
with short and long microvilli (mv) (a-c) and the cells beneath it were cuboidal cells 
with abundant lamellar bodies (d and e), lysosomes (Ly) and multivesicular bodies 
(mvb) (n=2). 
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Figure 8.8 
RT-PCR results confirmed the formation of endoderm (FoxA2 mRNA) as well 
demonstrating RNAs for SPC (marker for type II pneumocytes), AQP5 (type I 
pneumocytes) and CCSP (Clara cells) in encapsulated murine ES cells cultivated in 
the HARV integrated system (n=4).  
Key: Foxa2: forkhead transcription factor; SPC: surfactant protein C; AQP5: 
aquaporin 5; CC10: Clara cell; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; 
+ve: adult lung mRNA, -ve: water  
CC10 
 233
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.9 
To analyse the functionality of the differentiated cells, encapsulated cells from 
day 10 conditioned medium cultivated in HARV were decapsulated and 
cultured in 2D. TEM confirmed the typical features of type II pneumocytes 
with abundant lamellar bodies (LB), microvilli (mv) and tonofilaments (tono), 
lysosomes (Ly) and mutivesicular bodies (mvb) (a-d) (n=2).   
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Figure 8.10 
De-capsulated individual cells were plated onto T75 flasks to grow as 
monolayers or 2D cultures. The decapsulated cells showed homogeneous flat 
and cobblestoned shape (a).  Immunostaining showed proSPC expression in the 
monolayer cells (b) and RT PCR confirmed the expression of SPC mRNA 
following 7-8 passages (c) (n=3). 
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Figure 8.11 
Flow cytometry analysis demonstrated that 40.09% ±0.14 (mean ±SD) of the 
cells in 2D culture expressed proSPC (a) and 4.41% ±0.41 expressed AQP5 
(b) (n=3).    
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Figure 8.12 
SEM showed the presence of two different phenotypes in the monolayer cells 
(decapsulated from HARV culture), the flat type I pneumocytess and the dome-
shaped type II pneumocytes (a). The surface of the culture was covered with 
homogeneous, flat cells with elongated morphology that looked like a polygonal 
network with numerous short microvilli (black circle) (a,b). There were also 
junctional complexes (c-green arrow) between individual cells that indicated 
cell-to-cell contacts and interaction.  Budding or protrusion from the surface of 
the lining cells was observed and believed to be the evidence of lamellar body 
exocytosis to the external surface (black and white arrow) (c,d, e) (n=2).   
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Figure 8.13 
Lamellar body exocytosis was observed with LysoTracker (LTG; green) and 
FM1-43 (a).  Fluorescence resulted from accumulation of LTG in pre-exocytotic 
lamellar bodies. FM1-43 stained lamellar content (arrow) after fusion with 
plasma membrane.  This evidence corresponds with that obtained on TEM 
analysis showing protrusion of lamellar bodies (LB) and lipids (Lp) from the cell 
surface (b-d) (n=3).  
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CHAPTER 9 
 
DESIGN OF AN AIRLIFT BIOREACTOR 
 
 
_____________________________________________________________________ 
 
ABSTRACT 
 
An airlift bioreactor, or pneumatic reactor as it is sometimes called, does not 
involve any mechanical stirring for mixing and instead uses the circulation caused by 
the fluid flow and gas sparging to ensure adequate mixing.  This chapter will describe 
the design of an airlift bioreactor as a biomimetic of the lung.  The prototype was 
adapted and designed according to the physiological properties of the alveolar 
epithelial unit particularly those relating to pulmonary epithelial cells as the gas 
exchange unit.  The chapter covers the construction of each part of the prototype 
bioreactor up to the setting-up of the perfusion bioreactor system for the cultivation of 
pulmonary epithelial cells. A preliminary study to test the function of this prototype 
was also performed using the A549 line of lung epithelium-related cells and the 
results compared with those obtained using a well established bioreactor, the rotating 
wall or HARV bioreactor that was used to promote lung epithelial cell differentiation 
from murine embryonic stem cells in the previous chapter.  The preliminary results 
demonstrated that the airlift bioreactor is as good as the HARV in maintaining the 
viability of encapsulated A549 cells until day 12 in cultivation.  This is a promising 
initial finding indicating that the new prototype design could be a suitable bioreactor 
for the growth and cultivation of lung epithelial cells.   
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9.1 INTRODUCTION 
 
 
The gas exchange surface in the lung is a critical component of mammalian 
physiology in that it provides tissue oxygenation while clearing carbon dioxide.  
Efforts in developing an artificial lung have progressed slowly to date compared to an 
artificial liver, kidney or heart and is most likely due to difficulties associated with 
complex engineering and material challenges (Nalayanda et al, 2007).  Most of the 
previous studies of cultured lung epithelial cells only focused on monolayer or bilayer 
culture platforms (Fang et al. 2004; Johnson et al. 2002; Gueven et al. 1996). These 
studies are limited to maintenance of the basic phenotype of alveolar cells in culture 
(Dobbs et al. 1997; Alcorn et al. 1997) and lack simulation of the micromechanical 
forces imposed on the alveolar-capillary interface by air and blood flow during 
respiration (Hall-Stoodley et al. 2006). 
 
Nalayanda (2007) demonstrated the growth profile of two cell types, the 
alveolar epithelial cells and endothelial cells, in a continuous 2D perfusion cell 
culture device.  This was an in vitro model of the alveolar-pulmonary barrier and a 
step towards building a mircofluidic analogue of the lung’s gas exchange interface.  
However, this model does not reflect the physiological microenvironment of 
pulmonary cells.  This study showed that cell culture within three dimensional micro 
channel networks is vastly different from that in two dimensional static culture 
techniques. They also found that cell growth was dependent on medium flow rate.  
This was most likely due to limitations on mass transport at low flow rates which may 
have resulted in cell washout or death (Nalayanda et al. 2007). The parameters used 
in this study are important and should be addressed in any attempt to engineer a lung 
micro device in the future. Experimental modelling of this system would have broad 
applications and widespread efforts to engineer tissues are underway (Colon et al. 
2004; Dobbs et al. 1998; Chen et al. 2005).  More recently, bioprocessing technology 
has offered engineers and biologists the tools necessary to create more in vivo-like 
microenvironments within in vitro culture techniques (Nalayanda et al. 2007). 
 
In tissue engineering, a bioreactor must provide the appropriate environmental 
conditions necessary for component cells to form a functional tissue. Respiration is 
the process by which animals take in oxygen necessary for cellular metabolism and 
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release the carbon dioxide that accumulates in their bodies as results of the 
expenditure of energy.  Oxygen must be continuously supplied to the animal and the 
waste products must be continuously removed for cellular metabolism to function 
properly (Bailey et al., 2000).  Experimental modelling of this system must consider 
the above physiological parameters that would provide broad applications to any lung 
tissue engineering process.  However, to date, all efforts relating to tissue engineering 
of the lung have not addressed the critical interface between successful three 
dimensional-organ growth and provision of the new tissue with an adequate vascular 
and gaseous supply (Nalayanda et al. 2007).  
 
Airlift reactors have been widely used in various microbial fermentations as 
they have the characteristics of relatively low-shear stress, simple mechanical 
structure, low-energy consumption and higher cell mass production (Chao et al., 
1999).  Previously, airlift bioreactors have been used to culture mammalian cells 
(Highfil, 1996) but, as yet, no research has focused on lung cell differentiation.   
 
Airlift bioreactors are classified as pneumatic reactors without any mechanical 
stirring arrangements for mixing. They are divided into two main sections – the riser, 
where the gas is usually injected, and the down comer.  As a result of the different gas 
holdup in the riser and down comer, the bulk density of the fluid in these zones is 
different and liquid circulation is induced (Freita, 1998).  The turbulence caused by 
the fluid flow ensures adequate mixing of the liquid. The draught tube is provided in 
the central section of the reactor. It equally distributes shear stresses throughout the 
reactor and, thus, provides a healthier environment for cell growth. The introduction 
of the fluid (air/liquid) causes upward motion and results in circulatory flow in the 
entire reactor. As sparging from the air bubbles is very damaging to the cells, a draft 
tube is needed to prevent direct contact between the cells and the upcoming air. The 
cells receive oxygen from the sparging air. The air/liquid velocities will be low and 
hence the energy consumption is also low (Martin and Vermette, 2005).   
 
Such a system is difficult to design because of the complexity of flow 
characteristics and their unknown behaviour under different sets of design parameters.  
Of all the parameters, it is believed that the mass transfer coefficient is the most 
 241
important design variable (Ghosh et al., 1993). Airlift bioreactors can be used for 
both free and immobilized cells (Martin and Vermette, 2005).   
 
An airlift bioreactor was used in this study because the system mimics the 
environment of the lung in as far as turbulence flow and pneumatic reactions are 
concerned.  Alginate encapsulation, as described in Chapters 5, 6 and 7, was used to 
provide a 3D scaffold matrix to support cell growth by reducing external factors such 
as shear stress and gas bubbling that may cause direct damage and contact with the 
cells in the bioreactor. This is a novel approach of using an airlift reactor that could 
be used for human and murine ES cell cultivation and differentiation in the future, 
possibly providing an in vitro model for 3-D cell constructs comprising lung 
epithelial cells. 
 
9.1.1 Bioreactor design 
 
Ideally, a tissue engineering bioreactor should enable precise control of 
environmental factors (e.g. pH, oxygen, temperature, nutrient transfer and waste 
removal) at defined levels and also allow for aseptic operation (e.g. sampling and 
feeding) and automated processing steps (Darling and Athanasiou 2003; Portner et al. 
2005). These attributes are pivotal not only for controlled, reproducible investigations 
but also for routine manufacturing of tissues for clinical applications. Among these 
parameters, the diffusion limitations of mass transport have severely curtailed efforts 
to engineer tissues that normally have high levels of vascularity and/or cellularity 
(Freed and Vunjak-Novakovic 2000). In particular, the oxygen level is critical in the 
production of extracellular matrix (ECM) components in the context of cartilage 
engineering despite controversy concerning whether high or low oxygen 
concentration is more beneficial (Malda et al. 2003). It is well-established that 
mechanical forces improve or accelerate tissue regeneration in vitro. Fluid dynamic 
stress, or shear stress, induced by the fluid flowing across the construct surface and 
into the porous space, is believed to be the most important mechanical stimulus in 
activating the mechano-transduction signalling. Consequently, fluid flow-induced 
shear stress is frequently used as a mechanical stimulus (Vance et al. 2005).  
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A number of criteria have been used to establish a blueprint for the design of a 
bioreactor (Nasseri et al., 2003). The criteria may change for various tissue types 
under development, but according to Nasseri et al., in general, a bioreactor must be 
designed to meet the following requirements: 
• control the physiochemical environment 
• facilitate monitoring of cell/tissue quality 
• ensure the culture of tissue samples occurs under sterile conditions 
• establish a substantial level of cellular distribution and attachment to developing 
scaffolds 
• ensure tissues have sufficient nutrient and waste exchange with their 
surroundings (i.e. provide efficient mass transfer to the tissue) 
• expose the developing tissue to mechanical forces such as compression and 
expansion, as well as hydrodynamic forces such as shear stress and pressure 
• maintain a high degree of reproducibility 
• control the flow of media whether it is steady or pulsatile 
• reduce excessive turbulence in the fluid flow 
• provide a low volume capacity 
• make effective use of growth factors and medium components 
• ensure that the materials from which the bioreactor is fabricated are compatible 
with cells/tissues 
• be easy to clean and maintain 
• enable the user to easily fix the seeded scaffold in place 
• ensure the culture of tissue samples under physiological conditions 
• be compact in size to fit in a standard size incubator 
• avoid the accumulation of metabolites 
• establish a uniform distribution of cells on a three-dimensional (3D) scaffold 
 
 
The use of bioreactors evolved in response to the limitations of static cell and 
tissue culture. Static culture, the traditional method of seeding scaffolds (Shinola et 
al., 1998; Niklason et al., 1999; Shinoka et al., 2001), posed many problems such as 
an uneven cell distribution over the construct, cell death attributable to a lack of 
nutrients and oxygen and insufficient extracellular matrix production (Nasseri et al., 
2003). To overcome these limitations, bioreactors were created to seed cells 
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effectively onto polymers (Carrier et al., 1999), to improve subsequent tissue 
formation and to enhance the mechanical strength of the tissue-engineered constructs 
(Niklason et al., 1999; Hoerstrup et al., 2000). 
 
9.2 AIM AND HYPOTHESIS 
 
 The aim of this study is to design a suitable bioreactor system, an airlift 
bioreactor, that is believed to mimics the pulmonary environment and physiology.  
 
The hypothesis is that this custom-made airlift bioreactor is a better, or could be a 
better, device than a current, commercially available bioreactor, the HARV, for the 
cultivation of pulmonary epithelial cells.  
 
 
9.3 MATERIALS AND METHODS 
 
9.3.1 Design of an airlift bioreactor for tissue engineering of the lung 
 
 
9.3.1.1 Model development 
 
 
The design of a bioreactor is a complex task as an understanding of both 
engineering and biological backgrounds are required in order to develop such a 
mechanically controlled environment for the growth of animal and human tissue 
(Nasseri et al., 2003).  The bioreactor should enable the control of environmental 
conditions such as the oxygen tension, pH, temperature and shear stress and allow 
aseptic operation (Portner et al., 2005).  In addition, this bioreactor should allow 
automated processing.  This is essential not only for controlled, reproducible and 
statistically relevant basic studies but also for the future routine manufacturing of 
tissues for clinical application (Martin et al., 2004; Nagel-Heyer et al., 2005). 
 
 The prototype considered in this study assembles in three-phases, the body or 
vessel, the inner loop or the draught tube and the gas sparger (Fig. 9.1).  The major 
advantages of this design include its simplicity and compact size, low cost, reliability 
of operation, semi-automation, perfusion system and the relative ease of production 
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scale up.  Furthermore, the body or the vessels have no moving or complex parts and 
the risk of contamination is low. 
 
In this study, considering all the crucial factors and parameters mentioned 
earlier with the addition of cell type and the end tissue construct, a design was put 
together to produce a constructive prototype for the future development of engineered 
lung tissue constructs. The 3 dimensional designs were reconstructed using software 
called SolidWorks 2005 SP3 ®.   
 
9.3.1.2 Experimental apparatus and procedures 
 
A novel perfusion bioreactor system to cultivate lung epithelial cells was 
designed and set up taking into consideration the reactor parameters with simple 
geometric characteristics. The prototype consisted of 3 major phases: 
 
i. Body  
 
The body, or vessel, was made from polycarbonate material (Metal & Plastic 
Ltd, UK) with the optimum working volume of 75ml (Fig. 9.2).  The lid was made 
from Delrin rod (Metal & Plastic Ltd, UK) and has 3 openings; 2 holes of equal size 
at the right and left sides for probe or sensor insertion and a middle hole that allows 
membrane insertion for gas and pressure release. At the left and right corner of the 
lid, there are 2 small metal nails that act as a lock or seal to the body/vessel.  This 
non-threaded lock is a simple design that tightly seals the lid of the vessel so as to 
maintain aseptic conditions throughout each entire experiment.   
 
The diameter of the upper vessel is 64mm (height 31.6mm from top neck) and 
that of the lower part 30mm. The height of the whole vessel is 135 mm. The upper 
body has a broader interface and a slanting angle or slope of 118º to ease the 
movement of beads down to the down comer area.  At the opposing lower and upper 
corners of the body are located the inlet and outlet openings for inserting plugs for the 
perfusion system. The lower inlet is where the medium is pumped in from a fresh 
medium bottle and the upper outlet is for removal of used medium and is connected 
to the waste bottle. An additional lower opening, 24mm from the inlet opening, is the 
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location for insertion of the sample valve. The sampling port is connected with a 
valve that enables sampling of the beads into a container without having to remove 
the whole vessel and keeps the system under aseptic conditions.  Probes, such as 
those for measuring the dissolved oxygen (Cole Parmer, UK) and pH (Hanna 
Instrument, UK), are located in the lid of the vessel.  At the bottom of the vessel there 
is a narrow opening (16.25mm in diameter, 16.2 in height) for the insertion of the gas 
sparger adapter. 
 
ii. Inner loop 
 
The inner loop, or draught tube, was made from Delrin rod (Metal & Plastic 
Ltd, UK), is located at the centre of the vessel and has a diameter of 16 mm and 
length of 63 mm (Fig. 9.3).  It has three hands or holders that can be screwed into the 
inner wall of the vessel.  The draught tube divides the reactor into two sections.  The 
riser is the section in the middle where the sparge gas from the bottom enters and 
pushes the air/liquid upwards in the airlift with bubbles rising.  As the bubbles rise, 
they carry liquid with them.  Thus, there an upward force is created and must be 
counteracted by a downward force.  As a result, fluid is literally pushed down the 
other section of the reactor, called the down comer. This creates the circulating 
movement of the beads within the vessel.  It also equally distributes shear stresses 
throughout the reactor and provides a healthier environment for cell growth. 
 
iii. Gas sparger 
 
The gas sparger was made from Delrin rod (Metal & Plastic Ltd, UK) and 
consists of the sparger connecter (Fig. 9.4) and inserts.  The sparger connecter has a 
cone shape in the inner side.  The insert contains 44 fine holes, of 1mm diameter, that 
produce small bubbles (Fig. 9.5).  The transport of oxygen into and waste gases out of 
the bioreactor is controlled by diffusion of the gases into and out of bubbles.  The size 
of the bubbles is important as it determines the surface area for oxygen transfer,  e.g., 
small bubbles increase the surface area for oxygen transfer. 
 
The agitation and gassing mixture of environmental air in the incubator, that 
consists of 19% oxygen, 5% CO2 and is at a temperature of 37ºC, is supplied into the 
 246
vessel from the gas sparger. The gas sparger is connected with a silicone tube from an 
electronic pressure controller (VSO-EP, standard configuration, 0-5V control, 0-
100psi; Sensortechnics, GmbH, UK), that is connected from a small air pump (Air 
powered aquarium air pump, 0.17mbar, 2.0 L/min flow rate 230V 50 Hz 2.5W; 
Interpet, Surrey, UK).  Air is filtered using a syringe filter 0.2µm (Millipore, UK) that 
is placed just before the entrance of the sparger connecter and inlet of the air pump 
into the vessel.  Gas flow rates are controlled with an electronic pressure controller 
monitored from the control unit and the gas stream is continuously filtered.  Excess 
gas leaves the vessel through the membrane located in the lid. The introduction of the 
gas from the sparger causes upward motion and results in circulatory movement 
throughout the entire reactor. The turbulence caused by the fluid flow ensures 
adequate mixing of the medium. 
 
9.3.2 Functional testing of the prototype airlift bioreactor 
 
A preliminary study was conducted to test the performance of the customized 
perfusion airlift bioreactor system.  In order to show that microencapsulation 
combined with the use of low shear in the airlift bioreactor provides a suitable 
environment for cultivating pulmonary epithelial cells,.encapsulated A549 cells were 
cultivated  The survival of the cells in this environment was compared with that 
obtained using a commercially available, HARV bioreactor system. 
 
9.3.2.1 A549 cell culture 
 
Human type II pneumocyte tumour cells (A549 line, ATCC: American Type 
Culture Collection, Virginia, USA; # CCL 183; Lieber  et al. Int. J. Cancer 17,62-
70:1976) were defrosted and grown in T75 flasks (Orange Scientific, UK).  The cells 
were fed every 2 days and reached confluency very fast, within 2-3 days.    The 
medium comprised of F12K (Invitrogen, UK) supplemented with 15% fetal bovine 
serum (FBS) (PAA, UK) and 2mM L-glutamine (Invitrogen, UK).   
 
9.3.2.2 Encapsulation of A549 cells  
 
Confluent A549 cells were removed by treatment with trypsin-EDTA 
(Invitrogen, UK) and resuspended by pipetting a few times which resulted in single 
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cells.  Cell counts were performed using trypan blue (Sigma Aldrich, UK) to get 
20,000 cells per bead.  The alginate hydrogel consisted of 1.1% (w/v) low viscosity 
alginic acid (Sigma-Aldrich, UK) and 0.1% (v/v) bovine gelatin (Sigma, UK) (all 
dissolved in PBS, pH 7.4) solution at room temperature, as described in Chapter 3.  
Lastly, the beads were washed three times in PBS. 
 
20,000 A549 cells were encapsulated in each of bead.  The beads of equal size 
(2.5mm in diameter) were then divided into two groups; for cultivation in either the 
airlift perfusion system or the HARV bioreactor. Each group contained about 500 
beads. The cultures maintained for a total of 10 days as a preliminary test and samples 
of beads were harvested every 2 days throughout the cultivation period. Morphology 
was analysed by light microscopy and the viability of the encapsulated cells was 
assessed using the Alamar blue assay.  
 
9.3.2.3 Cultivation in the airlift-perfusion system  
 
All the individual parts of the airlift bioreactor, including the vessel, lid, 
draught tube, sampling tube and silicon tubing, were detached and autoclaved 
together to sterilize the whole system.  Setting up the system was found to be time-
consuming as it was not easy to connect and assemble the parts to the body as great 
care had to be taken not to cause any contamination.  The vessel was placed on its 
stand and the lines were set up according to the appropriate directions and 
circulations.  The peristaltic pump was set up between 14 to 17 rpm.  The minimum 
rotation for the pump is 14 rpm.  These rotations enable the flow of the system to be 
within 50ml over 24 hour.  The gas flow rate was set up between 15 to 17 psi.  These 
flow rates was optimize earlier.  
 
Prior to cultivation of the encapsulated cells in the bioreactor, the whole 
system was primed with PBS for 24 hours followed by the perfusion medium for 
another 24 hours.  The perfusion medium comprised A549 maintenance medium (see 
8.3.2.1) with 0.01% (v/v) Antifoam 204® (Sigma Aldrich) that was added to the 
medium to prevent any foam production by the gas sparger. 
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After the priming process, 500 beads were placed in the vessel by locating the 
whole system in the laminar hood to provide aseptic conditions while transferring the 
beads into the vessels.  This system was then transferred to an incubator at a 
temperature of 37oC with 19% (v/v) oxygen and 5% (v/v) CO2. Samples of about 20 
beads were collected every 2 days until day 12 for monitoring of morphological 
changes and for viability assay.  
 
 
9.3.2.4 Cultivation in the HARV bioreactor 
 
A HARV bioreactor was used as a control for comparison with the 
performance of the airlift system. As described in Chapter 8, 500 beads were 
transferred to the HARV vessels (Synthecon, USA).  The vessels were each filled 
with 50ml of maintenance medium, the same medium used for the perfusion system.  
The rotating speed was maintained as 17 rpm (resolution per minute) and the cells 
were fed every 2-3 days.  Samples of beads were taken every 2 days until day 12, as 
for beads grown in the airlift bioreactor.  
 
 
9.3.2.5 Imaging 
 
Phase contrast images were captured using a IX70 inverted microscope 
(Olympus, Southall, UK) equipped with a colour CoolPix 950 digital camera (Nikon, 
Kingston-upon-Thames, UK) or black and white, high resolution charge coupled 
device (CCD)-Camera (Soft Imaging Systems GmbH, Germany) with analySISB and 
analySISD software; or a BX60 upright (Olympus) microscope equipped with an 
Axiocam (Zeiss).   
 
9.3.2.6 Alamar blue assay 
 
The Alamar blue or, CellTiter-Blue® Cell Viability, Assay (Promega 
Corporation, USA) provides a homogeneous, fluorescent method for monitoring cell 
viability. The reagent was used according to the manufacturer’s protocol and was 
diluted to a final concentration of 1:5 with the maintenance medium.  About 20 beads 
were harvested from the airlift and HARV and using a 25ml pipette (VWr Ltd, UK), 
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each bead was dropped in each of the 96 well plate (VWR Ltd., UK). 100 µl of the 
dilution was added to each well of 96 well plates which contained one bead per well 
and incubated for 2 hours at 37ºC in 5% (v/v) CO2  and 20% (v/v) O2.  For 
measurement of fluorescence, the solution was transferred to a 96 white well plate 
(VWR Ltd., UK) and read using a micro titre plate fluorometer (MFX, Dynex 
Technology, Finland) with the excitation wavelength at 530-570 nm and emission at 
580-620 nm.   
 
9.3.2.7 Statistical analysis 
 
The results were expressed as mean ± SD (standard deviation) and analysed 
using a Student’s unpaired two-tailed T-test, comparing all data pairs.  Analysia was 
done using Sigma Stat for Window version 3.5, Build 3.5.0.54, copyright 2006, 
Systat software, Inc. Statistical significance was considered at P<0.01 and P<0.05. 
(Significantly different compared at P<0.01** and P<0.05*). 
 
 
9.4 RESULTS  
 
9.4.1 Construction of prototype airlift-perfusion system 
 
 
A perfusion system was used in order to provide fresh medium continuously 
and allow waste and toxic by-products to be constantly removed. 
The constructed perfusion system (Figs. 9.6, 9.7) consisted of; 
(i) peristaltic pump, electronic pressure controller and gas sparger controlled 
by a controller unit connected to a PC and operated using the Agilent VEE 
Pro software [version 7.0.6310.0 (1999-2004), Matlab®, The MathWork, 
Inc., Agilent Technologies, UK] that provides continuous reading and 
monitoring of the required flow rate and rotation.  This also allows 
continuous measurements to be recorded. 
(ii) riser and down comer circulation – these circulations are separated using 
the draught tube that is located in the middle of the vessel, consisting of a 
downcomer and riser area 
(iii) gas inlet and outlet/exhaust – gas inlet from the gas sparger and outlet 
through the membranes in the upper lid 
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(iv) sampling valve and port – sampling outlet with a plunger that controls the 
amount and ease of harvesting samples    
(v) probe point or sensors – pH, temperature and dissolved oxygen (DO) 
(vi) fresh medium bottle – fresh medium is pump into the vessel  
(vii) collecting or waste bottle – used medium from the vessel is pumped out 
from the vessel into the bottle 
(viii) silicon lines – tubes made from silicon as the line connecters from one 
inlet to another outlet for the entire system.    
(ix) syringe filters – to maintain sterility of the injected gas into the vessel 
 
Table 9.1 The geometrical dimensions of the bioreactor prototype are listed below: 
Symbol Dimension characteristic Value (mm) 
H Reactor height 135 
HR Height of riser 63 
HD Height of downcomer 116 
AD Area of downcomer 14 
AR Area of riser 16 
DR Riser diameter 16 
DD Downcomer diameter 7 
D Diameter of riser and downcomer 30 
d1 Bottom clearance 9 
d2 Top clearance 49 
 
 The specific geometrical measurement of the prototype (Fig. 9.8, 9.9) was 
made according to these specifications:  
The aspect ratio between downcomer and riser, H/D= 4.5 
Ratio diameter between riser and downcomer, DR/DD = 2.29 
Ratio area between down comer and area of riser, AD/AR= 0.875 
Bottom clearance ratio, d1/DR= 0.563 
Top clearance ratio, d2/DR= 3.0625 
 
The airlift perfusion bioreactor system was placed in an incubator at 37oC 
with 5% (v/v) CO2 and 19% (v/v) oxygen. A peristaltic pump provides an adjustable 
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and slow perfusion flow rate at 50ml/24hour, which can be monitored and adjusted 
continuously or made pulsatile with a frequency of 14 rpm (rate per min).   
 
9.4.2 Functional testing of the prototype airlift-perfusion bioreactor 
 
9.4.2.1 Morphology 
 
Cells grown in the HARV changed from being mainly single cells (Fig. 9.10a) 
at day 4 to forming aggregates as seen at day 10 (Figure 9.10b). The encapsulated 
cells grown in the airlift bioreactor did not show any aggregation at day 6 of 
cultivation (Fig. 9.10c) and only showed a few, small cell aggregates at day 10 (Fig. 
9.10d).  Another important observation showed from the cultivated beads were the 
wall of alginate hydrogel becomes thinner and easily broken into smaller pieces as the 
cultivation proceeds.   
 
9.4.2.2 Cell viability 
 
Viability assay of the cells grown in the HARV bioreactor showed an increase 
in the number of viable cells over the 10 days in cultivation (Fig 9.11).  The cells in 
the airlift bioreactor seemed to show a similar growth trend over the 10 days in 
cultivation but it was more gradual. However, statistical analysis shows significance 
difference at day 4 (P<0.01**), day 6 (P<0.05*) and day 10 (P<0.01**) between the 
HARV and airlift bioreactor (n=2). 
 
9.5 DISCUSSION 
 
 
The essential requirements for selecting a bioreactor for use as a mammalian 
cell culture system are: aseptic operation, mixing without damaging shear-sensitive 
cells, sufficient gas transfer (O2 and CO2), and ease of scale up, process control and 
automation, as well as compatibility with up- and downstream processes (Birch et al., 
1985).  In this study, all of the functions mentioned above were taken into 
consideration before designing the prototype for the perfusion airlift bioreactor with 
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additional semi-automation, continuous monitoring and control by a central computer 
system.   
 
An important feature of an airlift bioreactor is the mass transfer and mixing 
which is generally coupled; the gas flow rate is often set to achieve a specific 
dissolved oxygen concentration.  This gas flow rate will then determine the 
hydrodynamic conditions in the culture.  In general, the hydrodynamic characteristics 
for these reactors are reported in terms of relationships between gas throughput, gas 
hold up and circulation velocity (Varley and Birch, 1999). In this prototype, the 
dissolved oxygen concentration was set up at 19% according to the environment 
concentration. Other variables, such as the liquid velocity, will depend on flow 
conditions and reactor geometry. 
 
Hydrodynamic behaviour will to some extent depend on the configuration of 
the reactor, for example the use of external or internal loop or draught tube.  The 
importance of the ratio of area of down comer to area of riser (AD/AR) in relation to 
mixing times, liquid velocities and mass transfer has been reported (Chisti, 1987; Ade 
Bello et al., 1984; Griffiths, 1988).  In this study, an internal loop was used to make 
the construction of the internal draught tube simple and flexible. The optimum 
configuration for the draught tube is to have the diameter fixed to give AD=AR.  In 
this study, the diameter of AD was 14mm and AR was 16mm giving a ratio of 0.875 
which was within the recommended range (Chisti, 1987; Ade Bello et al., 1984; 
Griffiths, 1988). 
 
For the internal tube, the height of liquid above the draught has also been 
shown to be important (Russell et al., 1994).  Russell and co workers showed that the 
mixing time above the draught tube decreases as the height of the top section 
increases and concluded that there is a two zone flow pattern in the top section of the 
reactor.  In this study, the height of the top reactor was kept small to ensure a long 
mixing time. 
   
Gas sparger position and design have also been taken into consideration.  
Chisti and Moo-Young (1987) described that, for an internal tube reactor, the optimal 
position for the sparger is above the base of the baffle tube.  A recommendation is 
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given that the total cross-sectional area just below the baffle should not exceed 1.65 
times the down comer cross section. In this study, the position of the sparger was 
measured and placed according to this recommendation. 
 
 The design of the gas injection device has focused around the perceived need 
to achieve complete bubble dissolution before the bubbles reach the surface, thereby 
reducing any cell damage as bubbles collapse at the liquid surface (Varley and Birch, 
1999).  Other methods designed to provide gas liquid transfer, for example the gas 
permeable membrane, have been used earlier but there are disadvantages such as the 
difficulty in maintaining them, particularly keeping them clean when in place, and the 
occurrence of diffusion at low air pressure (Moreira, 1995).   
 
 Another important aspect of the reactor design was the choice of aspect ratio.  
Griffiths (1998) claimed that increasing height improves mixing time and mass 
transfer rates and those aspect ratios between 6:1 and 12:1 are normally used.  The 
choice of aspect ratio affects a number of process factors, including mixing time and 
oxygen transfer rate and, hence gas flow rate, liquid height above the baffle, carbon 
dioxide stripping during the process.  However, the effect of the aspect ratio was 
relatively small in this study, being 4.5:1 (H/D).   The ratio used was small because of 
the small vessel design.  This factor needs to be considered in the manufacture of 
future, improved versions of this prototype. 
 
Mass transfer and distribution of gases, nutrients and toxic products is 
important in animal cell cultures, especially for the culture of lung epithelial cells.  
Oxygen requirements will be cell line dependent, typically in the range of 0.05-0.5 
mmol oxygen per litre per hour for 106 human cells/ml (Fleischanker and Sinskey, 
1981).   
 
The gas transfer rate is given by kLa(C* - C), where kLa is the overall mass 
transfer coefficient, C is the concentration of dissolved gas and C* is the saturation 
concentration of the dissolved gas.   
 
For small scale cultures, oxygen transfer through the liquid surface is 
generally adequate.  The usual methods used to introduce gas include gas permeable 
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membranes and direct sparging with enriched air or oxygen (Varley and Birch, 1999), 
as seen in this study. 
 
 Another challenge encountered when running the perfusion and gassing in the 
bioreactor is foam formation.  Proteins which are surface active are believed to be the 
cause of foam formation either in the medium or secreted by the cells.  Even in 
protein-free media, protein secreted by cells may reach 500 mg/L which is sufficient 
to cause foaming (Bliem and Katinger, 1988).  To overcome this Antifoam 204® 
(Sigma Aldrich) was added to the perfusion culture. This antifoam is a mixture of 
organic non–silicone, polypropylene-based polyether dispersions.  The disadvantage 
of using the antifoam is that it affects mass transfer and can cause problems in 
subsequent downstream processing and may cause denaturization of some medium 
components.  Foaming can be reduced by using pure oxygen in place of air, which 
effectively reduces the total gas flow reaching the surface of the reactor.  However, 
this may not be feasible for this current design in which gas injection provides not 
only oxygen but also mixing requirements.  The role of foams in cell damage is not 
yet understood; foams may protect cells from high shear rates associated with bubble 
bursting, but the cells may be damaged on prolonged adsorption to the gas liquid 
interface in the foam.  Foaming will be affected by changes in gas flow rate, bubble 
size distribution, area of liquid surface/volume of liquid ratio, bubble residence times 
and liquid velocity or turbulence at the surface (Varley and Birch, 1999). In this 
study, cell damage caused by the mechanical stress was very unlikely and was 
observed in this study as the cells were protected by encapsulation in alginate 
hydrogel.  However, all these factors are still important and must be taken into 
consideration during the scaling-up process for the next design. 
 
To test the functionality of the bioreactor, proliferation of cells is the first step in 
establishing a tissue culture technique (Portnet et al., 2005). As a comparison, cells 
were cultivated in the prototype airlift bioreactor in parallel with an established 
bioreactor, the HARV system.  The numbers of the cultivated encapsulated cells that 
were viable in the airlift and HARV bioreactors showed similar increases.  The 
significance different at day 4, 6 and 10 between the airlift and HARV bioreactor 
system shows that the airlift is not as good as the HARV bioreactor although it gives 
constant increment of cell viability over the 10 days cultivation. However, it must be 
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taken into account that the HARV bioreactor is not the best comparison for the 
prototype airlift system.  The HARV bioreactor is well established and the function 
and importance of this system in tissue engineering was discussed previously 
(Chapter 8).  In this study, the HARV was used as a comparison due to its simple 
design and process. In addition, it is used routinely as a core bioreactor system in the 
laboratory where the studies were carried out to cultivate ES cells into specific cell 
type, the pulmonary epithelial cells, as demonstrated in the Chapter 8.  However, a 
better comparison would have been made with a commercially available airlift 
bioreactor.  This would have provided stronger evidence that the custom-designed 
prototype is indeed the optimal system for the cultivation of lung epithelial cells but 
currently there is no airlift bioreactor available with similar usage or size; the 
prototype designed in this study is the first of its kind.  From the preliminary results, 
it seems that this device can function perfectly together with the perfusion system and 
it can be concluded that this system is at least as good as the HARV bioreactor and 
probably could be made better if more efforts are made to optimize it and construct 
the next, improved prototype.   
 
Morphological observation showed that the wall of alginate hydrogel bead 
becomes thinner and easily broken into smaller pieces as the cultivation proceeds.  
This fragility is probably due to direct contact of the beads with the sparger bubbles 
that causes significant shear sensitivity.  The damage is probably due to direct 
interaction and collisions between the microcarriers and turbulent flow.  If cell 
suspension were used in this study, the possibility of having cell damage caused by 
bubbles is very high. A study done by Handa-Corringan et al. (1988) on the 
mechanism of cell damage by bubbles, looking at the effect of gas-liquid interfaces 
on the growth of cells, proposed mechanisms for the interaction of cells and 
disengaging bubbles.  They suggested that when culture medium is supplemented 
with antifoam, cell damage is a result of oscillatory disturbances caused by rapidly 
bursting bubbles.  In culture medium without antifoam, cell damage is due to a 
physical shearing effect in the draining liquid films around the bubbles and is due to 
the actual physical loss of cells in the foam.  The study also suggested that 
supplementing the medium with Pluronic F-68 allows a stable foam to be formed into 
which the cells do not penetrate and, thus, are protected against damaging effects of 
bursting bubbles and film drainage.  Previous research has indicated that bubble 
 256
generation and bursting has major effects on cell death or damage (Kioukia et al., 
1992; Cherry, 1993; Jobses et al., 1991).  Kunas and Papoutakis (1990) proposed that, 
for a particular hybridoma cell line, damage at high speeds (more than 700 rpm) was 
a result of microscale turbulent eddies, whilst at lower speeds gas entrainment and 
break up were the major factors.   
 
Handa-Corrigan et al. (1989) and Handa-Corrigan (1990) considered 
oxygenation and cell damage and recommended a few factors to minimize cell 
damage.  Firstly, to sparge with small, micron-sized bubbles so that stable foams are 
formed and to formulate media containing surface active components which result in 
stable foams.  However, the use of micron-sized bubbles must be considered as large 
bubbles and higher flow rates may be needed to overcome another issue that of 
removing dissolved carbon dioxide (Varley and Birch, 1999).  By using an 
encapsulation technique, cell damage can be prevented and results in increased 
viability over cultivation period, as seen in this study.   
 
9.6 CONCLUSION 
 
Previous studies have shown that integrated bioreactor system incorporating a 
HARV can be used successfully for the cultivation and differentiation of murine ES 
cells into lung epithelial cells.  In this study, a prototype of an airlift bioreactor has 
been designed with the aim of supporting the growth and differentiation of ES cells 
into lung epithelial cells in an environment that mimics the in vivo milieu.  This 
perfusion airlift bioreactor is easy to use although it was difficult to design because of 
the complexity of flow characteristics.   
 
Although the performance of airlift bioreactors depends on the geometric 
construction, internal design, operation modes and the gas sparger, the type of cell 
culture for the cultivation system is also a major factor. Obviously, there will be 
differences in the metabolic function from cell to cell especially when using ES cells 
that differentiate into various cell types.  However, the preliminary results in this 
study reveal that this perfusion airlift prototype is able to support the growth of a line 
of lung epithelial cells.  These results seem to be promising for a novel bioreactor 
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design to scale-up the differentiation process as well as to restore the function of the 
developing lung tissue. 
 
For the future, in order to scale up cell production, there are a number of 
issues that need to be considered, including mixing, mass transfer, shear and pressure 
effects that have been discussed earlier.  Although all these factors have been taken 
into consideration before producing the current prototype, the system will still need to 
be optimized and adjusted.  
 
 
 
 
 
 
 
 
Figure 9.1. 
The complete prototype of the airlift bioreactor, design from SolidWorks 2005 
SP3 ®.   
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Figure 9.2 
The body or the vessel of the airlift reactor with specific measurements (in 
millimetres). 
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Figure 9.3 
Figure showing the inner loop, or draught tube, with specific measurements (in 
millimetres). 
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Figure 9.4 
Figure showing the gas sparger connector located at the bottom of the vessel or body 
with specific measurements (in millimetres). 
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Figure 9.5 
Figure showing the perforated gas sparger insert located in the connecter with 
specific measurements (in millimetres). 
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Figure 9.6 
Schematic representation of the perfusion airlift bioreactor  
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Figure 9.7 
The complete set-up of the perfusion system located in an incubator at a 
temperature of 37oC in 5% (v/v) CO2 and 19% (v/v) oxygen. 
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Figure 9.8 
Geometrical dimensions of the airlift bioreactor 
H- Reactor height 
HR- Height of riser 
HD- Height of down comer 
AD- Area of down comer 
AR- Area of riser 
DR- Riser diameter 
DD- Downcomer diameter 
D- Diameter of riser and down comer 
d1- Bottom clearance 
d2- Top clearance 
 
The aspect ratio between downcomer and riser, H/D= 4.5 
Ratio diameter between riser and downcomer, DR/DD = 2.29 
Ratio area between down comer and area of riser, AD/AR= 0.875 
Bottom clearance ratio, d1/DR= 0.563 
Top clearance ratio, d2/DR= 3.0625 
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Figure 9.9 
Figure showing the full measurements (in millimetres) of the vessel with the 
lid, draft tube and gas sparger connected. 
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Figure 9.10 
Encapsulated A549 cells cultivated at day 4 in the HARV (a) and airlift 
bioreactor (b) were predominantly separate.  At day 10, most of the cells 
grown in the HARV had aggregated (c) but those in the airlift bioreactor 
still remained mainly separate (d) (n=2).   
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Figure 9.11 
The results of the viability assay showed an increment over time in the 
numbers of live A549 cells cultivated in the HARV bioreactor.   A 
similar overall increase in cell numbers was obtained with the airlift 
bioreactor (AL) but a more linear rise occurred.  Statistical analysis 
showed significance differences at day 4 (P<0.01**), day 6 (P<0.05*) 
and day 10 (P<0.01**) between the results obtained with the HARV 
and airlift (AL) bioreactors (n=2).  
** 
** 
* 
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CHAPTER 10 
 
CONCLUDING REMARKS AND FUTURE WORK 
__________________________________ 
 
10.1 CONCLUDING REMARKS 
 
In this thesis, the general aim of the series of studies was to achieve efficient 
and reproducible maintenance and differentiation of embryonic stem cells, in 2D and 
3D, to airway epithelium by developing appropriate bioprocessing technology.  The 
specific aims of the study were achieved and, thereby, evidence in support of the 
related hypotheses obtained, as described in the following: 
 
Phase 1: 2D embryonic stem cell differentiation 
1. To enhance the differentiation of murine and human ES cells into 
pulmonary epithelial cells using an approach that is designed to facilitate 
scale up of the process 
Protocols were developed based on a 2D culture system using A549-
conditioned medium to direct the differentiation process.  Both murine and human ES 
cells were shown to differentiate into type I and type II pneumocytes, characterized 
by immunocytochemistry, ultrastructure and RT-PCR assessment of gene expression.  
The proportion of cells expressing SPC, a specific marker for type II pneumocytes, 
was found on flow cytometry to average 32%, a figure considerably higher than the 
5-10% obtained using previously established protocols.  Proteomic analysis will 
identify the main protein in the conditioned medium that upregulate the 
differentiation process. 
 269
 
The work presented in this study provides evidence that both murine and 
human ES cells could be encouraged to differentiate into type II pneumocyte-like 
cells using A549-conditioned medium.  Murine ES cells were used mostly rather than 
human ES cells because of growth rate of the murine ES cell line used was much 
faster than that of the human ES cell lines available for study.  The murine ES cells 
were also a feeder-free line and these two factors simplified culture and allowed a 
wider range of variables to be examined than would have been possible with human 
ES cells within the time course of the study.  
 
Phase 2: 3D system for the maintenance and differentiation of ES cells 
2. To maintain the undifferentiated state and pluripotency of human ES 
cells in a feeder-free system without passaging or embryoid body 
formation during prolonged culture. 
 A new method was established for maintaining human ES cells free from 
animal contamination in an undifferentiated state without passaging or embryoid 
body formation.  These tightly formed aggegates, formed within alginate beads, 
survived for over 260 days and remained pluripotent without any mechanical 
expansion or manipulation. This observation was the first demonstration of prolonged 
maintenance of human ES cells in the undifferentiated state in 3D culture. 
 
One of the key findings made was that human ES cells could be differentiated 
to pulmonary epithelium without embryoid body (EB) formation.  Based on the stem 
cell phenotype and cell differentiation capacity of human ES cells, their potential 
applications in human basic developmental biology and regenerative medicine are 
obvious (Semb, 2005).  In the present study, the human embryonic cell aggregates 
described were better than EB formation in maintaining ES cell pluripotency and also 
in promoting differentiation to a specific cell type.  In addition, as the ES cell 
aggregates do not allow the formation of all 3 germ layers, as is seen in EBs, this will 
facilitate the study of the roles of particular growth factors in promoting 
differentiation to specific cell phenotypes and will eliminate the use of inhibitory 
factors that suppress derivation of one or two of the cell lineages.  Understanding the 
activity and regulation of these ES cells in aggregates that lead to the maintenance of 
their pluripotent epigenotype is a challenge for future studies by finding the 
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responsible genes that up- or down-regulate the undifferentiated state in the 3D 
culture.   
 
In parallel, these ES cell aggregates were further cultured in A549-
conditioned medium and commercially available medium to promote differentiation.  
The results showed that these aggregates were able to differentiate into a specific cell 
type and in this study pneumocyte type II, without the formation of the germ layers. 
Adopting a corresponding simplified culture system that regulates self-renewal and 
cell lineage determination provide a means to study the capacity of the cells to 
differentiate into specific cell types in static culture or in a bioreactor.  However, it is 
essential to study the response and functional capacity of the differentiated cells in 
vivo so as to enable us to use these techniques efficiently.   
 
Phase 3: 3D integrated stem cells bioprocessing 
3.  To develop an efficient single step culture system to produce pulmonary 
epithelial cells in an established bioreactor system 
4. To design and develop a novel bioreactor system that mimics the 
pulmonary environment. 
The 2D approach in this study, using A549-conditioned medium to drive 
differentiation to the pulmonary epithelial phenotype, gave higher yields of target 
cells than obtained with with the previous approaches used by colleagues, including 
cultivation in a commercial medium (Small Airway Growth Medium: SAGM), 
medium supplemented with growth factors, co culture with lung mesenchymal cells 
and cell extract-based in vitro reprogramming.  Following culture in a 2D system, a 
3D differentiation approach was developed in this study, which included culturing 
encapsulated murine ES cells with A549-conditioned medium, as well as co-culture 
with cells of the A549 line. This 3D static culture system was further developed to 
create a 3D integrated stem cell bioprocessing system in a bioreactor aimed towards 
the eventual engineering of functional lung epithelial cells. Cultivation of murine ES 
cells in this way resulted in 51% of the final cell population being type II 
pneumocyte-like cells that maintained their phenotype during subsequent passages. 
Furthermore, TEM revealed that pneumocyte differentiation occurred as early as day 
7. In short, this study represents the first attempt to use a bioreactor to enhance the 
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differentiation of murine ES cells to pulmonary epithelial cells and the resulting new 
method is both more efficient and quicker than previously published protocols.   
   
In vivo, lung cells are in direct contact with environmental gases and particles 
and are subjected to varying air and fluid pressure levels.  The requirement for an 
extensive, hydrated surface for gas exchange presents a most interesting 
bioengineering challenge, since surface tension at air–liquid interfaces creates 
collapsing forces that prevent respiration. To bioengineer a functional lung, an 
integrated system is essential that combines stem cell technologies with materials and 
a combination of growth factors that will enhance and scale-up the formation and the 
differentiation process.  To design and produce a complex bioreactor system, such as 
the airlift bioreactor, is a major success in this study.  To compare this system with 
another established bioreactor system and be able to prove that the cultivation system 
is as good is another achievement in the field of stem cell bioprocessing. 
 
 As a closing remark, this series of studies has shown novel findings for the 
engineering of lung epithelial cells.  All the initial objectives have been achieved and 
hypotheses that have been discussed in the first chapter tested. It was shown that 
human ES cells are able to maintain their pluripotency for up to 260 days in culture 
and that murine and human ES cells can differentiate into type I and type II 
pneumocytes in 2D and 3D culture conditions.  Evidence is provided that these 
processes can be scaled-up and yields of differentiated pneumocytes of up to 50% can 
be obtained using the HARV bioreactor.  Lastly, an airlift bioreactor and perfusion 
system have been designed and built and the preliminary results are very promising 
for the cultivation of lung epithelial cells. 
 
 
10.2 FUTURE WORK  
 
 
 Although the initial aims of this study have been achieved, there are still many 
challenges to overcome in the field of stem cell bioprocessing for the lung.  Many 
questions remain and, had there been more time, further studies would have been 
carried out following up on the promising results, in particular in order to move the 
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research nearer to clinical application that would be of great benefit to the field of 
medicine and tissue engineering.  The following summarises the key areas that need 
further investigation. 
 
 Chapter 4 focused on the differentiation of human and murine ES cells into 
lung epithelial cells using A549-conditioned medium.  Type II pneumocyte 
differentiation was demonstrated qualitatively using RT-PCR, TEM and 
immunohistochemistry but quantitative data from flow cytometry would be essential 
to confirm the yield of differentiated cells.  However, due to problems encountered in 
the growth of human ES cells, particularly the slow growth, it was not possible to 
carry out such an analysis. The proteins and cytokines secreted from A549 cell line 
were assumed to be the promoter/s that enhanced the observed differentiation process.  
Proteomics analysis could make it possible to pinpoint the exact factors that are 
upregulating differentiation to lung epithelium and, by modifying their concentrations, 
to enhance the effect further. 
 
In Chapter 5, a novel protocol for maintaining human ES cells pluripotency 
and their undifferentiated state for up to 260 days was presented.  However, 
insufficient data were obtained to allow any further significant conclusions to be 
drawn.  Questions that still need to be answered included how many viable cells 
remained within each bead.  It is challenging and difficult to work with human ES 
cells as they grow very slowly in the beginning and form very packed colonies that 
are not easily dispersed into single cells.  Thus, it is not easy to standardize the 
numbers of cells from day 0 until full differentiation is observed.  Quantitative data 
from flow cytometry is essential to quantify the numbers of cells expressing the 
corresponding proteins.  Another important point is to find the signalling pathway and 
the factors involved in the regulation of the cell-to-cell signalling in 3D that cause the 
ES cells to remain pluripotent within the beads.  To find the factors that regulate these 
genes will be another breakthrough in the field of ES cell pluripotency.  
 
Most of the previous reports of stem cell differentiation to pulmonary 
epithelium have used murine ES cells as the main cell source for differentiation.  In 
the current work, pneumocyte differentiation from encapsulated murine ES cells was 
achieved in static 2D culture, co-culture, 3D culture and in 3D culture within a novel 
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airlift bioreactor.  Obviously, the procedures need to be carried out using human ES 
cells so as to determine their possible relevance for clinical applications.  However, as 
the murine ES cell line used grew more quickly than the human ES cells and did not 
require a feeder layer, results could be obtained much more rapidly (as discussed in 
10.1).  Colleagues have previously established protocols for murine ES cells (Ali et al. 
2002) and then gone on to show that the same procedure, with very little modification, 
is equally successful with human ES cells (Samadikuchaksaraei et al. 2006), so this 
approach was used in the current studies. A further consideration is that, in the 
present work, the WiCell H1 line of human ES cells was used but additional research 
needs to be done using other human ES cell lines to confirm the reproducibility of the 
procedures.  Also, other stem cell sources, such as umbilical cord blood and bone 
marrow, should be tried, as they provide the possibility of autologous cell therapies, 
and the use of stem cells isolated from human amniotic fluid for lung differentiation 
is also promising.  For the latter, multipotent amniotic fluid cells were injected via the 
tail vein into mice with injured lungs and the cells were localized to the injured tissue 
where they had differentiated into pulmonary lineages (Carraro et al., 2008).   
 
The latest breakthrough in stem cell technology is the use of IPS (induced 
pluripotent stem) cells.  Recently, two groups headed by James Thompson and Shinya 
Yamanaka described a new method to reprogramme adult human cells to a 
pluripotent state (Takahashi and Yamanaka, 2006).  These cells are genetically 
modified by the integration of up to four DNA transcription factors into the adult cell 
genome and are reported to have the same properties and potential as ES cells.  IPS, 
therefore, might also be a source of pulmonary epithelium if differentiated using the 
methods developed in the current study.  
 
The integrated bioreactor system devised in this study gave promising results, 
as has been discussed in detail in Chapter 8.  This study demonstrated a yield from 
murine ES cells of type II pneumocytes that made up around 51% of the total final 
cell population.  However, it is likely that the other half contained a mixed population 
of early or immature and actively proliferating endoderm- and lung-committed cells 
together with undifferentiated, degenerative and apoptotic cells.  No differentiation 
towards other specific lineages was observed. To quantify and qualify these cell 
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populations is essential as a pure population of type II pneumocytes is needed in order 
to get an efficient scalable and controllable stem cell bioprocessing system 
 
A prototype airlift perfusion bioreactor prototype was established in this study. 
However, this first generation prototype still needs a lot of improvement and 
optimization for the cultivation of ES cells. However, there was not time to complete 
of this part of studies. 
 
Bioprocessing and commercialization of stem cell/tissue engineered products 
in regenerative medicine can translate breakthroughs from the bench to the bedside. 
Though many of these tasks can not be readily addressed and may require long-term 
commitment, some of the current challenges must remain the primary focus of this 
area of research and development. Process characterization and optimization is the 
key for any bioprocess start-up operation. Standardized operating procedures and 
know-how must be made possible for a process to be translated into a manufacturing 
operation. Improvements in the currently available process monitoring systems for 
bioreactors should be made for nutrients and metabolites, so that these key culture 
parameters can be monitored continuously and in real-time for good process control. 
Future challenges in bioprocessing and manufacturing will include advanced and 
sophisticated monitoring platforms that allow monitoring at the cellular level. 
Completely integrated, modular, automated, and controlled systems in a fully 
enclosed bioprocess operation from harvest to delivery will need to be considered.  
 
For the future production of engineered lung tissue for regenerative 
applications, a few suggestions can be made based on the results of this study; 
i) the use of a suitable cell source that has the high potential use for future 
transplantation, for example the use of stem cells;  
ii) selection of a suitable 3D scaffold or matrix that is biocompatible and 
biodegradable and suitable for the growth of lung cells;  
iii)  establishing the best combination of culture conditions and growth promoters 
that enhance the differentiation of ES cells ad mimics the pulmonary 
microenvironment to produce 3D engineered lung;  
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iv)  availability of a bioprocessing device, such as a bioreactor, that is amenable to 
scale-up and increases the efficiency of cell differentiation and proliferation that 
promote the 3D production of lung tissue.   
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APPENDICES 
 
APPENDIX 1 
Standard curve from Alamar blue assay 
 
A standard curve was generated by measuring the ability of living cells to 
convert a redox dye (resazurin) into a fluorescent end product (resorufin). Nonviable 
cells rapidly lose metabolic capacity and thus do not generate a fluorescent signal. 
Viable cells retain the ability to reduce resazurin into resorufin, which is highly 
fluorescent. The level of endogenous mitochondria dehydrogenase of murine ES cells 
was measured after 4 hours of seeding in accordance with serial cell seeding density 
using the Alamar blue or The CellTiter-Blue® Cell Viability Assay (Promega 
Corporation, USA) that provides a homogeneous, fluorescent method for monitoring 
cell viability according to previously described protocol in section 3. A standard 
curve was generated using the amount of total metabolic activity produced from the 
same cultured cells proportional to the number of viable cells.  For the final data 
analysis, the fluorescence value were normalised to the standard value of metabolic 
activity determined by the Alamar blue assay. 
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APPENDIX 2 
Bioprofiler analyis 
 
To measure the growth kinetics of the differentiated murine ES cells in HARV, 
media samples of 1.5 mL were taken at specific intervals during the duration of 
cultures. Na+, K+, Ca2+, NH4+, glucose, glutamate, lactate concentrations, PO2 and pH 
were measured using a BioProfile Analyser 200 (Nova Biomedical, USA). 
 
Appendix 2a 
 
The different concentrations of glucose in murine ES cells cultivated in 
maintenance medium and A549-conditioned medium in accordance with the culture 
time during differentiation in HARV bioreactor. 
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Appendix 2b 
 
The different concentrations of ammonia and pH changes in murine ES cells 
cultivated in maintenance medium and A549-conditioned medium in accordance with 
the culture time during differentiation in HARV bioreactor. 
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Appendix 2c 
The different concentrations of CO2, O2, Natrium, Kalium, glutamate, lactate, 
glucose, glutamine and ammonia in murine ES cells cultivated in A549-conditioned 
medium in accordance with the culture time during differentiation in HARV 
bioreactor. 
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APPENDIX 3 
The perfusion airlift bioreactor prototype 
 
Peristaltic pump, electronic pressure controller and gas sparger controlled by a 
controller unit connected to a PC and operated using the Agilent VEE Pro software 
[version 7.0.6310.0 (1999-2004), Matlab®, The MathWork, Inc., Agilent 
Technologies, UK] that provides continuous reading and monitoring of the required 
flow rate and rotation.  This also allows continuous measurements to be recorded. 
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Appendix 3a 
Figure shows the prototype of the plunger and sampling body port with 
specific measurements (in millimetres). 
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Appendix 3b 
 
Figure shows the prototype of the fitting connector and platform holder with 
the specific measurements (in millimetres). 
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Appendix 3c 
 
Figure shows the prototype of the bioreactor lid or cover with the specific 
measurements (in millimetres). 
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